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Abstract
The semi-dominant mutation Danforth's short-tail (Sd), arose spontaneously
in the 1940's and affects the posterior development of the mouse during
embryogenesis. In homozygotes (SdSd), the mutation is characterised by
severe malformation of the posterior vertebral column and the urogenital
organs. The notochord in these mice disintegrates from day 10 of
development, resulting in the aberrant expression of genes which determine
dorso-ventral patterning in the sclerotome and neural tube. In addition to
neural tube defects, homozygotes characteristically have bilateral renal
agenesis resulting in death soon after birth. The development of other
posterior organs such as the external genitalia, bladder and hindgut are also
affected by the mutation. Heterozygotes have a highly variable phenotype,
where tail length can vary independently of the severity of the kidney
phenotype, and where unilateral renal agenesis, or the reduction in size of
one or both kidneys, is commonly seen.
The principle aim of this project was to finely map the proximal region of
mouse chromosome 2, in order to identify markers genetically linked to the
Sd gene. To this end, an interspecific backcross in which Sd was
segregating was established, and the backcross progeny haplotyped using a
panel of simple sequence repeat markers. Potential candidate genes, such
as Pax8 and vimentin, were excluded by backcross mapping and markers
flanking Sd were identified and utilised in the screening of YAC libraries.
YACs isolated with these markers were used to generate a YAC contig in
the region of Sd.
Since tail length in the backcross varies considerably, the backcross was
used to identify regions of the genome affecting the expressivity of Sd. In a
collaboration with B. Taylor at the Jackson Laboratory, and with P. Keightly
at the University of Edinburgh, several regions of the genome have been
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found which show association with more or less severely affected tails. QTL
analysis has been applied to these data to confirm the presence of modifiers
acting on the Sd mutation at these loci.
Using an in vitro organ culture assay, the development of embryonic kidney
rudiments from Sd mice has been studied. Utilising fluorescent-tagged
antibodies against laminin and calbindin, laser-scanning confocal microscopy
was used to make a detailed analysis of the development of Sd kidneys in
vitro. From this work we conclude that mutant ureteric buds are able to
induce the metanephric mesenchyme to condense and undergo
epithelialisation but are unable to branch, possibly because they lack the
receptor to transduce the mesenchymal-derived signal, the signal itself is
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This chapter serves as an introduction to the use of the mouse in genetics
and to the Danforth short-tail mutation. At the beginning of each results
chapter, detailed introductions are given to the areas of research relevant to
the techniques used and the data presented.
1.1 The role of the mouse in genetics
The mouse is a vital model organism for the Human Genome Project and a
substantial emphasis has been placed on the genetic and physical mapping
of the mouse genome world-wide (Brown, 1992). Historically, the mouse has
been the mammal of choice for genetic analysis for a number of reasons:
because of its short gestation period and large litter sizes, the availability of
inbred and wild-derived strains, and because of the ability to perform
controlled matings in the mouse (Avner et ai, 1988; Copeland et at., 1993).
In addition to these inherent advantages, the comparison of mouse and
human genetic maps reveals large number of chromosomal regions where
both gene order and genetic content are conserved between the two
genomes (Copeland et at., 1993). These conserved linkage groups enable
the identification of mouse mutations which may be homologous to human
genetic disorders. In this way, mouse mutations provide powerful models for
many human genetic diseases, including reproductive disorders (Koopman
et a/., 1991; Pivnik et at., 1991), cancers (Moser et at., 1990), and polygenic
disorders such as diabetes (Todd et a/., 1991) and epilepsy (Rise et a!.,
1991).
In recent years, the advances made in the field of transgenic and embryonic
stem ceil technology have made it possible to generate new loss-of-function
and gain-of-function mouse mutations, through recombinant DNA techniques
such as gene targeting, as well as to express ectopically biologically diverse
genes in a tissue specific manner (Capecchi 1989; Joyner, 1991). This
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makes the mouse a highly manipulable organism to use in the identification
of new genes and in the analysis of gene function. Information generated in
this way can also be used in the analysis of human homologues.
Mouse mutations, whether spontaneously arisen, induced in radiation or
chemical mutagenesis programmes, or created by recombinant DNA
technology, provide a vital means of access to the mouse genome and offer
insights into the biological function of genes in the absence of their identity.
The advances made in mouse genetic mapping, such as the provision of
high resolution interspecific backcrosses (The European Backcross
Collaborative Group, 1994) and polymorphic DNA markers (Dietrich et at.,
1994) to the mapping community, have greatly facilitated the cloning and
identification of genes responsible for mutant phenotypes. Recently it has
become possible to introduce yeast artificial chromosomes into the mouse
germ line (Schedl et at., 1993), generating substantial potential for genome
analysis and for the development of new mouse models of human disease.
These technological advances, along with the inherent advantageous
properties of the mouse, make this organism an ideal experimental animal to
use in the analysis of both the mouse and human genomes.
The Danforth short-tail mouse mutation was investigated in this project in
order to identify the gene responsible for the mutation. Identification of this
gene may provide new information as to the developmental processes
required for the correct morphogenesis of the neural tube and kidney.
1.2 Danforth's short tail (Sd) mutation
Danforth's short-tail mutation was first identified by Professor C. H. Danforth,
among the descendants of his posterior duplication stock, a strain of mice in
which 20% of the offspring exhibit duplications of the pelvic region, urogenital
system and hind limbs (Danforth, 1930; Dunn et al., 1940). The mutant mice
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which arose from this strain did not exhibit the posterior duplication
phenotype but were found to have a novel mutation which segregated as a
semi-dominant, and which affected the development of the spine, tail and
urogenital system. This mutation was given the symbol Sd (for short-
Danforth) (Dunn eta!., 1940).
1.2.1 Phenotype of Danforth's short-tail mouse
Heterozygous phenotype
From the earliest analysis, the phenotype of Sd heterozygotes was found to
be highly variable and dependent on genetic background (Dunn et al., 1940;
Glueckson-Schoenheimer, 1943; Dunn and Glueckson-Schoenheimer, 1945;
Gruneberg, 1953).
In heterozygous neonates, skeletal defects are found concentrated in the
posterior region of the spine, with the caudal and sacral vertebrae frequently
fused together or malformed. In severely affected mice, the lower lumbar
vertebrae can also be affected (Glueckson-Schoenheimer, 1943; Gruneberg,
1953). One study found vertebral components, such as vertebral bodies and
intervertebral discs, to be absent in 14% of the heterozygous mice
examined, with the affected vertebrae concentrated in the sacral part of the
spinal column (Dietrich et al., 1993a). In Sd+ mice, the bodies of all
vertebrae are reported to be reduced in the dorso-ventral direction, with this
reduction most marked in the cervical and first few thoracic vertebrae
(Gruneberg, 1953), indicating that although the posterior half of the vertebral
column is the region most severely affected by this mutation, the anterior
vertebral column does not remain unaltered in the presence of Sd. An early
finding of interest was that Sd+ heterozygotes lack the odontoid process (the
dens epistrophei), a conserved structure which enables mammals to
articulate the head from side to side. Its loss was attributed to the
degeneration of the notochord during embryogenesis (Gruneberg, 1953).
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When Sd heterozygotes (Sd+) were examined during embryogenesis, it was
found that the development of the tail progressed normally up to day 10 of
gestation, after which progressive degeneration of the tail somites occurred
in a proximal direction (Glueckson-Schoenheimer, 1945). This degeneration
was characterised by the appearance of blebs and haematomas at the tip of
the degenerating tail bud, followed by a gradual decrease in the diameter
and length of the tail, often resulting in a contorted, boneless filament at the
distal end of the tail which persisted to adulthood (Glueckson-Schoenheimer,
1945).
Notochord development in heterozygotes is normal up to day 10 of gestation.
In serial sections through day 11 Sd+ embryos, the notochord becomes
discontinuous along the antero-posterior axis, and by mid-gestation has
collapsed and disappeared throughout the length of the animal (Glueckson-
Schoenheimer, 1945; Gruneberg, 1953; Center et al., 1982; Boloventa and
Dodd, 1991). This loss of the notochord during embryogenesis was
proposed to be the primary defect in Sd mice (Gruneberg, 1953; Theiler,
1959). More recently it has been found that the floor plate is also absent
during the development of the posterior vertebral column in Sd+ mice, and it
has been suggested that this loss of floor plate is intimately associated with
the loss of the notochord during Sd embryogenesis (Placzek et al. 1991;
Boloventa and Dodd, 1991).
In Sd+ neonates, abnormalities in the urogenital system can range from a
complete absence of both kidneys and both ureters, through all degrees of
malformation, to an apparently normal phenotype (Glueckson-
Schoenheimer, 1943). Reduction in the size of one or both kidneys has been
found to be the most common effect of the mutation, bilateral renal agenesis
being less common. The urogenital malformations in heterozygotes affect
postnatal viability in those mice more severely affected by the mutation,
phenotypic severity being dependent on genetic background (Dunn et al.,
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1940; Dunn and Glueckson-Schoenheimer, 1945). Where one kidney is
absent or malformed, the kidney originating from the left side of the body is
found to be the most frequently affected (Glueckson-Schoenheimer, 1943;
Mesrobian and Sulik, 1992).
During embryogenesis, the development of the urogenital system in
heterozygous mice is normal up day 10.5 when the ureters bud off from the
mesonephric ducts (Glueckson-Schoenheimer, 1945). Abnormalities in day
10 embryos are first seen when the ureteric bud appears to be
morphologically abnormal compared to wild type littermates. By day 11, the
ureteric bud is either inhibited or retarded in development and in severely
affected mice, the bud can fail to branch altogether (Glueckson-Waelsch and
Rota, 1963).
Homozygous phenotvpe
Homozygote neonates have a striking spectrum of developmental
abnormalities including a complete absence of tail, bilateral renal agenesis,
absence of external urinary and anal openings, and spina bifida (Dunn et al.,
1940; Glueckson-Schoenheimer, 1943; Glueckson-Schoenheimer, 1945).
These mice survive to term and compete to suckle, but die 18-20 hours after
birth due to autotoxicity (Dunn et al., 1940).
In the absence of a vertebral column in the posterior region of the embryo,
the spinal cord develops to a normal length but often ends in a cyst in the
sacral region of the spine, beneath the dorsal epidermis. Due to the absence
of lower lumbar, caudal, and sacral vertebrae, homozygous neonates are
sometimes paralysed, with luxated hind limbs (Dunn et al., 1940; Glueckson-
Schoenheimer, 1943). The cervical vertebrae in these mice show antero¬
posterior reductions, including the loss of the dens axis. Sagitally split
vertebrae are found in the lower thoracic and upper lumbar skeleton, with the
vertebral body absent from the vertebral anlagen. The terminal vertebrae are
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occasionally represented by amorphous lateral cartilage condensations.
When split vertebrae extend into the thoracic vertebral column, the ribs of
affected mice are disconnected from the vertebrae or completely absent.
These observations indicate that it is the ventral aspect of the vertebral
skeleton which is most severely affected by this mutation (Dunn et al., 1940;
Glueckson-Schoenheimer, 1943; Gruneberg, 1958; Dietrich et al., 1993a).
The rectum in homozygous mice fails to develop since the intestine rarely
continues beyond the colon. Failure in the development of the anus, the
external genital papillae and urethral openings are also features of
homozygote mice. On the rare occasion when kidneys are present, they are
always abnormal in size and structure, and often displaced. Development of
the bladder is frequently affected by this mutation, and is rarely of normal
size in homozygous mice. Occasionally, malformation of the genital duct has
been observed in female homozygotes (Dunn et al., 1940; Glueckson-
Schoenheimer, 1943).
Homozygous embryos are phenotypically distinguishable from wild type and
heterozygous littermates from day 9 of gestation, due to the constriction of
the tail bud at the base of the tail. The constricted tail is shorter and thinner
than the normal tail and is characterised by the presence of haematomas at
the distal tip of the tail bud. In sections of the tail bud at nine days, somitic
tail structures are abnormal and the notochord substantially fragmented
(Glueckson-Schoenheimer, 1945; Gruneberg, 1958; Theiler, 1959). By mid-
gestation the notochord is entirely absent from the antero-posterior axis of
homozygous embryos, as is the floor plate (Placzek et al. 1991; Boloventa
and Dodd, 1991).
By day 10 of gestation, the mesonephric ducts are often abnormal at their
posterior tips, and fail to reach beyond the point where the uereteric bud
branches off towards the metanephric blastema (Glueckson-Schoenheimer,
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1945; Glueckson-Waelsch and Rota, 1963). Failure of the posterior part of
the mesonephric duct to develop properly was proposed to be responsible
for the abnormalities in bladder development (Glueckson-Schoenheimer,
1945). However, the normal appearance of the gonads and their ducts
indicates that the mesonephroi, and the anterior part of the mesonephric
ducts, are morphologically normal. Nephrogenic tissue found at the tip of
homozygote ureteric buds has been described as failing to undergo
differentiation. Failure of the urogenital sinus and rectum to develop
separately after day 10 of gestation, can result in the persistence of a cloaca
(Glueckson-Schoenheimer, 1945; Glueckson-Waelsch and Rota, 1963).
1.2.2 Vertebral development in Sdmice
Components of the vertebral column are derived from the paraxial
mesoderm, a tissue laid down during gastrulation which flanks the notochord
and neuroectoderm. The axial skeleton of vertebrates is composed of a
metameric series of vertebral bodies and intervertebral discs. Both of these
structures are derived from the somites. The sclerotome, the part of the
somite which gives rise to skeletal structures, is generated as a
consequence of the differentiation of the somites into the mesenchymal
sclerotome and the epithelial dermomyotome. Following de-epitheliasation of
the somites, medial sclerotome cells migrate and proliferate towards the
notochord to form the anlagen of vertebral bodies and intervertebral discs,
whereas the lateral sclerotome forms the pedicles and laminae of the neural
arches and ribs (Christ and Wilting, 1992). The somite also produces a
second tissue, the dermomyotome, which subdivides into the dermotome
and myotome to form dermis and skeletal muscle. With respect to their
position, somite cells have to acquire a dorsolateral identity to become
dermomyotome, whereas a ventromedial identity restricts them to a
sclerotome lineage. Thus the dorsoventral differentiation of the somite is the
crucial step in the formation of the axial skeleton as a whole.
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A substantial body of experimental evidence has accumulated which
indicates that the dorso-ventral specification of the neural tube and somites
is strongly influenced by the notochord (Yamada et al., 1991). It has been
found in notochord ectomised amphibian neuralae and chick embryos, that in
the absence of the notochord, the myotome expands and the sclerotome
either degenerates or forms an unsegmented cartilage tube around the
spinal cord, indicating that the notochord is required for the development of
the sclerotome (Youn and Malacinski, 1980; Teillet and Le Douarin; 1983).
The notochord is also responsible for inducing the development of the floor
plate, a highly specialised region of the neural tube, since by grafting a piece
of notochord to the dorsal midline of the developing chick neural tube, the
ectopic induction of a floor plate can be induced (Yamada et al., 1991).
Evidence indicates that the floor plate plays a vital role in establishing cell
identity along the dorso-ventral axis of the neural tube, as well as guiding
commisural axon growth to, and across, the ventral midline of the spinal cord
(Jessel et al., 1989). In the absence of a floor plate, commisural axons are
found to have aberrant trajectories, and the number of motor neurones which
form are decreased or completely absent (Yamada et al., 1991).
The development of the notochord and perinotochordal sheath in
homozygous and heterozygous Sd mice has been studied (Center et al.,
1982). The perinotochordal sheath is a basement membrane which encloses
the notochord as a thin ring in the anterior half of the animal. Towards the
posterior region, the notochord remains attached to the ventral surface of the
neural tube and the perinotochordal sheath becomes continuous with the
basement membrane of the neural tube (Center et al., 1982). The
perinotochordal sheath was found in this study to be normal in the anterior
half of day 10 Sd+ embryos, but reduced in the mid-trunk to posterior half of
the animal, where the notochord was disorganised and malformed. In
homozygote mice, the anterior notochordal complex was abnormal in shape
and situated closer to the ventral surface of the neural tube than normal. By
8
day 12.5 of development, the sheath was reduced to a poorly formed,
anterior structure with no basement membrane in Sd+ mice. In the mid-trunk
to posterior region of these embryos, there was little to no indication of a
defined notochord or sheath. In the 12.5d homozygous embryos, very little
evidence of the notochordal complex was found at any level (Center et al.,
1982).
Notochordal cells in 11-11.5 day SdSd embryos have ultrastructural features
which differ in several respects from those of wild type (WT) littermates. The
cells of SdSd notochords lack surface protrusions, and are deficient in
cytoplasmic filaments seen in normal cells (Wilson et al., 1982). Also found
was a complete lack of glycogen in these cells, a carbohydrate which is
present in abundance in WT notochordal cells in the form of granules. This
lack of glycogen in mutant notochordal cells was thought to reflect either an
earlier than normal transition from a state of proliferation to a state of
differentiation, or an inability to form sufficient amounts of this energy source
during early differentiation (Wilson et al., 1982).
A number of studies have been performed to investigate the effect of the Sd
mutation on the dorsal-ventral patterning of the neural tube and somites
during development. These studies have examined genes which have highly
localised domains of expression during neural development, to investigate
whether their expression patterns are altered in Sd mice (Dietrich et al.,
1993a; Koseki et al., 1993a; Phelps and Dressier, 1993). In addition, work
has also been carried out to analyse the affect that the mutation has on
neuronal differentiation and axonal guidance in the developing neural tube,
processes which normally require the inductive activity of the floor plate and
notochord (Boloventa and Dodd, 1991).
Members of the paired box family of transcription factors, the Pax genes, are
expressed in distinct spatiotemporal patterns during embryogenesis. Several
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of these genes are expressed in overlapping dorsoventral patterns within the
developing neural tube (Deutsch and Gruss, 1991). The expression domains
of a number of these genes have been examined in Sd mice (Dietrich et al.,
1993a; Phelps and Dressier, 1993).
Pax1 is the earliest marker for the ventral region of the somite. At day 9.5 it
is expressed in the entire sclerotome, an expression pattern which later
becomes restricted to the ventral region of the sclerotome, the anlagen of the
intervertebral discs (Deutsch et al., 1988). The Pax1 mutation undulated (un)
affects mainly the development of vertebral bodies and intervertebral discs
(Balling et al., 1988), indicating that Pax1 is required for the correct
patterning and development of these ventromedial structures. When
homozygous undulated mice are crossed with Sd+ mice, the resulting double
mutants have a more severe vertebral phenotype than is seen in either
mutation alone, indicating that the mutations are not allelic, as predicted by
their map positions, and that Pax1 activity is affected by the degeneration of
the notochord (Koseki et al., 1993a).
In contrast to Pax1, the expression of Pax3 is restricted to the dorsal aspect
of both somite and neural tube (Goulding et al., 1991, 1993). The mouse
Pax3 mutation splotch demonstrates the importance of this gene for the
development of dorsal structures, as the dorsally emerging neural crest cells
are defective in these mice, frequently causing failure in neural tube closure.
Notochord excision in chick embryos results in the ventral extension of the
Pax3 expression domain in the neural tube (Goulding et al., 1993), indicating
that the notochord is responsible for maintaining the dorsally-defined
expression of Pax3, either directly or through the release of ventralizing
signals, such as sonic hedgehog (Bumcrot and McMahon, 1995). Thus Pax3
serves as an appropriate dorsolateral marker for analysis of the interaction of
the notochord with the somite and spinal cord (Dietrich et al., 1993a).
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Analysis of Pax1 and Pax3 expression showed that the expression of both
genes is altered as a consequence of the degeneration of the notochord in
heterozygous and homozygous Sd embryos (Dietrich et al., 1993a). The use
of the notochord-specific marker T, showed that the notochord degenerated
in homozygotes from day 9.5 to day 11 of development. In the anterior
region of homozygous embryos, despite the absence of the notochord, Pax3
and Pax1 expression were found to be unaltered, and induction of the floor
plate was evident (Dietrich et al., 1993a). Since transplantation experiments
have shown that the floor plate is able to mimic the ventralising function of
the notochord (Yamada et al., 1991), it was proposed that in Sd
homozygotes, the floor plate may similarly substitute for the notochord
function in establishing a ventral identity in the neural tube. Alternatively,
after sufficient development of the somite and neural tube, the degeneration
of the notochord may no longer be able to affect these tissues (Dietrich et al.,
1993a). At the posterior end of homozygous embryos, Pax1 expression
failed to be detected, whilst expression of Pax3 was found to be present
throughout the neural tube and somites, instead of being restricted to the
dorsal aspect of these structures as in WT embryos. Since the expression of
Pax3 is known to be restricted by the notochord, via the expression of
ventralizing genes such as Pax1, to the dorsal half of the neural tube, this
result indicated a number of conclusions (Dietrich et al., 1993a): that the
absence of notochord from the developing posterior half of the embryo
results in the failure of floor plate induction, and that in the absence of floor
plate and notochord, the developing somites and neural tube cannot acquire
a ventral identity, as indicated by the loss of Pax1 expression (Dietrich et al.,
1993a; Bumcrot and McMahon, 1995). Consequently, the neural tube and
somites develop with a dorsalized phenotype, brought about by the
unrestricted expression of dorsalizing genes, such as Pax3. This is reflected
in the phenotype where ventral structures such as the vertebral bodies and
intervertebral discs are among the skeletal elements most severely affected
by the mutation. The phenotype is less severe in the anterior portion of the
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vertebral column because the notochord functions sufficiently to induce floor
plate development before degenerating. The floor plate is then able to induce
the expression of ventralizing genes in the anterior neural tube and somites
(Dietrich et al., 1993a; Boloventa and Dodd, 1991).
The expression pattern of Pax2 has also been examined in heterozygote and
homozygote Sd mice (Phelps and Dressier, 1993). In the spinal cord, Pax2 is
expressed at the onset of neuronal differentiation as cells migrate from the
ventricular zone (Nornes et al., 1990). Pax2 expressing cells are initially
detected in the ventral two-thirds of the alar plate and the dorsal half of the
basal plates (Nornes et al., 1990). Although normal patterns of Pax2
expression were observed in the thoracic and lumbar regions of the spinal
cord of SdSd mice, the sacral and caudal regions showed ectopic Pax2
expression in the ventral half of the basal plate and through the ventral
midline. In the absence of floor plate or notochord, this ectopic expression of
Pax2 was proposed to inhibit the development of motor neurones in SdSd
mice. The development of motor neurones is greatly reduced in heterozygote
and homozygote mice (Boloventa and Dodd 1991), in the same way that
they are absent from chicks in which the notochord has been surgically
removed (Yamada et al., 1991). As in Sd mice, this not only causes
reduction and ectopic development of motor neurones, but also the loss of
floor plate and changes in the expression pattern of ventrally expressed
genes. Thus, alterations in the expression domain of Pax2 may be involved
in the reduction of motor neurone development in these mice (Phelps and
Dressier, 1993).
The loss of the notochord and floor plate in Sd+ and SdSd mice, not only
affects motor neurone development, but also the growth and trajectory of
commisural axons (Boloventa and Dodd, 1991). Evidence exists which
suggests that the floor plate may contribute to axon guidance, and it has
been proposed that it may be the source of diffusible chemoattractants which
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orientate the growth of spinal commisural axons (Tessier-Lavigne et at.,
1988). In SdSd mice, commisural growth axons project normally in the
ventral direction, but then fail to project ventromedially to the ventral midline
of the neural tube in parts of the spinal cord where the floor plate is absent
(Boloventa and Dodd, 1991).
Although these studies have provided valuable insights into the
developmental pathways which have been affected by the mutation, it is still
not known why the notochord in Sd+ and SdSd mice degenerates during
embryogenesis.
1.2.3. Kidney development in Scfmice
Embryological studies of mice heterozygous and homozygous for Sd have
revealed abnormalities in the formation, growth and differentiation of the
ureteric bud and metanephric mesenchyme (Glueckson-Schoenheimer,
1945; Glueckson-Waelsch and Rota, 1963).
The interdependence of the two main component tissues of nephrogenesis,
the ureteric bud and the metanephric mesenchyme, was first demonstrated
by Grobstein (1955, 1956). Tubule formation in the mesenchyme was shown
to be dependent upon an inductive influence provided by the ureteric bud,
while branching of the ureteric bud was found to be dependent on the
metanephric mesenchyme. Dorsal spinal cord was also found to be a more
potent in vitro inducer of mesenchymal differentiation than ureteric tissue. A
more detailed account of the development of the kidney, and the genes
involved in these inductive interactions, is given in the introduction to chapter
6.
An early study was undertaken to investigate the role of the Sd mutation in
the inductive interactions between the metanephric mesenchyme and ureter
during kidney development, using an in vitro organ culture assay in which
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embryonic kidneys were cultured in clots prepared from chicken plasma
(Glueckson-Waelsch and Rota, 1963). Kidney rudiments from 11-12 day
heterozygote and homozygote Sd mice were either cultured intact, or the
ureteric bud and metanephric mesenchyme were enzymatically separated
and cultured in combination with wild type/ mutant ureteric bud, metanephric
mesenchyme or spinal cord. Homozygous rudiments cultured intact were
found to be distorted and retarded in development. The ureteric branches
failed to branch properly, and although some tubule formation was seen
where ureteric branching had occurred, it was considerably retarded in
development. (Glueckson-Waelsch and Rota, 1963).
When the metanephric mesenchyme from homozygote rudiments was
separated from the ureteric bud and cultured with ureters from wild type (WT)
embryos, only 29% of cultures showed tubule differentiation. However, since
only 50% of normal mesenchymes underwent differentiation in the presence
of WT ureters, rudiment development was not consistent in this assay used.
Mutant mesenchyme produced less tubule differentiation in combination with
WT ureter than normal mesenchyme. When mutant mesenchyme was
cultured with WT dorsal spinal cord, most differentiated well. However, when
normal mesenchyme was combined with ureters from 11-12 day
homozygotes, although 50% of cultures showed mesenchymal
differentiation, the response was limited, since tubulogenesis occurred only
where ureteric branch tips had developed (Glueckson-Waelsch and Rota,
1963).
These data suggested that the Sd mutation does not completely suppress
either the inductive effect, nor the reacting ability of the ureter and
metanephric mesenchyme. Although differentiation was abnormal it was not
possible to conclude whether both tissues were retarded in development, or
whether the metanephric mesenchyme was retarded as a result of the
decreased responsiveness of the ureteric bud to branching stimuli
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(Glueckson-Waelsch and Rota, 1963). The findings produced by this study
are discussed further in chapter 6, section 6.2.2.
The expression of the transcription factor Pax2 in Sd rudiments has also
been investigated (Phelps and Dressier, 1993). As detailed in section 6.2.2,
Pax2 is expressed during kidney organogenesis in the pro- and mesonephric
tubuli and the ureteric bud (Dressier et al., 1990). Following nephrogenic
induction, Pax2 is present in the mesenchymal condensations and its early
epithelial derivatives, the comma and S-shaped bodies. As epithelial
differentiation continues and kidney tubules are formed, Pax2 expression
declines, indicating a role for Pax2 in the conversion of mesenchyme to
epithelium during kidney organogenesis (Dressier and Douglass, 1992). In
day 12 homozygous embryos, a metanephros could not be identified and by
day 13, the mesenchymal cells surrounding the posterior mesonephric duct
did not express Pax2. On the occasions when the ureteric bud branched
from the mesonephric duct, Pax2 expression was seen, but the cells
surrounding the bud failed to express Pax2 (Phelps and Dressier, 1993).
This work suggests that in the absence of ureteric branching, the signalling
cascade responsible for the mesenchymal to epithelial differentiation of the
metanephric mesenchyme is not activated in homozygous Sd mice. Normal
Pax2 expression in the mesonephroi and Wolffian duct of homozygotes
indicates that these structures develop normally, supported by the fact that
gonadal development is unaffected by the Sd mutation (Gluecksohn-
Schoenheimer, 1943).
1.3 Analysis of Danforth's short-tail mutation
Danforth's short-tail mutation was originally assigned to the fifth linkage
group in the mouse, where it was linked to pallid and agouti, two
phenotypically distinguishable mutations on the same chromosome (Borger,
1950). Later it was mapped to the proximal end of mouse chromosome 2
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(Beechey and Searle, 1980), where several cloned genes of interest have
been mapped (Siracusa and Abbott, 1994). At the onset of this project, the
paired box gene Pax8 was considered to be a strong candidate for the
mutation, owing to its map position in the proximal region of mouse
chromosome 2 and to its expression in both the developing spinal cord and
kidney (Plachov et al., 1990). One of the primary aims of this project was to
generate a high resolution map in the region of Sd to assess Paxffs
candidacy for the mutation. In order to do this, an inter-subspecific backcross
in which Sd was segregating was generated. A review of the approaches
used to map genes in the mouse, and the results of the mapping data, are
given in chapter 3.
Since Pax8 was excluded as a candidate gene for Sd on the basis of the
map that was generated in this study, a positional cloning exercise was
initiated with the aim of isolating the gene responsible for the mutation
(chapter 4). A review of the strategies which can be used to positionally
clone genes is given in the introduction to this chapter.
As mentioned in section 1.2.1, Sd has a highly variable phenotype. Whilst
generating the backcross it was noted that tail length varied between F1 and
backcross generations. As a result of this finding, a genome wide analysis of
backcross progeny was performed, to identify quantitative trait loci
responsible for modifying tail-length in the presence of Sd. A review of
quantitative trait loci mapping is given in the introduction to chapter 5, where
the results of this work are detailed.
An in vitro organ culture assay was used to investigate the development and
branching morphogenesis of embryonic kidneys from heterozygous and
homozygous Sd mice (chapter 6). A review of kidney organogenesis, and of
the genes involved in renal induction and morphogenesis, is given in the
introduction to this chapter.
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Danforth's short-tail mutation is a semi-dominant developmental mutation
which affects both the development of the neural tube and tail, and the
differentiation of the urogenital system (Gluecksohn-Schoenheimer, 1943;
Gluecksohn-Schoenheimer, 1944). From its wide-ranging phenotype it is
clear that the correct expression and biological function of this gene are vital
for the normal development of two diverse and highly patterned tissues
during embryogenesis. It is possible that the identification of the Sd gene
may lead to a better understanding of renal disorders in humans, such as the
dominantly inherited form of renal adysplasia which results in unilateral and
bilateral renal agenesis (McPherson et a/., 1987). In this way the
identification of the Sd gene may offer considerable insights into the genetic
basis of renal and neural tube disorders in both mice and humans.
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Chapter 2: Materials and methods
2.1 Maintenance of mice stocks
Mice were kept at the Biomedical Research Facility at the Western General
Hospital where their care was supervised by V. Ranaldi. The animal work
carried out in this project was authorised by the Home Office, licence number
60/01412 (Experimental Modification of the Mouse Genome).
2.1.1 Origins and strains of mice
Danforth's short tail mice (Sd) were obtained from Harwell where they were
maintained as a linkage stock on an outbred background. On arrival at the
Biomedical Research Facility, the Sd mice were bred with a M. musculus
inbred laboratory strain derived from CBA/Ca and were subsequently
maintained on this background. For the backcross, M. musculus castaneus
mice, of the strain CAST/Ei, were obtained from Harlan Olac.
2.1.2 Backcross protocol
One mating was set up to produce F1 offspring (Sd x M.m.castaneus).
Heterozygous Sd male and female F1 offspring were mated back to CBA/Ca
mice to produce the backcross progeny. Thirteen (F1 x CBA/Ca) mating pairs
were set up in a ratio of one male to one female.
Backcross progeny were killed three days after weaning and all were
dissected for the removal of their spleens and kidneys. Tail lengths were
measured and recorded, along with kidney size and any visible abnormalities.
Spleens and tail tips were snap frozen in liquid nitrogen and stored at -70°c
until required for the preparation of DNA.
2.2 Kidney culture assays
2.2.1 Media and growth factors used in kidney culture assays
Ham's F10 solution
Ham's F10 solution was purchased in powder form from Gibco BRL and
prepared according to the manufacturer's instructions.
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Improved Modified Eagles Medium, IMEM
Customised IMEM was made available to us as a kind gift from P. Ekblom
and was produced by Gibco, BRL. 1 litre of IMEM was prepared with 25mM
NaHC03 (Analar, BDH) and 20mM Hepes (Flow Labs) and the pH adjusted to
7.6 using NaOH. The medium was then stored in 10ml aliquots at 4°C.
Directly before use the medium was supplemented with 50|ig/ml sterile, iron-
poor apo-Transferrin (Sigma) and 300p.g/ml sterile glutamine (Gibco, BRL).
IF base
Phosphate Buffered Saline (PBS, Oxoid) supplemented with 1% Bovine
Serum Albumin (BSA, Boehringer Mannheim) and 0.01% sodium azide,
pH7.3
Mounting solution
Equal volumes of non-fluorescent glycerine (Merck) and PBS were mixed with
2.5% 1, 4, diazabicyclo-(2,2,2)octane (Sigma).
Hepatocyte Growth Factor (HGF)
5(ig human recombinant HGF (R&D Systems) was diluted in IMEM and
200ng/ml aliquots were stored at -20°C. Directly before use, each aliquot was
diluted with 2.5ml IMEM and used in culture at a concentration of 80ng/ml.
Phorbol dibutvrate (PDBu)
PDBu (Sigma) was diluted directly before use in IMEM, from a 1pM stock
stored at -20°C.
2.2.2 Antibodies used for immunohistochemistry
Primary antibodies
Mouse monoclonal anti-calbindin D antibody (Sigma) was diluted in IF base
and used at a final dilution of 1:200.
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Rabbit polyclonal anti-mouse laminin antibody (Euro-Diagnostica) was diluted
in IF base and used at a final dilution of 1:400
Secondary antibodies
Anti-mouse, host horse, Texas Red-conjugated antibody (Vector) was diluted
in IF base and used at a final dilution of 1:100.
Anti-rabbit, host goat, fluorescein isothiocyanate (FITC)-conjugated antibody
(Vector) was diluted in IF base and used at a final dilution of 1:100.
2.2.3 Isolation of embryos
Male and female heterozygote Sd mice were mated and the day of the
vaginal plug was designated as day 0.5. On day 12.5 of gestation, pregnant
females were killed by cervical dislocation and the embryos dissected intact
into ice cold PBS (Oxoid). Each embryo was phenotyped according to its tail
length and appearance as being homozygous for Sd (SdSd), heterozygous
{Sd+) or wild type (+/+).
2.2.4 Dissection of embryonic kidneys
Embryonic kidneys were dissected out into ice cold Ham's F10 solution, in
sterile glass Petri dishes, using 21 gauge hypodermic needles (Becton
Dickinson). In brief, kidneys were located by making transverse cuts just
anterior and posterior to the hind limb buds. Holding the hind limb region
dorsal side up, a saggital cut was made through the neural tube to separate
the embryo into left and right halves, and the limb bud was removed from
each half. The kidney rudiment was located by following the Wolffian duct
until the metanephric blastema could be seen. On dissection, as much
undifferentiated tissue from around the metanephric mesenchyme was
removed as possible and the kidneys were transferred, individually by
siliconised glass pipette, to a 96 well microtitre plate (Costar) where they were
stored in IMEM at 4°C until needed. From the time of the sagittal section
through the neural tube, it was noted from which side of the embryo (left or
right) each kidney was dissected from.
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2.2.5 Embryonic kidney culture assay
The organ culturing method used was based upon that described by Saxen,
1987.
Kidney rudiments were cultured for 24-60 hours on 1 pm nuclepore filters
(Costar) which had been placed on stainless steel Trowell grids. Trowell grids
were placed in Petri dishes to which supplemented IMEM was added almost
to the top of the grid (usually 2.5ml), in this way kidneys were cultured in a
film of medium generated by surface tension. Kidneys rudiments were
cultured in a humidified incubator in 7% C02, at 37°C, for varying lengths of
time.
Where kidney rudiments were cultured in the presence of growth factors, the
growth factors were diluted in IMEM and added to the culture medium directly
before incubation at 37°C. For each kidney rudiment cultured, its left or right
pair was cultured without growth factor as a control.
2.2.6 Immunohistochemical staining of cultured kidney rudiments
Cultured kidneys were fixed overnight at 4°C in methanol and washed the
following day in IF base, at room temperature, for 30 minutes. They were then
exposed to primary antibodies for 4 hours at 37°C, followed by a 3 hour wash
at room temperature in IF base, followed by overnight incubation with the
secondary antibodies at 4°C. Before mounting, the kidney cultures were given
a final wash in IF base at room temperature for 3 hours.
Kidney cultures were mounted on modified glass slides. To avoid crushing the
cultures with a cover slip, a small piece of glass was glued to either end of a
glass slide (Chance Propper Ltd.) and the kidney cultures placed in the space
between the two glass pieces. In this way, the cover slip rested on the glass
pieces and not the cultures themselves. Cultures were mounted using a
mountant containing an anti-fading reagent (see section 2.2.1), so that the
fluorescent signal of the secondary antibodies would be protected during
laser-scanning confocal microscopy. To prevent the mountant from drying
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out, slide edges were sealed using a vulcanized rubber solution (Stahlgruber,
Rema Tip Top solution).
2.2.7 Confocal imaging of cultured embryonic kidneys
The fluorescently stained kidney cultures were optically sectioned using an
Ortholux II microscope (Leitz) equipped for confocal microscopy with a MRC
600, Biorad scanhead. Fluorescently labelled cells were excited with an argon
laser and selected filters were used to allow for the simultaneous detection of
FITC and Texas Red signals. For the HGF experiments, a plan 10 objective
was used on the microscope and for the PDBu experiments, a 6.3 objective
was used.
2.3 Yeast cell culture and DNA isolation
2.3.1 Media and additives
AIHC broth and agar
AHC is a rich selective medium which lacks uracil and tryptophan. It was used
for selective growth of YAC recombinants prior to the isolation of YAC DNA
and the production of plugs.
1.7g yeast nitrogen base (without amino acids and ammonium sulphate)
(Difco), 5g ammonium sulphate and 10g casein hydrolysate (low salt) were
added to 1 litre distilled water and the pH adjusted to 5.8. 17-20g of Bacto
agar (Difco) were added to each litre of broth to make AHC agar. After
autoclaving and cooling, 50ml filter sterilised 40% glucose and 10ml of
2mg/ml adenine sulphate were added to the broth or agar.
YPD broth and agar
YPD medium was used for growing yeast cultures.
20g bactopeptone (Difco), 5g yeast extract (Difco) and 5g sodium chloride
were added to 1L distilled water. 1.5% agar was added at this stage for YPD
agar. After autoclaving and cooling, 50ml sterile 40% glucose was added to
the broth or agar.
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2.3.2 Yeast strains
Saccharomyces cerevisiae strains YP148 (Jones et al, 1989) and AB1380
(Link and Olson, 1991) were used as size markers for pulse field gel
electrophoresis. Table 2.3 lists the sizes of the chromosomes of the two
strains.
AB972
Chr. Number Size (kb)
YP148
Chr. Number Size (kb)
IV 1640 XII 2500
VII, XV 1105 IV 1500
XVI 955 XV 1125
XIII 930 VII proximal 1035
II 830 XVI 1000
XIV 790 XIII 940
X 750 II 830
XI 690 XIV 790
V, VIII 585 X 750
IX 445 XI 680
III 350 V 600
VI 285 VIII 550





Table 2.3: Chromosomal sizes of yeast size markers
Size of marker fragments is given in kilobases (kb).
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2.3.3 Isolation of DNA from yeast
Two methods were used for the isolation of yeast DNA.
A rapid method to extract high quality genomic DNA (Gustinich et at, 1991)
was used to prepare small quantities of yeast DNA. Briefly, a 5ml yeast
culture (108 cells/ml, grown in AHC) was spun down and washed twice in TE
(10mM Tris.HCI pH8.0; 1mM EDTA), and resuspended in 300pl of zymolyase
buffer (1M sorbitol, 0.1M citrate pH7, 0.06M EDTA, 0.1 mM (3-mercaptoethanol
(Sigma), 2mg/ml zymolyase [ICN Biomedicals Inc.]). Following incubation with
the zymolyase buffer for 30 minutes at 35°C, the cells were lysed with 600p.l
of lysis buffer (8% dodecyltrimethylammonium bromide [DTAB, Sigma], 1.5M
NaCI, 100mM Tris pH8.6, 50mM EDTA) at 68°C for five minutes. 900pl
chloroform was then added to the spheroblasts and the mixture centrifuged at
14,000rpm for 10 minutes. 750jllI of the upper aqueous layer was removed
and 900pl water and 5pl 10mg/ml RNA-ase A (Boehringer Mannheim) added
to it and incubated at 68°C for 10 minutes. 100|il of
hexadecyltrimethylammonium bromide (CTAB, Sigma), from a 5% stock in
0.4M NaCI, was added to the mixture and the DNA precipitated by
centrifugation at 10,000rpm for 5 minutes. The pellet was resuspended in
300jllI of 1.2M NaCI and 750|il ethanol added to it. Following centrifugation at
10,000 rpm for 10 minutes the pellet was washed in 70% ethanol and the
pellet resuspended in 300pl TE at 55°C for 10 minutes.
For larger scale preparation of genomic yeast DNA the Nucleon II Extraction
Kit was used (Scotlab). In brief, a yeast culture was grown to 3-4 x 109 cells/
ml in AHC. The cells were lysed with SCEM buffer ( 1M sorbitol, 10mM EDTA,
0.1 M sodium citrate, 18mM p-mercaptoethanol and 4 units zymolyase) and
incubated at 37°C for 2 hours. Spheroblasts were centrifuged and treated with
45|il 50pg/ml RNA-ase A (37°C, 30 minutes) and 1.5ml 5M sodium
perchlorate (15 minutes at room temperature). 5.5ml of ice cold chloroform
and 800pl of Nucleon silica suspension were added to the tube and after
centrifugation (3250 rpm for 3 minutes) the DNA-containing phase above the
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silica suspension was transferred to a fresh tube. The DNA was precipitated
with ethanol and washed in 70% ethanol and the pellet resuspended in 250-
500pl TE.
2.3.4 Preparation of agarose plugs
This method allows for the extraction of intact yeast chromosomes, including
yeast artificial chromosomes (YACs), from cells. It was adapted from Maule
(1994).
A 100ml culture was grown from a single, PCR-screened colony (see section
2.10.5). The culture was grown in selecting AHC medium at 30°C for 48 hours
or until the cells reached approximately 108 cells/ml. The culture was chilled
on ice for 15 minutes prior to centrifugation at 4,000 rpm for 10 minutes. The
supernatant was discarded and the cell pellet washed twice in 50ml chilled
50mM EDTA, pH7.5. After washing, the cell pellet was resuspended in 3ml
50mM EDTA pH7.5 and warmed to 37°C. Cell walls were disrupted by the
addition of 1.2ml freshly prepared cell wall digestion solution (2ml SCE, pH8.0
[1M sorbitol; 0.1 M sodium citrate; 60mM EDTA]; 1 OOjllI (3-mercaptoethanol;
2mg/ml zymolyase). 6ml of 1% low melting point agarose (Gibco BRL) in
0.125M EDTA, pH7.5, at 50°C was added to this. After mixing thoroughly,
10Opil aliquots of the solution were quickly dispensed into plug moulds and left
to cool on ice. Once set, the plugs were ejected into 25ml ETM solution
(0.45M EDTA; 10mM Tris.HCI, pH8.0; 7.5% (3-mercaptoethanol) and
incubated at 37°C in a waterbath for 24 hours. The ETM was replaced with
20ml 1% NDS solution (0.45M EDTA; 10mM Tris.HCI, pH9.0; 1% SDS)
containing Proteinase K (Boehringer Mannheim) at 1mg/ml, and the plugs
incubated at 55°C for 24 hours. This step was repeated with fresh 1% NDS
solution. Finally, the plugs were stored in 0.5M EDTA at 4°C.
2.3.5 YAC libraries
To isolate YACs the Genethon Mouse YAC screening service was used. This
service uses a PCR-based assay to screen three major libraries: the ICRF
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YAC library (Larin et al, 1991), the St. Mary's Hospital Library (Chartier et al,
1992) and the Research Genetics Library (Kusumi et al, 1993).
1mM of each primer was lyophilised and sent to Genethon to screen the
above three libraries with. All positive clones were returned in the form of agar
stabs which were then plated out onto AHC plates and grown at 30°C for 48
hours. Swabs were taken of colonies from each plate and resuspended in
water. After lysing at 100°C for 10 minutes, the lysates were PCR-screened
(section 2.10.5) for the presence of the marker with which the YAC had been
isolated. Single colonies were also picked and PCR-assayed (section 2.10.5)
to check for the presence of markers.
2.4 DNA isolation from murine tissues
2.4.1 DNA extraction from spleens
After dissection, spleens were snap frozen in liquid nitrogen and stored at -
70°C until required. DNA was extracted from spleens using a high salt
method.
Spleens were homogenised in 2mls TNES (50mM Tris.HCI, pH7.5; 400mM
NaCI; 100mM EDTA; 0.5% SDS) and incubated over night, at 55°C, with
100pg/ml Proteinase K. The resulting solution was split in two and an equal
volume of 2.6M NaCI added to each tube, to adjust its molarity to 1.5M. The
tube was briefly shaken and centrifuged at 12,000g for 5 minutes. The
supernatant was decanted to a clean tube and the precipitate discarded. An
equal volume of ethanol was added and the tube inverted to allow the DNA to
be spooled out using a sealed glass pipette. Once dry, the DNA was
dissolved in 500jj.I TE (10mM Tris.HCI, pH8.0; 1mM EDTA) or water.
If necessary, DNA was further cleaned by phenol/ chloroform extraction. An
equal volume of phenol was added to the tube and mixed, followed by
centrifugation at 3000rpm for 10 minutes. The upper aqueous layer was
removed and the process repeated, first with chloroform, then with a 24:1
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solution of chloroform: isoamyl alcohol. The DNA was precipitated by adding
two and a half volumes of ice cold ethanol and mixing thoroughly. The DNA
was spooled out and resuspended as before.
2.4.2 DNA extraction from tail tips
This method was adapted from Laird et al, 1991. The lysis buffer has been
adjusted to allow restriction digestion or PCR-amplification of the DNA without
prior organic solvent extraction.
Once the tail tip had been obtained, it was immediately placed into 0.5ml of
lysis buffer (100mM Tris.HCI, pH8.5; 5mM EDTA; 0.2% SDS; 200mM NaCI;
100|ig/ml Proteinase K) and incubated overnight at 55°C. The tubes were
then briefly vortexed before being spun in an Eppendorf centrifuge at
14000rpm for 15 minutes. The supernatant was decanted to a fresh tube and
0.5ml of isopropanol added to it to precipitate the DNA. After inverting the
tube, the DNA was spooled out using a disposable yellow tip and, after




1M Tris.HCI, pH8.0; 20mM EDTA; 1M boric acid, pH8.3.
20 X TAE
0.8M Tris.HCI, pH 8.0; 20mM EDTA; 0.4M acetic acid.
10 X DNA Loading Buffer
20% ficoll, 100mM EDTA, orange G.
6% Denaturing Polvacrvlamide
Pre-prepared acrylamide/ bis acrylamide (19:1) sequencing solution (Severn
Biotech Ltd.) was used, containing 6% w/v acrylamide, 7M urea and 1XTBE.
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60mls of this solution was used to pour each gel. 75jil of N,N,N,N'-
tetramethylethylenediamine (TEMED, Sigma) and 0.5ml of freshly made 10%
ammonium persulphate were added to the acrylamide directly before use.
8% Non-Denaturing Polvacrylamide
50mls of solution was made to pour each gel. 10mls of 40% 29:1 acrylamide:
bis-acrylamide solution (EasiGel, Scotlab) was diluted in 30mls of water and
10mls 5 X TBE. 700|il 10% ammonium persulphate and 30pl of N,N,N,N'-
tetramethylethylenediamine (TEMED, Sigma) were added to the acrylamide
immediately before pouring the gel.
HydroLink (Mutation Detection Enhancement - MDE) Gel
To make 50mls of solution: 25mls MDE gel solution (AT Biochem) was added
to 3 mis 10 X TBE and 22mls water. 300pl 10% ammonium persulphate and
30jil of N,N,N,N'-tetramethylethylenediamine (TEMED, Sigma) were added to
the gel solution immediately before pouring the gel.
Size markers used in Agarose Gel Electrophoresis
The size markers used were either X DNA digested with Hind\\\ (Boehringer
Mannheim) or<j)X174 digested with HaeIII (Boehringer Mannheim), depending
on the size of the DNA fragments being resolved. Marker sizes are shown in
table 2.5.
2.5.2 Agarose gel electrophoresis
DNA molecules were separated according to their size on horizontal agarose
(SeaKem LE, FMC Bioproducts) gels. The percentage of agarose used to
make the gel depended on the size range of the DNA molecules being
resolved. Restricted genomic DNA was commonly run on large, 300ml 0.8%
agarose gels, whereas smaller fragments, such as PCR products, were run
on 1-2% agarose gels. PCR fragments of 300bp or smaller were run out on
4% NuSieve (FMC, Bioproducts) gels. All agarose gels were made from and
run in either 1 X TBE or 1 X TAE. To visualise the DNA, ethidium bromide
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was added to agarose gels at a concentration of 1pg/ ml of buffer. 1/10 of the
sample volume of 10X loading buffer was added to the DNA prior to loading
the sample on the gel.
Mini gels were run in Northumbria Biologicals Ltd. gel boxes or Electro-4
Hybaid gel tanks. Gels made with and run in 1 X TBE were run at 100 volts,
and gels made with and run in 1 x TAE were run at 50 volts. Time of running
depended on the degree of separation needed.
DNA fragments were visualised on a UV transilluminator at 305nm and
















Table 2.5: DNA size markers pxHaelll and XHind\\\.
2.5.3 Purification of DNA from agarose
DNA fragments were run in low melting point agarose (Ultrapure LMP
agarose, Gibco BRL) in 1 X TAE. Gels were viewed on a UV transilluminator
at 305nm and the required fragment rapidly excised using a sterile scalpel
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blade. Care was taken to ensure that a minimum of agarose was excised with
the required band of DNA.
DNA was isolated from agarose using Geneclean (Bio 101 Inc.) according to
the manufacturer's instructions.
DNA to be used as hybridisation probes was treated as follows. After running
DNA on a 1% LMP gel, the required fragment was excised and weighed. 1-3X
its weight in water was added to it, the mixture boiled for 2 minutes and 20(il
aliquots made. Each aliquot, containing 25-50ng DNA, was stored at -20°C
and then used directly in labelling reactions.
2.5.4 Polyacrylamide gel electrophoresis
Denaturing polyacrylamide/urea gels were used to resolve DNA sequencing
reactions (see section 2.5.1) and end-labelled PCR products (see section
2.10.7).
Glass plates were prepared by washing thoroughly in detergent and distilled
water, followed by a final rinse with 100% ethanol. To prevent the gel from
adhering to the front plate, it was coated with dimethyldichlorosilane (Analar,
BDH) and left to dry. Spacers were placed at the sides of the back plate and
the front plate was placed on top. The sides and bottom of the plates were
sealed together with tape and clamps used to hold them in place. Freshly
prepared polyacrylamide was poured between the plates and a sharks-tooth
comb was inserted at the top of the gel. The gel was allowed to dry for at
least an hour at room temperature before running.
Gels were run in 1XTBE on a vertical slab gel apparatus (Gibco, BRL) at 55
volts for 2-6 hours. Tape at the bottom of the plates was removed prior to
running and wells were flushed out with buffer before loading.
After electrophoresis, tape at the sides of the plates was removed and the gel
blotted onto 3MM Whatman paper, covered with Saran wrap (Dow Chemical
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Company) and dried at 80°c on a Drygel Slab Drier (Hoefer) for one hour.
Once dry, the Saran wrap was removed and the gel exposed to Biomax
sequencing film (Kodak) or to a phosphorimage screen, overnight at room
temperature.
Non-denaturing 8% acrylamide gels were prepared as in section 2.5.1 and
were run in The Sturdier vertical slab gel apparatus (Model SE 400, Hoefer
Scientific Instruments) using 1.5mm spacers and comb. 8% acrylamide gels
were used to separate small PCR fragments with a size difference of 5-15bp.
2-1 Opil of PCR sample was mixed (10:1) with loading buffer and run at 250-
300 volts for 2-3 hours, depending on the size of the fragments, in 1 x TBE.
DNA electrophoresed on 8% acrylamide was visualised using silver staining.
On separating the glass plates, the gel was left on the back plate and washed
twice in a solution of 10% ethanol and 0.5% acetic acid. It was then incubated
in 500mls 1 g/L silver nitrate (Analar, BDH) for 10 minutes at room
temperature, followed by two washes in distilled water. The silver stain was
developed by incubating the gel with a staining solution (0.375M NaOH,
2.6mM NaBH4, 0.15% formaldehyde) for 20 minutes. Gels were photographed
using normal light and a video copy processor (Mitsubishi).
2.5.5 HydroLink gel electrophoresis
Non-denaturing HydroLink Mutation Detection Enhancement gels (MDE, AT
Biochem Inc) were used to detect conformational differences in double
stranded molecules (heteroduplexes). These gels were used to map loci
where restriction fragment length polymorphisms (RFLPs) could not be easily
found.
PCR products were denatured at 90°C for 10 minutes and allowed to cool
slowly, thus promoting the formation of annealed heteroduplexes, before
being run out on a MDE gel. 1pl loading buffer was added to 10pil sample
prior to loading. Gels were poured in the vertical slab Sturdier apparatus and
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run at room temperature for approximately 16 hours at 40 volts in 0.6 X TBE.
DNA was visualised by ethidium bromide staining.
2.5.6 Pulse field gel electrophoresis
Agarose plugs were washed once in TE and equilibrated in the running buffer
(0.5 X TBE) over three hours. A 1% agarose gel was made up in 0.5 X TBE
and the plugs inserted into the wells. The wells were sealed with 1% agarose
and the gel run in pre-cooled 0.5 X TBE at 12°C. Gels were run using the
Chef-DR II pulse field tank and control module (Biorad) and run times and
conditions were varied depending on the size resolution required.
After electrophoresis, DNA was visualised by staining the gel in running buffer
containing ethidium bromide at 5pg/ml for 40 minutes.
2.6 Transfer of DNA to membranes
2.6.1 Southern transfer protocol
DNA was transferred from gels to nylon membranes by capillary blotting. This
method was adapted from Southern (1975).
Prior to blotting, gels were photographed with a ruler to allow for future sizing
of DNA fragments. Pulse field gels underwent an additional pre-blotting step
where they were UV-irradiated at 305nm for 5 minutes. This was done to aid
the transfer of large yeast chromosomes and YACs.
The DNA was denatured by incubating the gel in denature solution (0.5M
NaOH, 1.5M NaCI) for 45 minutes. The gel was then neutralised with
neutralising solution (1M Tris.HCI, 2M NaCI, pH5.5) for an additional 45
minutes. A large strip of 3MM filter paper (Whatman) was soaked in 20 X
SSC (3M NaCI, 0.3M Na3C6H507.2H2O, pH7.0) and placed on a board. The
ends of the paper were placed in a reservoir of 20 X SSC, generating a wick,
and the gel was placed on top of the wick and a piece of nylon membrane (N-
bond, Amersham), cut to fit and pre-soaked in 2 X SSC, was placed directly
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onto the gel. Air bubbles were removed and two pieces of 3MM blotting
paper, also pre-soaked in 2 X SSC, were placed on top of the membrane.
Any exposed wick was screened off with Saran wrap (Dow Chemical
Company) and a weighted-down stack of paper towels placed on top.
The length of blotting time varied according to the size of fragments which
were being transferred. Pulse field gels were blotted for two days, genomic
digests and smaller fragments overnight.
After blotting the membranes were rinsed briefly in 2 X SSC and DNA was
bound to the filter by exposing it to 1200(iJoules of UV irradiation
(Stratagene's UV Stratalinker). Nylon membranes were stored in Saran wrap
at room temperature. Gels were also restained after blotting with ethidium
bromide, to check that all the DNA had been transferred.
2.7 Enzymatic manipulation of DNA
2.7.1 Restriction enzyme digestion of genomic DNA
Digestion of DNA with restriction endonucleases was carried out in the
appropriate buffer at the recommended temperature. Commonly, 5pg of DNA
was digested in 50ptl volume in 10 units of enzyme for 2-3 hours. High
molecular weight DNA was often digested overnight in the presence of 5mM
spermidine (Sigma) and the amount of restriction enzyme used reduced
accordingly. If two different enzymes were used, both of which required the
same buffer, the digests were carried out simultaneously. Otherwise,
digestion with the enzyme requiring the lower salt buffer concentration was
carried out first. The salt concentration was then altered by addition of
appropriate amounts of sodium chloride before the second digestion was
carried out. When necessary, reactions were terminated by heating to 68°C or
80°C for 15 minutes, according to the heat sensitivity of the enzyme (NEB
Catalogue, 1992). Restriction digests which were to be run on gels were
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terminated by the addition of 1/1 Oth of their volume of "stop mix" (100mM
EDTA, pH8.0; 20% Ficoll and Orange G).
2.7.2 Restriction digests of agarose plugs
Agarose plugs, used for pulse field analysis, were pre-treated with
phenylmethylsulfonyl fluoride (PMSF, Sigma) prior to restriction. PMSF is a
potent inhibitor of Proteinase K and was used to inactivate residual
Proteinase K present in the plugs as a result of their preparation (see section
2.2.4). Directly prior to use a 20mg/ml solution of PMSF was prepared, at
55°C, in propan-2-ol. The protocol followed was that from Maule, 1994.
Plugs were soaked in a large excess of sterile TE at room temperature for 10
minutes. They were then transferred to a solution of TE containing 40|ig/ml
PMSF. The plugs were incubated in this solution for 1 hour at 50°C with one
change of solution after 30 minutes. The plugs were then soaked in 1 X
restriction enzyme buffer for 2 hours at room temperature, with frequent
inverting.
For restriction enzyme digestion, each plug was placed in a 1.5ml microfuge
tube (Treff, AG) and put on ice. To it was added 0.1% Triton X100 (Sigma)
and 200pg/ml Bovine Serum Albumin (BSA, Boehringer Mannheim). 20 units
of restriction enzyme was then added and the volume adjusted to 200pl.
Digestion was carried out overnight at the appropriate temperature. Following
digestion, the tube was cooled on ice for 15 minutes, to facilitate the handling
of the plugs, and the liquid removed with a fine tip pastette. The plugs were
washed once in ice cold TE and the reaction stopped by placing the plugs in
200pl stop buffer (0.5 X TBE, 10mM EDTA, 2mg/ml Orange G) for 20 minutes
before loading the plugs onto the gel.
2.7.3 Restriction enzyme digestion of PCR products
Usually, 20pls of PCR product was digested in a volume of 30pls with 1-2
units of restriction enzyme. The appropriate amount of 10X concentrated
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restriction buffer was added to the digestion mix. When using enzymes which
required a low salt buffer, the PCR product was cleaned using Wizard PCR
Preps DNA Purification System (Promega) following the manufacturer's
instructions. If necessary, this was preceded by a gel purification step (see
section 2.4.3).
2.7.4 Restriction of plasmid pBR322
To generate probes which would recognise the right and left arms of the YAC
vector, pYAC4, a double digest of the plasmid pBR322 was carried out using
the restriction enzymes, PvuW and BambW. Since both enzymes require the
same salt buffer, the digestions were carried out simultaneously. 2pg plasmid
DNA was restricted in 30pl volume with 5 units of each enzyme, at 37°C for 3
hours. The digests were electrophoresed on a 1% LMP gel (section 2.5.3)
and two bands excised from the gel for use as hybridisation probes. The band
used as the right arm probe was 1.4 kb in size, and that used for the left arm
probe was 2.6kb in size.
2.8 Radiolabelling of DNA
2.8.1 Random Priming of DNA probes
Probes were labelled with [32P]dCTP by random priming from
hexadeoxyribonucleotides using the Klenow fragment of E. Coli DNA
Polymerase I (Feinberg and Vogelstein, 1983, 1984).
25-50ng DNA (either in the form of a gel slice or in solution) in a volume of
20pil was denatured by incubation at 100°C for 10 minutes. If the DNA was in
solution, the reaction was cooled rapidly on ice, or if a gel derived probe was
used, the reaction was cooled at 37°C for 3 minutes. A Random Priming kit
(Boerhinger Mannheim) was used to label the probe. 3pl of 10X reaction
buffer, 1 jnl each of dATP, dTTP, dGTP (0.5mM), 2 units of Klenow enzyme
and 30|iCi [32P]dCTP (Amersham) were added to the denatured probe, which
was then incubated at 37°C for at least 45 minutes. At the end of the
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incubation the amount of [32P]dCTP label incorporated into the probe was
assayed for using trichloroacetic acid precipitation (Sambrook et at, 1989).
Once a sufficiently high level of incorporation had been achieved (at least
50%), unincorporated nucleotides were removed from the probe using a Nick
Column (Pharmacia). On removal of the storage buffer, the column was
equilibrated in 800|il TNE (10mM Tris.HCI, pH8.0; 1mM EDTA, pH8.0; 0.2M
NaCI). TNE was also added to the probe, to bring its volume to 1 OOjllI, before
it was added to the column with a further 300|il of TNE. The probe was then
eluted with a further 400jj,I TNE. 500)ig of sonicated salmon sperm DNA was
added to the probe and the mix denatured together at 100°C for 10 minutes.
The probe was chilled on ice for 10 minutes before being added to a Hybaid
hybridisation bottle.
2.8.2 Preannealing of repetitive sequences
Probes containing repeat sequences were annealed, after labelling, to repeat-
containing DNA. This was done to prevent the repetitive part of the probe
from taking part in the hybridisation reaction. This procedure was adapted
from Sealey et at, 1985.
After the probe was labelled, it was denatured at 100°C for 10 minutes in the
presence of 1mg sonicated mouse DNA. The two were then incubated
together in a pre-warmed lead pot at 65°C for 30 minutes, before being added
to the hybridisation mixture.
2.8.3 End labelling of DNA oligonucleotides
Oligonucleotides were labelled by the transfer of a 32P-labelled phosphate
onto the terminal 5'-OH group.
30ng oligonucleotide was labelled in a 20pil volume which contained 1X
Polynucleotide kinase buffer (5mM Tris.HCI, pH8; 1mM MgCI2, 0.5mM DTT,
Boehringer Mannheim), 10 units of polynucleotide kinase (Boehringer
Mannheim) and 30pCi [32P]yATP (Amersham). Reactions were incubated at
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6X SSC, 10% dextran sulphate, 0.1% sodium pyrophosphate, 0.5% sodium
dodecyl sulphate, 4X Denhardts solution (from 100X Denhardts solution: 2%
BSA; 2% polyvinylpyrrolidone; 2% ficoll; 1mM EDTA; stored at 4°C).
Oligo hybridisation mix
5X SSC, 0.05% BSA, 0.05% ficoll, 0.1% sodium dodecyl sulphate, 0.05%
polyvinylpyrrolidone, 0.1% sodium pyrophosphate.
2.9.2 Pre-hybridisation protocols
When an end-labelled oligonucleotide was used, the pre-hybridisation of
filters was carried out in oligo hybridisation mix at 5°C below the Tm of the
oligonucleotide (section 2.10.1). For random primed probes, pre-hybridisation
took place at 68°C in hybridisation mix, except for the hybridisation of YAC
end fragments (section 2.10.6) onto YAC, or mouse genomic, DNA filters,
when a hybridisation temperature of 65°C was used. Filters were placed
between two gauze sheets, soaked in 2X SSC and placed in a hybridisation
bottle (Hybaid). Air bubbles were removed from the gauze and 10ml of
hybridisation mix added to the small bottles and 20ml to the larger ones.
Bottles were placed in a Hybaid hybridisation oven on a rotating spindle for at
least one hour before the addition of labelled probes. When salmon sperm
was used to block the probe, a 100)ig/ml solution was denatured and added
to the hydridisation mix.
2.9.3 Hybridisation and washing protocols
End-labelled oligonucleotides hybridisations were carried out for 4-16 hours at
the appropriate hybridisation temperature, usually 45-48°C. Filters were
removed from the hybridisation bottles and given three, five minute washes
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using a solution, at the same temperature at which the hybridisation was
carried out in, of 4X SSC, 0.1% SDS.
Random primed hybridisations were incubated at 68°C or 65°C for 16 hours.
Filters were washed first in their bottles using a wash solution of 2X SSC,
0.1% SDS for 20 minutes at 68°C (65°C for YAC end fragment hybridisations).
They were then removed from the bottles and washed with increasing
stringency with 1X SSC, 0.1% SDS and finally in 0.1 X SSC, 0.1% SDS at
68°C, or 65°C.
2.9.4 Detection of hybridisation signal
Autoradiography The filters were placed in a light-safe cassette with a signal
enhancing screen. They were then exposed to X-OMAT x-ray film (Kodak) for
a length of time dependent on the amount of radiolabeled probe left bound to
the filter (several minutes to several days). Filters hybridised to 32P-labelled
probes were exposed at -70°C, those labelled with 35S were exposed at room
temperature. Stratagene Glogos II luminescent markers were used for
alignment. The film was developed on an automatic x-ray film processor RGII
(Fuji).
Phosphorimaging Alternatively, the filters were exposed to a phosphor screen
(Molecular Dynamics) for periods ranging from a few hours to several days.
The screen is scanned on a Phosphorlmager (Molecular Dynamics), where a
laser beam converts the radioactive signal into a digital image, with variations
in the pixel value proportional to the amount of radioactive signal present. The
grey-scale image was adjusted as desired and the image printed out on a
laser printer (Hewlett and Packard).
2.9.5 Removal of radioactive probes from filters
Filters may be used several times with different hybridisation probes, so it
was sometimes necessary to remove radioactive probes from filters. This was
done in one of two ways. Firstly, the filters could be washed in 0.4M NaOH at
38
50°C for 30 minutes, to denature the probe DNA strand from the surface of
the filter. The neutral pH was then restored by a 30 minute wash in a solution
of 0.1x SSC, 0.1% SDS and 0.2M Tris.HCI, pH 7.5, also at 50°C. Alternatively
the filters could be subjected to one very stringent wash, in 0.1% SDS at
100°C for 5 minutes.
The filters were then exposed to x-ray film overnight to check that the
radioactive probe had been removed.
2.10 Amplification of DNA by the Polymerase Chain Reaction (PCR)
PCR is a technique used for the amplification of a specific DNA sequence
(Saiki et al, 1988; Mullis and Faloona, 1987). The specificity is provided by
oligonucleotide primers complementary to the 5' ends of the two strands of
the sequence to be amplified. These primers anneal to the template DNA
strand and direct amplification by a thermostable polymerase. The PCR
reaction is a series of cycles, each consisting of three steps. The first is a
short high temperature step (92-94°C) to denature the template. This is
followed by a reduction in temperature to allow the primers to anneal to the
template (~50-65°C depending on the primers used), then finally the
temperature is increased to 72°C to permit extension from the primers by the
polymerase. Multiple cycles of these three steps result in exponential
amplification of the desired sequence.
2.10.1 PCR conditions
Commonly 100ng of template genomic DNA was amplified in a 50pl total
volume, with 0.2pl (1 unit) Amplitaq (Perkin Elmer Cetus) in 1x reaction buffer
(10mM Tris.HCI, pH 8.3, 50mM KCI, 1.5mM MgCI2, 0.01%(w/v) gelatin) and
0.1% Triton X-100 (Sigma). The reaction employed 300ng of each primer and
200pM each dNTP (Advanced Biotechnologies). The reaction was overlaid
with 40jllI mineral oil (Sigma).
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PCR programmes were run on an Hybaid Omnigene machine. The basic
programme was 30 cycles of 3 different steps:
a) Denaturation: A short step at 92-94°C. Usually 3 minutes in the first cycle
and 30 seconds thereafter.
b) Annealing: The annealing temperature is critical in determining the success
of the PCR reaction and is dependent on the structure of the primer. The
annealing temperature of the primer was always 5°C lower than the melting
temperature (Tm) of the primer, which was determined using the equation:
Tm at 1M Na+ concentration = 4(G+C) + 2(A+T)
In a number of cases conditions were modified in order to optimize
amplification. If, at first, no product was produced then the annealing
temperature was dropped by 2°C until a product was amplified. The MgCI2
concentration was also modified if amplification failed. Where non-specific
amplification occurred, the annealing temperature was increased by 2°C until
a product of a specific size was seen.
c) Extension: The extension time is also critical in determining the success of
the PCR, since larger products need longer extension times (approximately 1
minute per kb of sequence). Thirty cycles of 72°C was generally used but the
number of cycles were increased where amplification after 30 cycles was
insufficient. If the size of the product was unknown, longer extension times
were used with an increase after 10-20 cycles.
After the reaction, 5-1 Opil of the PCR reaction was visualised by
electrophoresis on 1-4% agarose gels (see section 2.4.2).
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2.10.2 Oligonucleotide Synthesis
Oligonucleotides were synthesised as ammonium stocks on an Applied
Biosystems 381A oligonucleotide synthesiser.
Oligonucleotides were precipitated from ammonium stocks by the addition of
1/10th volume of 3M sodium acetate and 2.5 volumes of ethanol, followed by
one hour incubation at -20°C. The precipitated DNA was pelleted by
centrifugation at 4°C, washed twice in 80% ethanol and resuspended in 200pil
TE. The concentration of the DNA was determined by measuring the optical
density of the solution, where the absorbance at 260nm (ABS260) = 1 at
25|ig/ml single stranded DNA.
2.10.3 Oligonucleotide primer design
Primers were designed using the programme Oligo4 (Hybaid). Primers were
designed from available sequence information and were between 18 and 25
oligonucleotides in length depending on the DNA source on which they would
be used. They were chosen to be stable oligonucleotides with a Tm between
45°C and 65°C.
2.10.4 Oligonucleotide sequence
The primer sequences, conditions of amplification, size of the amplified
fragment and the source of sequence information is given in table 2.10.4 (at
the end of the chapter).
2.10.5 PCR from yeast colonies
This method was adapted from Taylor (1991).
Individual yeast colonies were picked with a sterile wooden toothpick and
resuspended in 50pl of dHaO. The resuspension was boiled for 10 minutes,




Adapted from Arveilerand Porteous, 1991.
This method was used to isolate fragments from the ends of YACs. 2|ig YAC
DNA was digested with a range of enzymes in a volume of 20|il (see section
2.6.1). For right arm end fragments, YAC DNA was digested individually with
Psfl, Rsa\, EcoRV and A/del, and for left arm end fragments Taq\, Rsa\, EcoRI
and Sad were used (all enzymes from Boehringer Mannheim). The digestion
products were cleaned using Geneclean (Bio 101), resuspended in 20|il H20
and ligated under dilute conditions, to generate monomeric circles.
Ligation reactions were carried out in a 10pl volume which contained: 0.1 unit
of T4 DNA ligase (Boehringer Mannheim), 1pl of the digested, cleaned DNA
and 1 ptl of 10X ligase buffer (Boehringer Mannheim, 50mM Tris.HCI, pH7.4;
100mM MgCI2; 10mM DTT; 1mM spermidine; 1mM ATP; 100g/ml BSA).
The reaction was incubated overnight at 16°C, after which the enzyme was
heat inactivated by incubation at 68°C for 20 minutes. Ipl of this ligation
reaction was used in a 50|llI volume PCR reaction as described in section
2.9.1.
PCR products from inverse PCR reactions were run out on 1% agarose gel.
Each checking gel was Southern blotted (section 2.5.1) and the filter probed
with internal oligos; the right arm oligo used was 770 and the left arm one was
768 (see table 2.10.4). This was done to verify which inverse PCR products
were derived from YAC inserts and which had arisen as a result of non¬
specific amplification. Where 2 or more bands arose following inverse PCR,
the PCR reaction was run on a 1% LMP gel (section 2.5.3) and the upper
band was excised for use as an end fragment probe.
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2.10.7 PCR using end-labelled oligonucleotides
End-labelled oligonucleotides were used for PCR amplification when the
species-specific size polymorphisms in PCR products were too small to be
resolved on 4% NuSieve or 8% acrylamide gels.
One of the PCR primers was end-labelled in a 20pJ volume labelling reaction,
as in section 2.8.3. The PCR was set up as detailed in section 2.10.1, with
the addition of 1pl of the end-labelled oligonucleotide. Before loading onto the
gel, 5)0.1 of the PCR reaction was mixed with 5pl of Stop solution (95%
deionised formamide, 20mM EDTA, 0.05% bromophenol blue, 0.05% xylene
cycinol FF) and denatured at 90°C for 10 minutes, then chilled on ice. 4|oJ of
the sample was then loaded onto a 6% denaturing polyacrylamide gel (see
section 2.5.4) for electrophoresis.
2.11 DNA sequencing
2.11.1 Sequencing of PCR products
This method has been modified from Winship, 1989.
In order to directly sequence PCR products, the required product was purified
from a gel in order to separate it from primer dimers and spurious PCR
products. A substantial amount of DNA was required in the reaction itself, so
in some cases, the product of several PCR reactions were pooled and
concentrated into a smaller volume by ethanol precipitation. The resulting
product was gel purified by running it on a 1% LMP agarose gel and the
required band was excised. The DNA was recovered from the gel slice as
described in section 2.5.3. Following resuspension, the DNA concentration
was checked by running 1pl of the sample on an agarose gel, next to a
known amount of size marker. Approximately 200ng DNA was used per
sequencing reaction.
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The sequencing reactions were carried out using a Sequenase Version 2.0 kit
(Amersham). Firstly, the DNA was mixed with 300ng sequencing primer,
1.25pJ DMSO and 2.5pl 5x Sequenase reaction buffer and made up to a total
volume of 12.5pl with water. This mix was denatured by heating it to 100°C
for 3 minutes. Following denaturation, the tube was immediately removed to
liquid nitrogen or dry ice, to snap freeze the DNA mix and prevent the strands
from re-annealing.
A labelling mix was made up from the kit containing 1.75(xl enzyme dilution
buffer, 1pl DTT, 0.4pl dGTP labelling mix and 0.25)il Sequenase enzyme per
reaction. To this was added 1.6jil water and 0.5|j.l of 10piCi/ptl [a-35S]-dATP,
and the tube kept on ice. One tube of DNA mix was thawed quickly, then
5.5|jJ of the labelling mix was immediately added and mixed by pipetting. 3.5|il
of this was then applied to the side of 4 Eppendorf tubes, each one containing
2.5jil of one of the 4 termination mixes containing 10% DMSO (G,A,T and C).
The 4 tubes were then briefly spun to combine the labelling and termination
mixtures simultaneously. The time from thawing the DNA, to mixing with the
termination mix, was kept to approximately 1 minute.
Termination tubes were transferred to a 37°C water bath and incubated for 5
minutes. Reactions were stopped by the addition of 4pl stop mix (95%
formamide, 20mM EDTA, 0.05% bromophenol blue, 0.05% xylene cyanol FF)
and were stored at -20°C for up to one week. Prior to loading, the sequencing
reactions were heated to 80°C for 2 minutes to denature the DNA and 2.5[il of
each sample was electrophoresed on a 6% denaturing polyacrylamide gel
(section 2.5.4).
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2.12 Statistics used in backcross analysis
2.12.1 Calculation of genetic distance
Genetic distances, measured in centiMorgans (cM), were calculated using the
following equation:
Distance in centiMorgans = (R/ N) X 100
where R = the number of recombinants
and N = the number of animals haplotyped at that locus
2.12.2 Calculation of standard errors
In order to calculate the standard error for genetic distances, the following
equation was used and the result multiplied by 100 for use with cM distances:
SE = pq
n
where: p = recombination frequency
q = 1 - p
n = no. of animals
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5'GTCA GGCAT T3' 5'CCTAGGTT AAG C3'




95°Cfor2minx1 92°Cforimin] 55°Cfor1min]x33 72°Cfor1min30sees]
Zahedietl{1991)
nodal
5'CTCAA TG G3' 5'GGCAGT TCCAT3'
95°Cfor2minx1 92°Cforimin] 50°Cfor1min30sees]x30 72°Cforminl
Zhouetal(1993)
InversePCR Leftarm Rightarm
5'GAATGGATCCC3' 5'GCCAAGTTTAG3' 5'GGAACGAC3' 5'GCCCGAT TA3'
94°Cfor3minx1 92°Cfor45sec] 60°Cfor1min]x17 72°Cformin30sec] 92°Cfor45sec} 60°Cfor1min}x17 72°Cfor3min} 72°Cfor10minx1
Arveiler&Port ous(1991)
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Chapter 3: Chromosome 2 mapping in the
region of Sd
3.1 Introduction
In mouse genetics, the search for a gene responsible for a mutation with an
unknown biochemical basis begins with the establishment of a detailed
linkage map. This approach is also used in human genetics, but mapping
genes in the mouse is simpler than mapping genes in humans because
controlled matings between different strains of mice can be used. Mouse
genetic mapping serves two distinct purposes. Primarily, mapping allows a
locus responsible for a mutation to be placed onto a map relative to other
chromosomal markers, either probes derived from functional genes or
anonymous DNA markers. In this way, known genes can be mapped with
respect to mutant loci. If a gene fails to recombine with such a locus, and if it
has an expression pattern or known biochemical function which correlates
with the mutation's aetiology, such a gene can be considered as a
"candidate" gene for the mutation. Several genes have successfully been
cloned in this way, including the a, subunit of the inhibitory glycine receptor,
responsible for the mouse mutation spasmodic (Ryan et at., 1994) and
tyrosinase-related protein, the gene responsible for the mouse mutation
brown (Jackson, 1988). The drawback to this strategy is that cloning by the
candidate gene approach still depends on partial functional information about
the disorder being available, allowing for "educated" guesses to be made as
to the identity of the gene responsible. To some extent, high resolution
mapping can reduce the guesswork involved in the candidate gene approach
since the resolving power of a cross increases with its size. In this way,
genes which appear to be ideal candidates for a mutation can be excluded if
they recombine outwith of a defined interval, the size of which decreases
with the number of animals mapped.
The other main purpose that mouse genetic mapping serves is in the
development of physical maps. Physical maps become vital when mutant
genes cannot be identified by the candidate gene approach, thus
necessitating the initiation of a positional cloning exercise (Collins, 1995).
Markers that have been finely mapped and ordered via backcross, or
intercross, mapping serve as a scaffold onto which overlapping YAC or
cosmid clones can be placed and positioned relative to each other and the
mutant locus.
Mapping in the mouse is not without its drawbacks. In situ hybridisation and
somatic cell hybrids, which have been powerful tools in the mapping of
human disorders, have been used less successfully in mouse genetic
mapping. In the case of in situ hybridisation, this has been due to the
acrocentric nature of mouse chromosomes making it harder to cytologically
discriminate between individual chromosomes. In addition, somatic cell
hybrids that carry single mouse chromosomes, or chromosomes with
deletions or translocations, are not as widely available in mouse genetics as
they are in human genetics (Copeland et al., 1993). For this reason, mouse
genetics relies heavily on backcross and intercross mapping for the
assignment of markers to loci of interest. In response to this emphasis, new
types of genetic markers have been developed to allow for the rapid
generation of high resolution linkage maps. Mouse mapping traditionally
relied on the identification of restriction fragment length variants (RFLVs)
which allowed published genes to be mapped using inherent polymorphisms
between strains or species of mice. A more rapid and recent means of
mapping, has been to utilise simple sequence repeat variants (usually di-, tri¬
or tetranucleotide repeats), which have a high frequency of polymorphic
length variation between strains and species of mouse. These are PCR-
amplifiable and have been generated in large numbers, now covering most
of the mouse genome (Love etal., 1990; Dietrich et al., 1994).
In addition to the rapid generation of new markers, a substantial
improvement in the power of backcross and intercross mapping came with
the introduction of interspecific crosses (Avner et al., 1988). Until relatively
recently, mouse gene assignments relied on crosses between laboratory
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strains of mouse or on recombinant inbred strains (Taylor, 1989). These
crosses were, however, limited by the low degree of allelic variation between
the strains, a problem which was overcome with the introduction of
interspecific crosses. Interspecific crosses exploit the genetic diversity
between wild species of mouse (such as Mus spretus) and laboratory strains.
For this reason, most genes and DNA fragments are variant in an
interspecific cross and can be ordered relative to other genes and markers in
a single cross. There are, however, disadvantages in using Mus spretus as
the wild mouse species in an interspecific cross, the main one being that the
F1 males are infertile, thus preventing the study of male meiosis and slowing
down the accumulation of sufficient backcross progeny to allow for high
resolution mapping. It is for these reasons that we chose to use the Mus
musculus sub-species, Mus musculus castaneus, in place of Mus spretus in
setting up the Sd backcross, since both male and female F1 mice are fertile.
Using M.m.castaneus has allowed us to rapidly generate sufficient numbers
for mapping Sd in a highly polymorphic backcross.
3.2 Sd backcross
Mice heterozygote for Danforth's short tail (Sd) mutation were obtained from
Harwell and were maintained by the Biomedical Research Facility, at the
Western General Hospital. An Sd stock was established by crossing the Sd
mice to an inbred laboratory strain of mouse derived from CBA/Ca, for two
generations prior to setting up the backcross. Sd mice were then mated with
inbred M.m.castaneus CAST/Ei mice to produce the F1 generation. Thirteen
F1 heterozygous Sd mice, both male and female, were set up in breeding
pairs with CBA mice to produce the backcross progeny. All the backcross
offspring were killed at 24 days of age except in a small number of cases,
when backcross offspring were killed at a later age due to errors in the
identification of pregnant females.
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The backcross generated 336 offspring: 156 females and 180 males. Sd is
fully penetrant in this backcross with a ratio of 164 Sd mice to 163 wild type
mice, showing the expected 50:50 ratio of a fully penetrant genetic trait. The
first nine offspring of the backcross were not included in this calculation as
the wild type mice from these litters were mistakenly killed. For a summary of
the breeding protocol used in this backcross, see figure 3.2.
3.3 Phenotypic records of backcross progeny
A detailed phenotypic record was kept of each backcross animal, both wild
type and Sd. Kidneys were dissected and their size and appearance
recorded (kidney length was measured in millimetres). It was noted whether
there was a difference in size between the two kidneys, and if so, from which
side of the animal (left or right) the larger/ smaller kidney came from. Tail
length was measured and any abnormalities in the tails' appearance were
noted. If the overall size of the animal was different from its littermates, and
on the few occasions when paralysis of the hind limbs was evident, this was
noted along with the overall condition of the animal. For a summary of results
of the phenotypic analysis of the backcross progeny, see table 3.3.1 at the
end of the chapter.
Bred onto a CBA background for two generations, the Sd mice used in this
study and produced by the backcross did not show the high rate (70%) of
postnatal mortality observed in the original Sd mice (Dunn et al., 1940),
suggesting that the phenotype of the mutation on this genetic background is
not as severe as it has been on others (Dunn et al., 1940). Data presented in
table 3.3.1 indicates that the increased viability of heterozygous mice, in this
study, is likely to be due to the decreased severity of the kidney phenotype










Figure 3.2 Breeding protocol for Sd backcross
The first pair of chromosomes, 1, represent the Sd allele (denoted with a
minus sign) on a CBA background (clear centromere, bold line). Sd mice
were crossed with CAST/Ei mice (2), to produce the F1 generation (3) (the
M.m.castaneus alleles are depicted by a filled in centromere and fine line).
Mice heterozygous for Sd in the F1 generation were then backcrossed to
CBA mice (4), to produce heterozygous Sd (5) and wild type (6) backcross
progeny. Allele pairs 5 and 6 are depicted as recombinant chromosomes.
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In order to facilitate the search for genes modifying the expressivity of Sd,
records were made of the tail length and kidney phenotype of a number of
the F1 generation. For a summary of this data see table 3.3.2.
Pair No. Sex Phenotype Tail length Kidney phenotype
Pr4 female Sd+ 4.5cm normal
Pr4 male WT 9cm normal
Pr5 female WT 9.5 normal
Pr5 male Sd+ 5.5cm normal
Pr6 female WT 9.5cm normal
Pr6 male Sd+ 6cm small
Pr7 male Sd+ 4.5cm normal
Pr7 female WT 9.5cm normal
Pr9 female Sd+ 5cm small
Pr9 male WT 9.5cm normal
Pr13 female Sd+ 3.3cm normal
Pr13 male WT 9.5cm normal
Table 3.3.2 Phenotypic analysis of F1 breeding pairs
Sd+ indicates heterozygous Sd mice, WT indicates wild type mice. Tail
lengths are given in centimetres. Small kidneys were those of less than 1cm
in length.
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3.4 Mapping Sd backcross
The first 100 mice of the backcross were typed for the following markers:
D2Mit1, D2Mit31, Pax8, D2Mit79 and D2Mit7. The D2Mit markers were
typed by PCR using the conditions shown in table 2.10.4. Pax8 (figure 3.4.2)
was typed by amplifying the 3' end of the gene using the PCR primers shown
in table 2.10.4, and resolving the PCR product on a HydroLink gel using the
running conditions given in section 2.5.5. The haplotyping of these mice is
shown in figure 3.4.1. This initial data established D2MH31 and D2MH7 as
markers which flanked Sd.
Mice subsequent to the first 100 offspring were initially typed using D2Mit31
and D2MH7. Mice that were recombinant in this interval were typed for Pax8.
Those mice which were recombinant between D2MH31 and Pax8 were
mapped more finely using the following panel of markers: D2Mit119,
D2Mit149 (vimentin), D2MH118, D2M4267, D2MH464, D2MH362, D2Mit178,
D2Mit80, D2Mit6, 111 rn and D2MH292 ( see table 3.4.1). Once Pax8 had
been excluded as a candidate gene, the last 56 animals (280-336) were
initially typed for just D2MH31 and D2Mit7 and the recombinant mice finely
mapped with the markers in table 3.4.1. Since it proved difficult to find a
variance between CBA and CAST/Ei DNA to use in the mapping of Pax8, the
majority of animals were already mapped for D2MH31 and D2MH7 before the
3' variant was found which could be typed using HydroLink analysis. For this
reason, once the backcross analysis had excluded Pax8 as a candidate
gene, it was no longer mapped due to the greater effort involved than with
the simpler PCR-able D2Mit markers.
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Figure 3.4.1 Haplotype analysis of the first 100 mice of the backcross
The filled in black box (■ ) denotes the M.m.castaneus allele and the unfilled
box ( CJ denotes the Sd allele. The figures at the end of each column indicate
the number of mice which were recombinant between the markers shown.
The underlined figure at the top of each set of columns indicates the number
of backcross animals typed.
58
Distance CBA- Sd- CAST/Ei
Mit between derived derived -derived Gel used
Marker markers allele allele allele to resolve
(cM) (bp) (bp) (bp) alleles
D2MH1 0 120 120 140 4% NuSieve
D2MH31 7 +/- 2.5 136 136 96 4% NuSieve
D2Mit119* 0 148 148 142 HydroLink
D2Mit 149* 0.6 +/- 0.4 197 197 209 8% acrylamide
D2Mit118* 0 123 123 72 4% NuSieve
D2MH267* 1.5 +/- 0.7 133 133 119 4% NuSieve
D2MH464* 0.6 +/- 0.4 126 140 134 8% acrylamide
D2MH362* 0 115 115 147 4% NuSieve
D2Mit178 N/D 125 127 127 6% acrylamide
D2MH80* 0.9 +/- 0.5 180 180 186 8% acrylamide
D2MH6* 0 124 124 105 8% acrylamide
D2MH292* 0.6 +/- 0.4 140 140 122 4% NuSieve
D2MH79 0 142 142 118 4% NuSieve
D2MH7 11 +/-3.1 214 214 256 4% NuSieve
Table 3.4.1 D2Mit marker panel used to type Sd backcross
D2Mit1 was used as the most proximal marker on chromosome 2 according
to its map position from the MIT database. Recombination distances for the
remaining markers were calculated from the Sd backcross and the cM value
given indicates how far each marker maps from the marker directly above it.
Recombination distances between D2Mit1 and D2MH31, D2MH292 and
D2MH79, and D2MH79 and D2MH7 were calculated from the first 100
recombinants of the backcross. Remaining recombination distances were
calculated from the whole backcross. Standard error and cM values were
calculated as in section 2.12. Markers denoted with an asterix (*) were
mapped to a panel of mice which were non-recombinant between the
markers D2MH31 and D2Mit7. Two markers, D2MH464 and D2MH178,
amplified differently sized Sd and CBA alleles. It was not possible to map
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Figure 3.4.2 Pax8 haplotyping of backcross
Pax8 was amplified by PCR (table 2.10.4) and the product resolved on a
HydroLink gel using conditions given in section 2.5.5. Figure a) shows the
CBA, CAST/Ei and F1 DNA controls, and figure b) DNA from the backcross.
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Figure 3.4.3 111 rn haplotyping of backcross
111 rn was amplified by PCR (table 2.10.4) and the product resolved on a
HydroLink gel using conditions given in section 2.5.5. Figure a) shows the
CBA, CAST/Ei and F1 DNA controls, and figure b) DNA from the
recombinant panel of backcross mice. The upper pair of bands show the
CBA-CAST/Ei heteroduplex.
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To ensure that the markers used for the haplotyping of the recombinant mice
were mapping to the correct region of chromosome 2, those marked with an
asterix in table 3.3.1 were mapped to a panel of mice which were non-
recombinant between the markers D2MH31 and D2Mit7. All markers showed
concordance with the haplotype derived from the mapping of these two
markers. Il1rn (figure 3.4.3) was typed in a similar way to Pax8, by PCR-
amplifying the 3' untranslated end of the gene and resolving the PCR
product on a HydroLink gel, using the running conditions given in section
2.5.5. As with Pax8, this allowed size-retarded CBA-CAST/Ei heteroduplexes
to be identified, which could be used for backcross haplotyping (see section
2.5.5).
Of the markers mapped onto the recombinant panel of mice, only D2Mit178
could not be haplotyped, since the products produced from the Sd and
CAST/Ei allele were identical in size (table 3.4.1). D2MH464 also amplified
differently sized products from the CBA and Sd alleles. These markers may
therefore define a congenic interval flanking Sd which is not derived from the
CBA genome, but from the unknown strain on which Sd arose.
For a summary of the mapping data see table 3.4.2 and figure 3.4.4.
Mapping data for the whole backcross is given in figure 3.4.4. Table 3.4.2
gives the individual haplotypings of the mice in the recombinant panel which
were finely mapped with the markers between D2MH31 and D2Mit7.
From figure 3.4.4 it can be seen that segregation distortion has occurred
between two sets of markers, D2Mit118 and D2Mit267, where 5 out of 5
recombinations have been from the CAST/Ei allele to the CBA allele; and
between D2MH362 and D2Mit80, where 3 out of 3 recombinations have been
from the CAST/Ei allele to the CBA allele. It is not possible from this number

















































































































































































































































































































































Figure3.4.4:HaplotypingsfthemicrecombinantbetwD2Mit31andH7(conti u dxpa e)
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Figure 3.5.1 Genetic map of mouse chromosome 2, in the region of Sd
Mapped loci are listed to the right of the chromosome, distance between loci
in centiMorgans (cM) to the left. Figures in parentheses show the number of
mice recombinant between loci, over the number of mice haplotyped. cM
distances and standard errors were calculated as in section 2.12. Regions of






















































Figure 3.5.2: Genetic maps of mouse chromosome 2 generated from male
and female meioses
Map A was generated from progeny arising from female F1 mice, and
map B from the offspring of the male F1 mice. The figures in
parentheses indicate the number of mice recombinant in each interval
over the total mapped. There were 233 backcross progeny from the
male meioses, and 103 from the female meioses. In the first 100
offspring, there were 29 mice from the female, and 71 mice from the
male meioses. In the first 280 backcross mice, there were 189 male-
meioses and 91 female-meioses offspring. CentiMorgan distances (cM)
and standard errors were calculated as in section 2.12.
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Genetic maps in the region of Sd generated from male and female meioses,
are given in figure 3.5.2, whilst an integrated map using mapping data from
the whole backcross is shown in figure 3.5.1. Mammalian recombination
frequencies are generally higher in females (Roderick and Hillyard, 1989),
and this proves to be true for the Sd backcross, since the size of the region
between D2MH1 and D2Mit7 is greater in the female map (30.9cM), than in
the male map (18.9cM). However in map A (figure 3.5.2) a cluster of linked
loci can be seen (D2MH6, D2MH80, Pax8, Il1rn, D2MH79 and D2MH292),
between which recombination in the female meioses has not occurred. In the
male map B, some of these loci can be ordered due to increased
recombination in this region.
3.5 Discussion
At the outset of this project, the gene Pax8 was a very strong candidate for
the Danforth's short tail mutation, since it was known to map to the region
and is expressed in both the kidney and the neural tube during development
(Plachov et al., 1990). Other members of the Pax gene family had previously
been found to be responsible for a number of semi-dominant developmental
mutations, e.g. Pax6 was found to be mutated in small eye mice (Hill et al.,
1991) and in humans with aniridia (Jordan et al., 1992); similarly, Pax3 was
found to be mutated in the mouse mutation splotch (Epstein et al., 1991),
and in humans with Waardenburg's syndrome Type I (Tassabehji et al.,
1992)). These findings gave weight to the possibility that Pax8 could have
been responsible for Sd. Before it was possible to map Pax8 onto the Sd
backcross considerable analysis of the gene was carried out, including
sequencing of the gene from cDNA prepared from homozygous and
heterozygous mice, and in situ analysis of Pax8 expression in Sd embryos.
We were unable exclude Pax&s candidacy, however, until the gene was
mapped onto the backcross and shown to be outwith the region directly
flanking Sd (figure 3.5.1), confirming the findings of Koseki et al. (1993b).
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Using the backcross, we were also able to assess other candidate genes in
the region. D2Mit149 is a marker derived from a repeat within the vimentin
gene, which is expressed in both the kidney (Franke et al., 1982) and central
nervous system (Cochard and Paulin, 1984) during mouse development, and
as such was a potential candidate for Sd. Backcross analysis, however,
showed that this gene maps 2.7cM proximal to Sd and is therefore not
responsible for the mutation (figure 3.5.1). Finally, interleukin 1 receptor
antagonist, 111 rn, has also been excluded by the mapping presented here as
a candidate gene for the mutation.
The resulting genetic map of the region around Sd (figure 3.5.1) shows that
D2MH362 and D2MH464 are the closest flanking markers proximal to Sd, and
that D2Mit6 and D2MH80 are the closest flanking markers distal to Sd. By
using these flanking markers to screen YAC libraries, a positional cloning
exercise was initiated in order to isolate the gene responsible for Sd.
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Paren¬ Pheno- Tail Tail Kidney Abnorm.
No. Sex tage type Length Type No. kidneys
1 Male Pr2L1 Sd+ 1.5cm E 1 LHS
2 Male Pr2L1 Sd+ 0.8cm F 2 RHS>LHS
3 Female Pr2L1 Sd+ 3cm B 1 LHS
4 Male Pr3L1 Sd+ 1cm C 1 LHS
5 Male Pr3L1 Sd+ 1,8cm D 1 LHS
6 Female Pr3L1 Sd+ 2.7cm D 2 small RHS>LHS
7 Female Pr3L1 Sd+ 3.5cm E 2 RHS>LHS
8 Female Pr3L1 Sd+ 0.8cm C 2 LHS>RHS
9 Female Pr2L2 Sd+ 4.4cm B. 2 small
10 Male Pr2L2 WT 8cm A 2
11 Male Pr2L2 WT 8cm A 2
12 Male Pr2L2 WT 7.5cm A 2
13 Female Pr3L2 WT 7.1cm A 2
14 Female Pr3L2 WT 7.5cm A 2
15 Male Pr3L2 Sd+ 1,5cm B 2 small
16 Male Pr3L2 Sd+ 1cm C 2 small
17 Male Pr3L2 Sd+ 2.5cm B 2
18 Male Pr3L2 Sd+ 1.3cm D 2 small
19 Male Pr3L2 WT 7cm A 2
20 Male Pr3L2 WT 7cm A 2
21 Female Pr4L1 Sd+ 0.3cm C 2 small
22 Female Pr4L1 WT 7cm A 2
23 Female Pr4L1 WT 6.5cm A 2
24 Female Pr4L1 Sd+ 1.3cm D 2
25 Male Pr4L1 WT 6.4cm A 2
26 Male Pr4L1 Sd+ 2.1cm B 2
27 Male Pr4L1 WT 7cm A 2
28 Male Pr4L1 WT 7cm A 2
29 Male Pr3L3 Sd+ 2.3cm F 2 RHS>LHS
30 Male Pr3L3 Sd+ 1.7cm B 2 RHS>LHS*
31 Male Pr3L3 Sd+ 1cm C 2
32 Male Pr3L3 WT 7cm A 2
33 Female Pr3L3 Sd+ 1.5cm D 2 RHS>LHS
34 Female Pr3L3 WT 6cm A 2
35 Female Pr3L3 WT 6cm A 2 small
36 Male Pr2L3 Sd+* 0.5cm C 2 RHS>LHS
37 Male Pr2L3 Sd+ 0.8cm C 2 small
38 Male Pr2L3 WT 6.5cm A 2
39 Female Pr2L3 Sd+ 2.5cm E 2
40 Female Pr2L3 Sd+ 3cm B 2 RHS>LHS*
41 Female Pr2L3 WT 6cm A 2
42 Female Pr2L3 WT 7.1cm A 2
Table 3.3.1 Phenotypic analysis of backcross progeny
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Paren¬ Pheno- Tail Tail Kidney Abnorm.
No. Sex tage type Length Type No. kidneys
43 Female Pr2L3 WT 7.1cm A 2
44 Female Pr3L4 Sd+ 2cm B 2 RHS>LHS
45 Female Pr3L4 Sd+ 1.7cm B 2
46 Female Pr3L4 WT 6.5cm A 2
47 Male Pr3L4 Sd+ 2.3cm B 2 small
48 Male Pr3L4 Sd+ 1.2cm E 2 RHS>LHS
49 Male Pr3L4 WT 6.5cm A 2
50 Male Pr7L1 Sd+ 2.4cm B 2
51 Male Pr7L1 WT 7.5cm A 2
52 Female Pr7L1 WT 7cm A 2
53 Male Pr7L1 WT 7cm A 2
54 Male Pr5L1 WT 7.2cm A 2
55 Male Pr5L1 Sd+ 2.7cm E 2 RHS>LHS
56 Male Pr5L1 Sd+ 1cm D 2 RHS>LHS
57 Male Pr5L1 Sd+ 1,6cm D 2 RHS>LHS
58 Male Pr5L1 WT 7.5cm A 2
59 Male Pr5L1 WT 7cm A 2
60 Male Pr5L1 WT 6.5cm A 2
61 Female Pr5L1 Sd+ 0.5cm C 2 RHS>LHS
62 Male Pr2L4 Sd+ 1.5cm B 2 RHS>LHS
63 Male Pr2L4 WT 6.5cm A 2
64 Male Pr2L4 WT 6.7cm A 2
65 Male Pr2L4 WT 7.1cm A 2
66 Male Pr2L4 WT 6.5cm A 2
67 Female Pr2L4 WT 6.7cm A 2
68 Female Pr2L4 Sd+ 1cm C 2 small
69 Female Pr6L1 WT 6.6cm A 2
70 Female Pr6L1 Sd+ 1,7cm B 2 RHS>LHS
71 Female Pr6L1 WT 7.5cm A 2
72 Female Pr6L1 WT 7cm A 2
73 Male Pr6L1 WT 7cm A 2
74 Male Pr9L1 Sd+ 1.5cm E 2 small LHS*.
75 Male Pr9L1 Sd+ 1.5cm B 2 small RHS>LHS*
76 Male Pr9L1 Sd+ 3cm B 2
77 Male Pr9L1 WT 6.2cm A 2
78 Male Pr9L1 WT 6cm A 2
79 Female Pr9L1 Sd+ 2cm E 2 small RHS>LHS*
80 Female Pr9L1 WT 6.5cm A 2
81 Male Pr8L1 Sd+ 0.9cm C 2 LHS>RHS
82 Male Pr8L1 Sd+ 0.4cm C 2 small
83 Male Pr8L1 WT 7.5cm A 2
84 Male Pr8L1 WT 7cm A 2
Table 3.3.1 Phenotypic analysis of bac <cross progeny (continued)
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Paren¬ Pheno- Tail Tail Kidney Abnorm.
No. Sex tage type Length Type No. kidneys
85 Female Pr8L1 Sd+ 2.8cm E 2
86 Female Pr8L1 Sd+ 1cm D 2
87 Female Pr8L1 Sd+ 2.5cm E 2 small RHS>LHS
88 Female Pr8L1 WT 7.1cm A 2
89 Female Pr8L1 WT 6.7cm A 2
90 Male Pr4L2 Sd+ 1.5cm B 2 small
91 Male Pr4L2 Sd+ 1.6cm E 2 RHS> LHS
92 Male Pr4L2 WT 7cm A 2
93 Male Pr4L2 WT 7cm A 2
94 Female Pr4L2 Sd+ 1cm C 2 small RHS>LHS
95 Female Pr4L2 Sd+ 3cm E 2 small
96 Female Pr4L2 Sd+ 1.2cm D 2 RHS>LHS*
97 Female Pr5L2 Sd+ 2cm E 2 RHS>LHS
98 Male Pr5L2 Sd+ 2cm E 2
99 Female Pr5L2 Sd+ 2.3cm E 2 small RHS>LHS
100 Female Pr5L2 WT 6.4cm A 2
101 Female Pr5L2 WT 6.5cm A 2
102 Male Pr5L2 Sd+ 2.7cm B 2
103 Male Pr5L2 Sd+ 3.5cm B 2
104 Male Pr5L2 Sd+ 1.4cm E 2
105 Male Pr5L2 WT 7cm A 2
106 Male Pr7L2 WT 7.2cm A
107 Female Pr7L2 Sd+ No tail 2 RHS>LHS
108 Female Pr6L2 Sd+ 2cm B 2 small RHS>LHS
109 Male Pr6L2 WT 6.2cm A 2
110 Male Pr6L2 WT 6cm A 2
111 Male Pr2L5 Sd+ 1.5cm B 2
112 Male Pr2L5 WT 6.8cm A
113 Female Pr2L5 Sd+ 1.5cm C 2 small
114 Female Pr2L5 Sd+ 1.7cm B 2 small
115 Female Pr2L5 Sd+ 0.7cm C 2 RHS>LHS
116 Female Pr2L5 WT 6.5cm A 2
117 Female Pr8L2 Sd+ 2.5cm E 2 small
118 Female Pr8L2 WT 7.7cm A 2
119 Female Pr8L2 Sd+ 1.2cm C 2 small
120 Male Pr8L2 WT 7.4cm A 2
121 Male Pr8L2 Sd+* 0.1cm C 2 RHS>LHS
122 Female Pr9L2 WT 7.5cm A 2
123 Female Pr9L2 WT 7.3cm A
124 Female Pr9L2 WT 7cm A
Table 3.3.1 Phenotypic analysis of backcross progeny (continued)
72
Paren¬ Pheno- Tail Tail Kidney Abnorm.
No. Sex tage type Length Type No. kidneys
125 Female Pr9L2 Sd+ 1,5cm B 2 small RHS>LHS
126 Male Pr9L2 WT 7cm A 2
127 Male Pr9L2 Sd+ 2.5cm B 1 RHS only*
128 Male Pr9L2 Sd+ 1cm C 2 small
129 Male Pr7L3 WT 7.1cm A 2
130 Male Pr7L3 Sd+ 3cm B 2 RHS>LHS
131 Male Pr7L3 Sd+ 2cm B 2
132 Female Pr7L3 WT 7.5cm A 2
133 Female Pr7L3 WT 7.5cm A 2
134 Female Pr7L3 WT 7cm A 2
135 Female Pr7L3 Sd+ 3.5cm E 2
136 Female Pr4L3 WT 7.7cm A 2
137 Male Pr4L3 WT 8cm A 2
138 Male Pr4L3 WT 7cm A 2
139 Male Pr4L3 WT 7.5cm A 2
140 Male Pr4L3 WT 7.7cm A 2
141 Male Pr4L3 Sd+ 2.5cm B 2 small
142 Male Pr4L3 Sd+ 3cm E 2 RHS>LHS
143 Female Pr3L5 WT 8cm A 2 RHS>LHS
144 Female Pr3L5 WT 7.9cm A 2
145 Female Pr3L5 Sd+ 3.5cm B 2 RHS>LHS
146 Male Pr6L3 WT 6.5cm A 2
147 Male Pr6L3 Sd+ 2.5cm D 2 small RHS>LHS
148 Female Pr6L3 WT 6.7cm A 2
149 Female Pr6L3 Sd+ 2.1cm D 2 RHS>LHS*
150 Male Pr5L3 Sd+ 2.5cm F 2
151 Male Pr5L3 Sd+ 2.5cm D 2 RHS>LHS*
152 Male Pr5L3 Sd+ 2cm C 2 RHS>LHS*
153 Female Pr5L3 WT 7cm A 2
154 Female Pr5L3 WT 6.8cm A 2
155 Female Pr5L3 Sd+ 4.5cm F 2 RHS>LHS
156 Female Pr5L3 Sd+ 1.5cm C 2 RHS>LHS
157 Female Pr7L4 Sd+ 2.3cm B 2 RHS>LHS
158 Female Pr7L4 Sd+ 0.5cm C 2 RHS>LHS
159 Male Pr7L4 Sd+ 1cm C 2 small
160 Male Pr7L4 WT 6.5cm A 2
161 Male Pr7L4 Sd+ 3cm B 2 small RHS>LHS
162 Male Pr7L4 Sd+ 1.2cm C 1 .smal LHS *
163 Male Pr7L4 Sd+ 2.5cm B 2
164 Female Pr9L3 Sd+ 2.5cm E 2 RHS>LHS
165 Male Pr9L3 WT 6.5cm A 2
166 Male Pr9L3 WT 6.8cm A 2
Table 3.3.1 Phenotypic analysis of bac kcross progeny (continued)
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Paren¬ Pheno- Tail Tail Kidney Abnorm.
No. Sex tage type Length Type No. kidneys
167 Male Pr9L3 WT 7cm A 2
168 Male Pr9L3 Sd+ 2.5cm B 2 RHS>LHS
169 Male Pr9L3 Sd+ 2cm B 2 small
188 Female Pr5L4 Sd+ 3.5cm B 2
189 Female Pr5L4 Sd+ 3.5cm E 2 RHS>LHS
190 Male Pr5L4 WT 7.5cm A 2
191 Male Pr5L4 WT 8cm A 2
192 Male Pr5L4 Sd+ 1.5cm B 2 RHS >LHS
193 Male Pr3L7 Sd+ 3.5cm B 2 RHS>LHS
194 Male Pr3L7 Sd+ 3cm B 2
195 Male Pr3L7 Sd+ 2.3cm E 2
196 Male Pr3L7 Sd+ 2cm B 2 RHS>LHS
197 Female Pr3L7 WT 7cm A 2
198 Female Pr3L7 WT 7cm A 2
199 Female Pr3L7 Sd+ 1.5cm C 2 small
200 Male Pr9L4 WT 7.5cm A 2
201 Male Pr9L4 WT 7.5cm A 2
202 Male Pr9L4 Sd+ 1cm B 2 small
203 Female Pr9L4 Sd+ 0.9cm B 2 small
204 Female Pr9L4 Sd+ 0.2cm C 2 small RHS>LHS
205 Female Pr7L5 Sd+ 4.5cm F 2 RHS>LHS
206 Male Pr7L5 WT 8.5cm A 2
207 Male Pr7L5 WT 8.5cm A 2
208 Male Pr7L5 WT 8.5cm A 2
209 Male Pr7L5 Sd+ 3cm D 2
210 Male Pr7L5 Sd+ 3cm D 2
211 Male Pr7L5 Sd+ 3cm E 2 LHS>RHS
212 Male Pr6L5 WT 8cm A 2
213 Male Pr6L5 WT 8cm A 2
214 Male Pr6L5 Sd+ 4cm E 2
215 Female Pr6L5 WT 7.5cm A 2
216 Female Pr6L5 WT 8cm A 2
217 Female Pr6L5 WT 7.5cm A 2
218 Female Pr6L5 Sd+ 2.5cm E 2 RHS>LHS
219 Female Pr6L5 Sd+ 1.5cm B 2 small
220 Female Pr6L5 Sd+ no tail 2 RHS>LHS
221 Male Pr13L1 WT 7cm A 2
222 Male Pr13L1 Sd+ 2cm F 2
223 Female Pr13L1 WT 6.5cm A 2
224 Female Pr13L1 Sd+ 3cm B 2 small
225 Female Pr13L1 Sd+ 1cm E 2
Table 3.3.1 Phenotypic analysis of backcross progeny (continued)
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Paren¬ Pheno- Tail Tail Kidney Abnorm.
No. Sex tage type Length Type No. kidneys
226 Female Pr9L5 WT 6cm A 2
227 Female Pr9L5 WT 7.5cm A 2
228 Female Pr9L5 WT 7cm A 2 small
229 Female Pr9L5 WT 7.5cm A 2
230 Female Pr9L5 Sd+ 1,5cm B 2 RHS>LHS
231 Male Pr9L5 WT 7cm A 2 LHS>RHS
232 Female Pr6L6 WT 6.5cm A 2
233 Female Pr6L6 WT 6.5cm A 2 RHS>LHS
234 Female Pr6L6 WT 7m A 2
235 Male Pr6L6 WT 6.5cm A 2
236 Male Pr6L6 Sd+ 2cm B 2 small RHS>LHS
237 Male Pr6L6 Sd+ 1cm D. 2
238 Female Pr4L5 WT 7.5cm A 2
239 Female Pr4L5 Sd+ 2cm E 2 small
240 Female Pr4L5 Sd+ 3cm B 2 small RHS>LHS
241 Male Pr4L5 WT 7.5cm A 2
242 Male Pr4L5 WT 7.5cm A 2
243 Male Pr4L5 Sd+ 1.5cm E. 2
244 Male Pr4L5 Sd+ 0.4cm C 2 LHS*
245 Male Pr4L5 Sd+ 0.4cm C 1 LHS only
246 Male Pr13L2 Sd+ 1,5cm E 2
247 Female Pr13L2 WT 6.5cm A 2
248 Female Pr13L2 WT 5.5cm A 2
249 Female Pr13L2 WT 5.5cm A 2
250 Female Pr13L2 Sd+ 1.5cm B 2 RHS>LHS
251 Female Pr7L6 Sd+ 1.3cm D 2
252 Male Pr7L6 WT 7cm A 2
253 Male Pr7L6 Sd+ 1.8cm B 2 small LHS*.
254 Female Pr5L5 WT 7cm A 2 RHS>LHS
255 Female Pr5L5 WT 7cm A 2
256 Male Pr5L5 WT 7.3cm A 2
257 Male Pr5L5 Sd+ 2cm E. 2
258 Male Pr6L7 Sd+ 0.9cm B 2 small
259 Female Pr6L7 WT 6.5cm A 2
260 Female Pr6L7 WT 7cm A 2
261 Female Pr6L7 WT 5.5cm G 2 small
262 Female Pr6L7 Sd+ 2.5cm E. 2 small
263 Female Pr6L7 Sd+ 3cm F. 2
264 Female Pr6L7 Sd+ 2cm E. 2
265 Female Pr6L7 Sd+ 2cm B 2 small
266 Female Pr9L6 WT 7.2cm A 2
Table 3.3.1 Phenotypic analysis of backcross progeny (continued)
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Paren¬ Pheno- Tail Tail Kidney Abnorm.
No. Sex tage type Length Type No kidneys
267 Female Pr9L6 WT 7cm A 2 LHS>RHS
268 Female Pr9L6 WT 7.5cm A 2
269 Female Pr4L6 WT 7cm A 2
270 Female Pr4L6 Sd+ 0.5cm E 2.small
271 Male Pr4L6 WT 6.5cm A 2
272 Male Pr4L6 WT 8cm A 2
273 Male Pr4L6 WT 7.5cm A 2
274 Male Pr4L6 WT 7.5cm A 2
275 Male Pr4L6 Sd+ 1cm B 2
276 Male Pr4L6 Sd+ 0.2cm C 2
281 Female Pr5L6 WT 7cm A 2
282 Female Pr5L6 WT 7cm A 2
283 Female Pr5L6 Sd+ 1,5cm E 2 RHS>LHS
284 Male Pr5L6 Sd+ 1.2cm C 1 RHS, big
285 Male Pr6L8 WT 6.5cm A 2
286 Male Pr6L8 WT 7.2cm A 2
287 Male Pr6L8 Sd+ 2.5cm B 2 RHS>LHS
288 Female Pr6L8 WT 7cm A 2 RHS>LHS
289 Male Pr13L4 WT 7cm A 2
290 Female Pr13L4 WT 6.5cm A 2
291 Female Pr13L4 WT 6.3cm A 2
292 Female Pr13L4 Sd+ 3cm E 2 RHS>LHS
293 Male Pr4L7 WT 6.7cm A 2
294 Male Pr4L7 WT 6.5cm A 2
295 Female Pr4L7 WT 6.7cm A 2
296 Female Pr4L7 WT 7cm A 2
297 Female Pr4L7 Sd+ 3cm E 2 small RHS>LHS
298 Female Pr4L7 Sd+ 3.5cm D 2 small
299 Female Pr4L7 Sd+ 1cm F 2 RHS>LHS*
300 Female Pr6L9 WT 5cm G 2
301 Female Pr6L9 Sd+ 2.5cm D 2 RHS>LHS
302 Male Pr6L9 Sd+ 0.5cm C 2 RHS>LHS
303 Female Pr4L8 WT 6cm A 2
304 Female Pr4L8 WT 6cm A 2 RHS>LHS
305 Male Pr4L8 WT 6.3cm A 2
306 Female Pr4L8 Sd+ 1,5cm B 2 RHS>LHS
307 Female Pr4L8 Sd+ 1.8cm B 2 small RHS>LHS
312 Male Pr13L6 WT 6.5cm A 2
313 Male Pr13L6 Sd+ 0.6cm E 2 small RHS>LHS
314 Female Pr13L6 WT 7cm A 2
315 Female Pr13L6 Sd+ 1.1cm D 2 small
316 Female Pr13L7 WT 6.5cm A 2
Table 3.3.1 Phenotypic analysis of backcross progeny (continued)
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Paren¬ Pheno- Tail Tail Kidney Abnorm.
No. Sex tage type Length Type No. kidneys
317 Female Pr13L7 Sd+ 1.5cm E 2
318 Male Pr13L7 Sd+ 0.8cm E 2
319 Male Pr13L7 Sd+ 1.2cm D. 2 RHS>LHS
320 Male Pr13L8 Sd+ 0.5cm C 2
321 Female Pr13L8 Sd+ 2cm B 2 small
322 Female Pr13L8 Sd+ 2.8cm D 2
323 Female Pr13L9 Sd+ 3.2cm F 2 small
324 Male Pr13L9 WT 7cm A 2
325 Male Pr13L9 WT 6.5CM A 2
326 Male Pr13L9 WT 7cm A 2
327 Male Pr13L9 WT 6.5cm A 2
328 Male Pr13L9 Sd+ 2.5cm E 2 RHS>LHS
329 Female Pr13L9 Sd+ 0.5cm C 2 RHS*>LHS
330 Female Pr13L10 Sd+ 1cm C 2 small
331 Male Pr13L10 WT 5.8cm A 2
332 Male Pr13L10 WT 6.2cm A 2
333 Male Pr13L10 WT 6.1cm A 2
334 Male Pr13L10 Sd+ 0.4cm F 2 small
335 Male Pr13L10 Sd+ 1.2cm F 2 RHS>LHS
336 Male Pr13L10 Sd+ 1.4cm E 2 small
Table 3.3.1 Phenotypic analysis of backcross progeny (continued)
Parentage of each mouse was recorded from the breeding pair (Pr) and the
number of the litter (L) from which the mouse came. Tail length is given in
centimetres (cm).
The type of tail each mouse had was classed into one of 7 classes (A - G). A
represents a normal tail; B, a tail which is normal up to a point of constriction, after
which no bone is present but filament and skin are. C represents tails which have
no bone, only skin and filament. These were usually very small. D represents tails
which are similar to B but which have kinked filament at the end of them, and E
represents tails in which the bone itself was crooked. These tails often had
constrictions in them, followed by kinked filment and skin. F represents tails which
were straight and appeared normal except for their length and G represents tails
from wild type mice which appeared smaller than average.
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The length of each kidney was measured (data not shown) and any differences in
size or appearance noted. When both kidneys were smaller than average, 'small'
has been typed next to the number of kidneys present. The final column details
abnormalities in the size or appearance of the kidneys. An asterix (*) denotes
kidneys which were abnormal in appearance or very much smaller in size than the
kidney from the other side of the body. When the kidneys from an animal were not
of equal size, the symbol > was used to show from what side of the body the
larger kidney arose from.
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Chapter 4: Positional cloning - assembly of a YAC
contig in the region of Sd
4.1 Introduction
Through the identification of disease causing genes, progress has been
made in the dissection of many mammalian developmental and biological
pathways. In humans, disease genes have generally been identified using
two strategies: functional cloning and positional cloning.
4.1.1 Cloning strategies
Functional cloning relies on pre-existing information regarding the basic
biological defect of a disease being available. Strategies such as purification
of a protein using immunoprecipitation, followed by amino acid sequence
determination, allow a gene to be identified on the basis of prior knowledge
about its product. As the name suggests, genes can also be cloned when
information regarding gene function is available. In this way, the genes for a
number of transmembrane receptor proteins (Lin et a!., 1992; Matthews and
Vale, 1991) and metabolic disorders, such as severe combined
immunodeficiency (Valerio et ai, 1985), have successfully been cloned.
However, since there are a large number of human disorders for which no
functional or biochemical information exists, the number of genes which can
be cloned using this strategy is considerably limited.
Positional cloning is a more recent strategy and consequently fewer genes
have been cloned using this approach. Whereas functional cloning
depends on application of biological information, positional cloning is
initiated when a disease locus is mapped to a chromosomal location. Such
a strategy was originally called "reverse genetics" but was renamed
"positional cloning" (Collins, 1992) to indicate that a gene could be
isolated on the basis of its genetic and physical location in the genome,
without prior knowledge of its biological function. This strategy is
frequently more time consuming than a candidate gene (see chapter 3) or
a functional cloning approach, since a chromosomal walk from flanking
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genetic markers is required, followed by analysis of transcripts in a defined
interval. Nevertheless, a number of human disease genes have
successfully been positionally cloned, such as the gene responsible for
cystic fibrosis (Riordan et ai, 1989; Rommens etai, 1989).
In the study of human disorders, positional cloning begins with a collection of
pedigrees in which a disease gene is segregating. These pedigrees are
analysed with polymorphic markers until evidence of linkage to a marker is
established. Additional fine mapping can then be employed to narrow down
the region, since by decreasing the size of the interval and the number of
candidate transcripts requiring analysis, the effort required to find the correct
one can be reduced. However, the number of informative meioses in
available pedigrees limits the extent to which a region of linkage can be
finely mapped. Because of this, fine mapping is often limited to candidate
intervals of around 1cM, approximately 1 million basepairs (Collins, 1992).
Depending on the gene density of a chromosomal region, this could result in
a long and time consuming search through many transcripts before
identifying the correct one. One of the advantages of positionally cloning
genes in the mouse is that the problem of a limited number of informative
meioses is overcome by producing crosses with large numbers of progeny.
This increases the number of meioses for fine mapping and reduces the
effort required to find the correct gene, since a smaller physical interval can
be defined.
An alternative means of cloning new genes in mouse and man is to employ
both strategies in a single study. This combined approach has been termed
the "positional candidate strategy" (Ballabio, 1993). This entails defining a
candidate interval through linkage analysis and then screening computer
databases for genes or cDNA's which have already been isolated, and
assessing them as candidates on the basis of their mapped location and
biological function. This differs from a straight forward candidate gene
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approach in that weaker candidate genes come into consideration as the
mapping of an interval becomes finer.
An alternative means of accessing novel genes is to clone disease genes in
the mouse. A recent comparative mapping study has shown that of 2616 loci
mapped in the mouse, 917 have mapped human homologues (Copeland et
al., 1993). These loci cover 101 segments of conserved linkage homology.
Because of this, it is possible to use genes identified from mouse mutations
as candidate genes for human disorders which have a similar aetiology; for
example, the cloning of the mouse microphthalmia (mi) gene (Hodgkinson et
al., 1993) led to the discovery of the human homologue, MITF (Tachibana et
al., 1994) which was found to be responsible for Waardenburg syndrome
type II (Tassabehji et al., 1994). Similarly, identification of a type VII myosin
gene responsible for the mouse mutation shaker-1 (Gibson et al., 1995), led
to the discovery that mutations in the human homologue were responsible
for Usher syndrome type 1B (Weil et al., 1995). Mapping genes in the mouse
can also facilitate the cloning of human genetic disease loci in the absence
of appropriate mouse models, since it is often easier to map a new gene in
the mouse and then predict its location in humans, than it is to map the gene
directly in humans.
4.1.2 Yeast artificial chromosomes
Yeast artificial chromosomes (YACs) have been an essential tool in the
positional cloning approach, as they have considerably facilitated the
generation of physical maps from genetic linkage data. YACs contain the
basic functional units of yeast chromosomes: centromeres, telomeres and
autonomous replication sequences (Burke et al., 1987). When these
elements are combined within a cloning vector, they allow large linear DNA
molecules (from 50kb to 2Mb) to be transformed into yeast and maintained
there as an artificial chromosome. Traditional cloning systems, such as
plasmid and cosmid vectors, are well suited to the analysis of tightly packed
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genomes, but are unsuitable for the larger and more complex mammalian
genome, since their cloning capacity is small. The development of YACs has
therefore permitted large contiguous genomic regions to be clonally
propagated in a single vector, allowing the analysis of genes to take place
within their immediate genomic context.
There are many advantages of using such a high capacity cloning system.
Using genetically linked flanking markers, YACs can be isolated from a
number of widely available mouse or human YAC libraries (see section
2.3.5). YAC end fragments can be generated in a number of ways, for
example by vectorette (Riley et al., 1990) or inverse PCR (Arveiler and
Porteous, 1991) (see section 2.10.5), for use as new markers in backcross or
pedigree analysis and chromosomal walking. The large insert capacity of
YAC vectors means that complete genetic units can be analysed in a single
vector. This becomes important when the search for a mutation within the
coding regions of a gene is unsuccessful. Promoter and enhancer elements
can then be analysed for mutations within the same, or an overlapping, clone
without extensive screening required to find a new set of clones to cover
potentially large regions. A powerful means of employing YACs in the search
for murine developmental genes is to reintroduce YACs into the germline. In
this way it is possible to assay for complementation of a mutant phenotype
(Schedl et al., 1993). However, such an analysis is only successful in loss of
function mutations, either a recessive mutation or a dominant
haploinsufficient mutation. Genes for gain of function mutations cannot be
identified using this technique, unless the YAC library itself has been made
from mutant DNA.
The use of YACs is not without its drawbacks. Despite the generation of YAC
libraries in recombination deficient strains of yeast (Chartier et al., 1992),
YAC clones are still prone to instability and internal deletions. High rates of
chimerism are common and YACs require careful analysis to ensure that the
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insert is of a single origin. A considerable problem is the time consuming task
of isolating all the transcripts within a large genomic region, in order to
identify the correct one. This has been mitigated to some extent by the
development of new techniques, such as novel exon trap vectors (Nehls et
al., 1994), however, the effort required to proceed from YAC analysis to the
isolation of a candidate transcript is still substantial.
4.2. YAC analysis
The markers D2MH267, D2MH362 and D2MH80 were sent to the Genethon
YAC screening service. Of the YACs that were returned, only those isolated
with D2Mit362 have been analysed in detail.
4.2.1 PCR analysis of D2Mit362 YACs
15 YACs isolated with D2MH362 were returned from the Genethon YAC
screen. From the 15 YACs analysed, 8 were positive for D2MH362 by PCR
(section 2.10.5). Positive single colonies identified by PCR were used to
prepare single colony streaks for the preparation of DNA (section 2.3.3) and
agarose plugs (section 2.3.4). Subsequently it was not possible to identify
positive colonies in single colony streaks for YACs 362Lh/1 and 362Ln/2,
and they were considered to be too unstable for further analysis. For a
summary of data from the D2Mit362 isolated YACs, see table 4.2.1
A PCR-screen for the presence of the two markers which flank the Sd region,
D2Mit80 and D2MH267, on the 8 YACs isolated with D2MH362, showed that

























362Br/1 St. Mary's V ?
362Br/2 St. Mary's V ?
Table 4.2.1 YACs isolated with the marker D2MH362
A question mark indicates those YACs which did not show a single clone on
pulse field analysis (figure 4.2.3b). The size of YACs 362Ln/2 and 362Lh/1
were not ascertained as they proved to be unstable at an early stage in YAC
analysis. N/D indicates not done.
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4.2.2 Pulse field analysis of D2MH362 YACs
Agarose plugs prepared from YACs 362Ln/1, 362Lh/2, 362Lh/3, 362Lh/4,
362Br/1 and 362Br/2 were analysed by pulse field gel electrophoresis
(section 2.5.6). In figure 4.2.2, 362Lh/2, 362Lh/3 and 362Br/1 YACs are
clearly visible as distinct chromosomes, whilst YACs 362Ln/1, 362Br/2 and
362Lh/4 are not resolved from yeast chromosomes under these running
conditions.
4.2.3 Southern blot analysis of D2Mit362 YACs
Southern blots were made of 362 YAC pulse field gels as detailed in section
2.6.1. A D2Mit362 primer was end-labelled (section 2.8.3) and hybridised
(section 2.9.3) to a 362 YAC pulse field blot. Figure 4.2.3a shows D2MH362
to be present in the YACs 362Ln/1, 362Lh/2, 362Lh/3, 362Lh/4, 362Br/1 and
362Br/2.
Probes generated from the right and left arms of the YAC vector (section
2.7.4) were radiolabeled (section 2.8.1) and hybridised (section 2.9.3) to a
Southern blot made from the pulse field gel shown in figure 4.2.2. The right
arm probe (figure 4.2.3b) shows a hybridisation pattern consistent with the
presence of a single YAC clone in YACs 362Ln/1, 362Lh/2 and 362Lh/3.
YACs 362Lh/4, 362Br/1 and 362Br/2 show a hybridisation pattern which
indicates the presence of either two YACs in a single clone, or a secondary
YAC with a deleted insert. Hybridisation of the probe to the larger YAC in
both 362Br/1 and 362Br/2 is considerably weaker than its hybridisation to the
smaller one. Figure 4.2.3a shows that, of the two YACs present in 362Br/1
and 362Br/2, only the smaller YAC is picked up by the D2MH362 probe.
From this data it would appear that only the smaller YACs present in 362Br/1
and 362Br/2 are positive for the D2MH362 region of mouse chromosome 2.
This could be due to the larger YACs not being of chromosome 2 origin or
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because the D2MH362 probe hybridises to the larger YACs too weakly to
give a visible hybridisation signal, in the way that the right arm probe gives a
weaker signal in figure 4.2.3b. It is of interest that in YAC 362Lh/4, it is the
larger YAC that is positive for the D2MH362 marker, thus the smaller YAC is
most likely a derived deletion product. Hybridisation of the left arm probe to
these YACs gives an identical result (figure 4.2.3c), supporting the
conclusion that 362Ln/1, 362Lh/2 and 362Lh/3 contain a single YAC clone,
whilst 362Lh/4, 362Br/1 and 362Br/2 contain either 2 YACs in a single clone
or an additional, deleted YAC.
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Figure 4.2.2 Resolution of D2MH362-isolated YACs by pulse field gel
electrophoresis
Agarose plugs were electrophoresed in 0.5 X TBE at 12°C, at 200 volts for
24 hours. The pulse rate was ramped from 50-90 seconds. Chromosome
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Figure 4.2.3 Southern blot analysis of the D2MH362-isolated YACs
The filter used in figures a, b and c was prepared from the pulse field gel
shown in figure 4.2.2, as in section 2.6.1. Figure a shows the hybridisation of
the D2Mit362 marker to the YACs 362Ln/1 to 362Br/2. Figure b shows the
hybridisation of the right arm probe of the YAC vector, and figure cthat of the
left arm probe of the vector, to the D2Mit362-isolated YACs.
4.3 YAC end fragment analysis
4.3.1 Generation of YAC end fragments
End fragments from the mouse DNA inserts of the 5 of the 362 YACs were
isolated using a method adapted from Arveiler and Porteous, 1991 (section
2.10.6). A summary of the end fragments that were generated is given in
table 4.3.1.
4.3.2 Southern blot analysis of end fragments
Yeast genomic DNA was prepared (section 2.3.3) from YACs 362Ln/1,
362Lh/2, 362Lh/3, 362Lh/4, 362Br/1and 362Br/2 and from 4 control YACs:
160, I80D2, I84A11 and I82E2. Following restriction with EcoRI (section
2.7.1), the digests were electrophoresed (section 2.5.2) and Southern blots
prepared from the gels (section 2.6.1).
In order to assemble a contig of the 362 YACs, each end fragment in table
4.3.1 was radiolabeled (section 2.8.1) and hybridised (section 2.9.3) to the
Southern blots prepared from the EcoRI digests of YAC DNA. After
radiolabelling, all end fragments were preannealed to mouse genomic DNA
to compete out hybridisation of the probe to murine repetitive sequences in





















362Ln/1 Ln1 LAT ~600bp HinchH RFLV Ln1 RAR ~900bp Taq\ RFLV
362Lh/2 Lh2LAT ~750bp Not found Lh2RAP ~600bp Not found





362Br/1 Br1 LAT ~950bp N/D BrIRAR ~700bp N/D
362Br/2 Br2LAT ~400bp N/D Br2RAR ~600bp N/D
Table 4.3.1 End fragments generated from 362 YACs
For left arm and right arm probes, the last letter of the name indicates the
restriction enzyme digest from which the probe was generated. T=Taq\, R=
Rsa\ and P=Pst\. End fragments were not generated for the YAC 362Lh/4.
Not found has been used where a restriction fragment length variant (RFLV)
was not found, and N/D indicates where a procedure was not done.
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When hybridised to the EcoRI blots, the right arm end fragment from YAC
362Ln/1 (LnlRAR) gave two sets of hybridisation signal (figure 4.3.2a). The
upper signals, A, appear in all tracks, and are due to the vector sequence in
the end fragment hybridising to the vector DNA in the YACs. The second set
of signals, B, are derived from the YACs' insert, as this hybridisation signal is
not present in the control YACs, indicating that it is not as a result of the end
fragment hybridising to vector or yeast DNA. This result shows that the end
fragment LnlRAR hybridises to the YAC it was generated from, 362Ln/1,
and to a similarly sized fragment in YACs 362Br/2, 362Lh/2 and 362Lh/3
indicating that the right arm of 362Ln/1 is present in these YACs. LnlRAR
does not hybridise to 362Br/1 or 362Lh/4, and is unlikely therefore to overlap
with these YACs.
The left arm end fragment generated from 362Ln/1 (LnlLAT) does not give a
clear hybridisation signal (figure 4.3.2b). Bands appear to be present in all
the lanes and could be due to the vector sequence in the end fragment
recognising the vector DNA in the YACs, or a repeat sequence in the end
fragment which is present in mouse or yeast DNA. The bands that appear in
362Br/1 and 362Br/2 do not appear in 362Ln/1, and so are unlikely to be
insert derived. It is not possible to conclude from these data with which YACs
the left arm of 362Ln/1 overlaps.
The right arm end fragment from YAC 362Lh/2 (Lh2RAP) gives two
hybridisation signals when used as a probe on the EcoRI blots (figure
4.3.2c). Signal A is in all the lanes, including the control YACs, and is due to
the vector sequence in the end fragment hybridising back to the YACs.
Signal B shows the end fragment hybridising to the YAC from which it was
derived (362Lh/2) and to an identically sized fragment in YAC 362Ln/1. This
hybridisation signal does not arise in any of the other YACs, indicating that
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Figure 4.3.2. Southern blot analysis of YAC end fragments (a-d)
End fragment probes were hybridised to Southern blots prepared from
EcoR1 digests of YAC DNA. Hybridisations with the following end fragments
are shown: a) Ln1 RAR; b) LnlLAT; c) Lh2RAP; and d) Lh2LAT.
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Figure 4.3.2. Southern blot analysis of YAC end fragments (e-f)
End fragment probes were hybridised to Southern blots prepared from
EcoR1 digests of YAC DNA. Hybridisations with the following end fragments
are shown: e) Lh3LAT; f) Br1 RAR; g) BrILAT; and h) Br2LAT.
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The hybridisation signal from the left arm end fragment of 362Lh/2 (Lh2LAT)
also gives two hybridisation signals (figure 4.3.2d). Signal A appears faintly
in all the lanes, including the control YACs and is probably the vector derived
signal. Signal B shows Lh2LAT hybridising back to the YAC from which it
was derived, 362Lh/2 and hybridising to similarly sized fragments in YACs
362Lh/3, 362Lh/4 and 362Ln/1. It is therefore possible that the left arm of
YAC 362Lh2 overlaps with these YACs and not with YACs 362Br/1 and
362Br/2.
The left arm end fragment generated from YAC 362Lh/3 (Lh3LAT) gives two
hybridisation signals when hybridised to the EcoRI blots of YAC DNA (figure
4.3.2e) which appear to be almost identical to the Lh2LAT hybridisation
pattern in figure 4.3.2d. The fainter signal, A, is present in all the lanes and is
likely to be the vector derived signal. The second, more intense signal, B
shows Lh3LAT hybridising back to the YAC from which it was generated,
362Lh/3, and to similarly sized fragments in YACs 362Lh/2, 362Lh/4 and
362Ln/1. This hybridisation signal is not present in the control YACs or in
362Br/1 or 362Br/2. It is possible, therefore, that the left arm of 362Lh/3 is
present in 362Lh/2, 362Lh/4 and 362Ln/1, or that the end fragment is repeat-
derived, and that the same repeat is present in end fragment Lh2LAT. An
alternative explanation for these results could be that Lh3LAT and Lh2LAT
have been derived from the same YAC insert sequence. Because of these
ambiguities, it is not possible to conclude which YACs Lh2LAT and LH3LAT
definitely overlap with. Right arm end fragments for 362Lh/3 could not be
generated using the inverse PCR method.
When hybridised to the YAC EcoRI blots (figure 4.3.2f), the right arm end
fragment of YAC 362Br/1 (BrIRAR) gave 3 hybridisation signals. Signals A
and B, present in all the lanes, are likely to be either vector or repeat derived.
Signal C is of a stronger intensity and is not present in the lanes containing
control YAC DNA. This signal shows BrIRAR hybridising back to the YAC it
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was generated from, 362Br/1, and hybridising to a similarly sized band in
YACs 362Ln/1, 362Lh/2, 362Lh/3, 362Lh/4 and 362Br/2. This suggests that
the right arm of this YAC is present in all the 362 YACs.
The left arm end fragment generated from YAC 362Br1 (BrILAT) gives a
number of bands when hybridised to the EcoRI blots of YAC DNA (figure
4.3.2g). Two sets of bands, A, are common to all tracks. A single band, B,
can be seen where the probe has hybridised back to the YAC from which it
was derived. BrILAT does not hybridise to a similarly sized band in the other
lanes, indicating that the left arm of 362Br/1 is not present in any of the 362
YACs. Either this end of the YAC is at the extreme end of the contig, or this
part of the YAC is not derived from the D2Mit362 region of mouse
chromosome 2 and is therefore chimeric.
The right arm end fragment generated from 362Br/2 (Br2RAR) hybridised to
multiple fragments when used as a probe on the YAC EcoRI blot. When the
end fragment was remade from a EcoRV restriction digest of YAC 362Br/2
DNA, the new probe gave a similarly unclear result (data not shown). It is not
possible to conclude from this result whether the right arm end of 362Br/2 is
present in the other 362 YACs, or whether it is chimeric.
The left arm end fragment made from 362Br/2 (Br2LAT) gives 3 classes of
hybridisation signals when hybridised to the EcoRI blot of YAC DNA (figure
4.3.2h). Two of these signals, A and B, are present in all the YACs, including
the controls and are likely to be vector derived. Signal C shows Br2LAT
hybridising back to the YAC it was generated from, 362Br/2, and to a
similarly sized fragment in YAC 362Br/1. This suggests that this end of
362Br/2 is present in YAC 362Br/1, but not in any of the other 362 YACs.
Figure 4.3.3 gives a summary of the YAC contig that was assembled on the






















Figure 4.3.3 Contig of 362 YACs generated from end fragment analysis
The presence of the marker D2Mit362 is indicated by a line running through all
the YACs. The presence of end fragments in other YACs is indicated by a
broken line. Filled in YAC ends (■) are those which could not be placed onto
the contig. Hatched and shaded YAC ends are those which are present in other
YACs. The presence of end fragment LnlRAR is represented by a dark
hatched box fs), end fragment Br1 RAR is represented by a light hatched box
(n), Lh2RAP by a stippled box (n) and Br2RAR by a shaded box (■). Internal
deletions are indicated by a broken line in YACs 362Lh/4, 362Br/2 and 362Br/1.
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4.3.3 Discussion of contig assembly
The contig was assembled using results from those end fragments which
clearly hybridised to other 362 YACs, primarily LnlRAR and Lh2RAP, and
were the least likely to be chimeric. LnlRAR, the end fragment derived from
the right arm of 362Ln/1, is present in 3 YACs: 362Lh/2, 362Lh/3 and
362Br/2. Since this end fragment is not present in 362Lh/4, it is possible that
the insert region of 362Lh/4 which would have contained the LnlRAR
sequence has been deleted (see figure 4.2.3b). Since hybridisation with
Lh2RAP clearly shows the right arm end of 362Lh/2 to be present in
362Ln/1, it is unlikely that the left arm end of this YAC could also be present
in 362Ln/1, due to 362Lh/2 being larger in size. It is therefore doubtful that
Ln1 RAR is at the extreme end of the contig, but in the absence of clear data
from the end fragments Lh2LAT and Lh3LAT, it is not possible to conclude
which end fragment marks the left hand contig boundary.
The other extreme of the contig can be defined by the result that shows that
the right arm of 362Lh/2 is present in only 362Ln/1. In the absence of data
from the left arm end fragment of this YAC (LnlLAT), this result suggests
that the left arm of 362Ln/1 is at the end of the contig, however, it is not
possible to tell from this result whether it is chimeric or not. The left arm end
fragment from 362Br/1 (BrILAT), which is not present in the other 362 YACs,
could be at the end of the contig, but since it is likely that this YAC has either
a chimeric or deleted inset (see figure 4.2.3b), it would not be a very
informative marker to use in further analysis. The presence of deletions in
YACs 362Br/1, 362Br/2 and 362Lh/4 are proposed on the basis of the pulse
field results in section 4.2, which show the presence of additional clones in
each YAC. However, there are alternative contig arrangements of the YACs
that could be derived from this data. To ensure that the correct end
fragments were used in a chromosomal walk, those thought to be at the
extremes of the contig were mapped onto the backcross.
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4.4 Analysis of backcross recombinants
As a result of the Southern blot analysis, the end fragments thought to be
either non-chimeric or at the ends of the contig were LnlRAR, LnlLAT and
Lh2RAP. Lh3LAT was also included in this analysis to gauge whether it was
at a more extreme point in the contig than LnlRAR. In order to map these
end fragments onto the Sd backcross, RFLVs between M.m.castaneus and
CBA DNA were identified.
DNA from M.m.castaneus and CBA DNA was digested with the restriction
enzymes: Bgl\\, EcoRV, EcoRI, Psfl, Ba/nHI, Hind\\\ and Taq\ (section 2.7.1).
The digests were electrophoresed (section 2.5.2) and Southern blotted
(section 2.6.1).
End fragments LnlRAR, LnlLAT, Lh2RAP and Lh3LAT were radiolabeled
(section 2.8.1), preannealed to genomic mouse DNA, to minimise
hybridisation of the probe to murine repeat sequences (section 2.8.2) and
hybridised to the CBA/ M.m.castaneus polymorphic detection blots
(polyblots).
4.4.1 Backcross analysis with end fragment LnlRAR
When used as a probe on the CBA/ M.m.castaneus DNA polyblot, the right
arm end fragment generated from YAC 362Ln/1 (LnlRAR), gave a
hybridisation signal that showed a Taq\ RFLV between CBA and
M.m.castaneus DNA (figure 4.4.1a). The difference in size between the CBA
and M.m.castaneus bands in the BamHI lane is most likely due to incomplete
restriction giving rise to partially digested fragments. The remaining lanes
show that the probe hybridises to the identically sized fragments in CBA and
M.m.castaneus DNA when restricted with Bgl\\, EcoRV, EcoRI, Psfl and
Hind\\\.
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Genomic DNA was prepared (section 2.4.1) from the mice recombinant
between D2Mit118 and D2Mit80 and restricted with Taq\ (section 2.7.1). The
digests were electrophoresed and Southern blots prepared (section 2.6.1).
LnlRAR was radiolabeled as before and hybridised to the Taq\ blot of the
recombinant mice. Figure 4.4.1b shows that this probe gave two signals
when hybridised to the Taq\ blot. Signal A is the CBA-specific fragment
detected by the probe, and can be seen in all the lanes, except for the
M.m.castaneus DNA control lane. Since the backcross progeny were
generated by backcrossing to CBA, it is expected that all the backcross
offspring be positive for this band. Signal B is a band of smaller size and is
present in the M.m.castaneus DNA control, and in mice 26, 136, 234, 271
and the non-recombinant DNA control. These mice, heterozygous for the
M.m.castaneus and CBA alleles, were haplotyped at this locus (as in the
chapter 3) as being C, and those homozygous for the CBA allele, were
haplotyped as being M (table 4.4.2).
To ensure that the end fragment LnlRAR was derived from the D2MH362
region of mouse chromosome 2, genomic DNA from the first 25 animals of
the backcross was restricted with Taq\. A Southern blot was prepared of the
digests and probed with LnlRAR (figure 4.4.1c). The backcross offspring on
this blot were haplotyped as above. From these results, it was possible to
conclude that the right arm of 362Ln/1 (Ln1 RAR) was chromosome 2 derived
(table 4.4.1), and that it mapped two recombinants distal to D2MH267 and
was non-recombinant with D2MH362 on the Sd backcross (figure 4.4.5).
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Figure 4.4.1 Mapping of YAC end fragment LnlRAR onto Sd backcross
1 denotes CBA DNA, 2 denotes CAST/Ei DNA in figure a. The last 2 tracks
show the 7~ag1 RFLV used to map LnlRAR. The mapping of LnlRAR onto
the recombinant panel of mice is shown in b, and onto the panel of non-
recombinant mice in c.
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4.4.2 Backcross analysis with end fragment LnlLAT
When the left arm end fragment of YAC 362Ln/1 (LnlLAT) was hybridised to
the polyblot shown in figure 4.4.1a, the probe hybridised to differently sized
M.m.castaneus and CBA Hind\\\ fragments. This RFLV was used to map the
end fragment onto the backcross.
Genomic DNA from the recombinant panel of mice, and from the first 15
mice of the Sd backcross, was restricted with Hind\\\. The digests were
electrophoresed and Southern blotted. LnlLAT was radiolabeled and
hybridised to the Hind\\\ blot (figure 4.4.2). Lanes 1, 2 and 4 do not give a
hybridisation signal with this probe as these DNAs were not fully digested.
The remaining lanes show two hybridisation signals. Signal A is the smaller
band and is present in all the lanes except for the M.m.castaneus DNA
control and lanes 1, 2, and 4. This is the CBA-specific band and it is present
in all the backcross offspring. Signal B, the larger band, is present in the
M.m.castaneus control lane and is the M.m.castaneus-specific band. This
band is present in mice 10, 11, 12, 13, 14, 136, 234 and 271. As in chapter
3, these mice were haplotyped as being C at this locus and the mice with
only band A were haplotyped as being M. Since the typing of the first 15
mice at this locus was in concordance with their haplotyping at other
backcross markers (table 4.4.1), it was concluded that this end of YAC
362Ln/1 was derived from the proximal region of chromosome 2, indicating
that the YAC is non-chimeric at both ends. Since there is no data from this
end fragment to show that it has sequence in common with the other YACs,
it is not known on the basis of this analysis whether 362Ln/1 contains any
internal deletions.
Analysis of the recombinant panel of mice (table 4.4.2) positioned LnlLAT
on the backcross map as being non-recombinant with Sd (figure 4.4.5 and
4.5), crossing one recombinant between marker D2Mit362 and Sd. Because
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Ln1 LAT provided a new marker which was non-recombinant with Sd, the end
fragment was sequenced (section 2.11) in order to generate PCR primers
which could be used for the screening of YAC libraries.
4.4.3 Backcross analysis with end fragment Lh3LAT
The left arm of YAC 362Lh/3 (Lh3LAT) was used as a probe on the polyblot
shown in figure 4.4.1, and hybridised to differently sized M.m.castaneus and
CBA EcoRI fragments. This RFLV was used to map the end fragment onto
the backcross.
Genomic DNA from the recombinant panel of mice and four control DNA's
from the backcross were restricted with EcoRI. The digests were
electrophoresed and Southern blots prepared from the gels. When Lh3LAT
was hybridised to the EcoRI blot two bands could be identified (figure 4.4.3).
Band A, the smaller CBA-specific band was present in all the lanes except
for the M.m.castaneus DNA control lane; and band B, the larger
M.m.castaneus-specific band, was present in the M.m.castaneus DNA
control and lanes 26, 136, 234, 271, and control DNAs 10 and 27. The
background smear in each lane is likely to be due to the probe hybridising to
a murine repeat sequence. Since the haplotyping of the control mice at this
locus was concordant with their haplotyping at other backcross markers
(table 4.4.1), we concluded that this end of YAC 362Lh/3 was derived from
the proximal region of chromosome 2. Haplotype analysis of the recombinant
mice (table 4.4.2) placed this marker 2 recombinants distal to D2MH267,
showing that it was non-recombinant with D2MH362 and the right arm end
fragment of YAC 362Ln/1, LnlRAR, and one recombinant away from Sd
(figure 4.4.5 and 4.5).
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Figure 4.4.2 Mapping of YAC end fragment LnlLAT onto Sd backcross
LnlLAT was mapped onto the backcross using a Hind\II RFLV. Tracks 1-15
show DNA from the non-recombinant panel of mice, and the remaining
tracks show DNA from the recombinant mice, with CBA and CAST/Ei DNA
controls. DNA samples were digested with Hind 11.
LU
(D (\l <f t- Ol w M(ooNntnsr.offlr Oh-
CMNOI-t-CMCMCOOOU-IOT-CM
m - =fi_A
Figure 4.4.3 Mapping of YAC end fragment Lh3LAT onto Sd backcross
Lh3LAT was mapped onto the backcross using a EcoRI RFLV. The first 8
tracks show DNA from the recombinant panel of mice. The remaining tracks
show CBA, CAST/Ei, F1 and non-recombinant DNA controls. DNA samples
were digested with EcoRI.
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4.4.4 Backcross analysis of end fragment Lh2RAP
Despite the clean hybridisation signal that this probe gave when hybridised
to YAC DNA, it was not possible to use this end fragment as a probe on
mouse genomic DNA blots, as it contained a murine repeat sequence. Pre-
annealing the probe to mouse genomic DNA to compete out recognition of
repeat sequences did not work sufficiently well to make the probe usable. To
overcome this problem, the end fragment was sequenced (section 2.11.1) in
order to generate PCR primers (section 2.10.3).
The primers that were generated (table 2.10.4) were used to PCR amplify
(section 2.10) the end fragment sequence from CBA and M.m.castaneus
DNA. PCR products were analysed for size differences between the two sub¬
species of DNA. Since no size differences were found, the PCR products
were restricted with a range of frequent cutter enzymes (section 2.7.3) and
the digestion fragments electrophoresed on 4% NuSieve (section 2.5.2) and
8% acrylamide gels (section 2.5.4). However, no polymorphisms were
identified by which this end fragment could be mapped onto the backcross.
Since data suggests that this marker could be at the extreme end of the
contig in the direction of Sd, work is in progress to find a means of mapping
this marker.
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No. D2Mit D2Mit Lh3 Ln1 D2Mit Sd Ln1 D2Mit Pax8
31 464 LAT RAR 362 LAT 80
1 M M M M M
2 M M M M
3 M M M M
4 M M M M
5 M M M M M
6 M M M M M
7 M M M M M
8 M M M M M
9 M M M M M
10 C C C C C C
11 C C c C c
12 C C c c c C
13 C c c c c
14 C c c c C
16 M M M M
17 M M M M
21 M M M M
22 C C C C
23 C c c C
24 M M M M
25 C c c C
Table 4.4.1 Genetic mapping of YAC derived markers to chromosome 2.
End fragment markers, Lh3LAT, LnlRAR and LnHAT, derived from YACs
isolated with the D2MH362 marker, were mapped onto a panel of mice from
the Sd backcross which were non-recombinant between the markers D2Mit31
and Pax8. This was done to ensure that the markers were derived from the
D2Mit362 region of mouse chromosome 2. Boxes which are lightly shaded
denote loci which were not typed. Mice scored with an M were homozygous
for the CBA-sized allele, those scored with a C were heterozygous for the
CBA and M.m.castaneus sized alleles.
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No. D2Mit D2Mit Lh3 Ln1 D2Mit Ln1 Sd D2Mit D2Mit
31 464 LAT RAR 362 LAT 80 7
295 C C N/D N/D C C C M
271 C C C C C C c M M
234 c c C C c C c M M
26 c c C C c M M M M
142 c M M M M M M M M
265 c M N/D N/D M N/D M M M
264 c M N/D N/D M N/D M M M
319 c M M M M M M M M
97 c M M M M M M M M
70 c M M M M M M M M
199 c N/D N/D N/D N/D N/D M M M
306 M M N/D N/D M N/D M M C
330 M M N/D N/D M N/D M M C
318 M M N/D N/D M N/D M M C
277 M M N/D N/D M N/D M M C
15 M M N/D M M M M N/D C
136 M C C C C C C C C
242 M C N/D N/D C N/D C C C
Table 4.4.2 Genetic mapping of YAC derived markers onto recombinant
panel of mice.
End fragment markers, Lh3LAT, LnlRAR and LnlLAT, derived from YACs
isolated with the D2MH362 marker, were mapped onto a panel of mice from
the Sd backcross which were recombinant between the markers D2Mit31 and
Pax8. The mice were scored as being M or C as for table 4.3.1. Loci not
haplotyped are indicated (N/D, not done). Only one end fragment, LnlLAT,
crosses a recombination point, in mouse no. 26, indicating that this end of
























D2MH362, D2MH464, LnlRAR, Lh3LAT
Sd, LnlLAT
D2MH80, D2Mit6
Figure 4.5 Genetic map of proximal mouse chromosome 2, showing the
map position of new end fragment markers relative to Sd.
End fragment markers were derived from YACs isolated with the D2MH362
marker and are shown in bold type (LnlRAR, LnlLAT and Lh3LAT). As can
be seen from this map, LnlLAT is non-recombinant with Sd. Genetic
distance, in centiMorgans (cM), between the markers is given on the left
hand side of the figure. CentiMorgan and standard error values were
calculated as in section 2.12.
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4.4.5 Discussion of end fragment mapping
By mapping the end fragments LnlRAR, LnlLAT and Lh3LAT onto the Sd
backcross, it was possible to orientate the YAC contig with respect to Sd
(figure 4.4.5). LnlLAT crosses a single recombinant between the marker
D2Mit362 and Sd and thus provides the project with a new marker which is
non-recombinant, and therefore closely physically linked with Sd. With the
aim of isolating new YACs which will cross the recombinants on the D2Mit80
side of Sd, PCR primers generated from LnlLAT will be used in the
rescreening of YAC libraries. Once a contig is established in which YAC
ends are crossing recombinants on both sides of Sd, it will be possible to
identify YACs in the contig which contain the Sd gene. The isolation of the
gene is then feasible through the use of techniques such as exon trapping
(Nehls et al., 1994), cDNA selection (Lovett et at., 1991) and candidate
transcript analysis. A detailed discussion of the approaches which can be
taken to isolate candidate gene transcripts is given in chapter 7.
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Chapter 5: Mapping tail-length modifying
loci in Srfmice
5.1 Introduction
Mutations in many genes which follow monogenic, Mendelian patterns of
inheritance allow the genotype of a particular locus to be unambiguously
inferred from the phenotype of an individual. These alleles, which give rise to
major phenotypic effects, have been called macromutations (Tanksley,
1993).
Whilst macromutations are common in the laboratory, they are rarer in
natural populations since many are deleterious to survival and are removed
through natural selection. The incidence of macromutations sustained in
natural populations is therefore low. Nevertheless, phenotypic and genetic
variation still exists in these populations. Whilst genetic variation is occurring
at discrete loci, phenotypic variation is continuous for many traits, controlled
by allelic variation at several genetic loci, each contributing small effects to
an overall phenotype. Traits, whose phenotypic variation is continuous and
determined by the segregation of multiple loci, have been referred to as
complex or quantitative traits, and their mode of inheritance as polygenic
(Lander and Botstein, 1989; Tanksley, 1993). The identification of genes
contributing to a quantitative phenotype is problematic in that the relationship
between genotype and phenotype breaks down, since the same phenotype
can result from different genotypic combinations.
As in other species, macromutations in the human genome are deleterious to
survival, because of this many human diseases for which the genetic basis
has been established have been rare in the human population as a whole.
Since most common traits of medical relevance do not follow simple
Mendelian monogenic inheritance, it has been harder to identify the genes
responsible for common human complex traits such as susceptibility to heart
disease, epilepsy, hypertension, diabetes, obesity and cancer (Lander and
Schork, 1994; Copeland et at., 1993). Disorders such as these have a high
incidence in western populations, and the need for a means of analysing the
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complex nature of their aetiology has given recent prominence to the field of
quantitative trait loci mapping.
Although it is possible to analyse polygenic traits in human populations, the
inability to control human matings and non-genetic sources of variation, such
as environmental conditions, makes such analysis difficult and complex. For
this reason, the mouse is an ideal experimental model to use in the genetic
dissection of polygenic traits. The ability to carry out controlled matings and
standardise environmental conditions remove sources of variation which are
not possible to control with humans (Avner, 1994). Mouse strains also show
striking variation in their susceptibility to a number of murine disorders which
are models for polygenic human diseases, such as epilepsy (Rise et al.,
1991) and type 1 and type 2 diabetes (de Guoyon et al., 1993; Todd et al.,
1991; Bahary et al., 1990).
A good example of interstrain variation is the incidence of intestinal
adenomas in multiple intestinal neoplasia (Min) mice (Dietrich et al., 1993b).
Min mice carry a mutation in the Ape gene, the mouse homologue of the
human APC gene, responsible for the Mendelian-inherited colon cancer,
adenomatous polyposis coli. It has been found that within some human APC
pedigrees, family members who have inherited the same APC mutation,
show a striking variation in the number of colonic polyps and other
neoplasias that they develop. Since different laboratory strains of mice
carrying the Min mutation also showed variation in the numbers of colonic
tumours they developed, it was possible to utilise them to investigate
whether the variation in mice was due to differences in genetic backgrounds.
Through the mapping of backcrosses set up between the most severely
affected strain (C57BI/6J) and the least severely affected strain (Akr) of Min
mice, a locus on chromosome 4 was found that strongly modified tumour
multiplicity, called Mom-1 (for Modifier of Min-1). Mom-1 was shown to
contribute -50% of the genetic variance responsible for intestinal neoplasia
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in Min mice. The recent identification of a mouse candidate gene for Mom-1,
the secretory phospholipase A2 gene (MacPhee et al., 1995) indicates how
mouse models of complex human traits can enable the identification of
modifier loci. Alternative methods for this type of analysis are discussed
further in the chapter.
5.1.1 Markers used in quantitative trait loci mapping
The principles of quantitative trait loci (QTL) mapping were first established
by Sax (1923), when he reported an association of seed size in beans (a
quantitatively inherited character) with seed-coat pigmentation (a monogenic
trait). This finding gave rise to the idea that the segregation of a single gene
marker could be used to detect and estimate the effect of a linked polygene.
Thoday (1961) proposed that if single gene markers were scattered
throughout the genome, it should be possible to map and characterise all of
the polygenes affecting a character. However, a considerable problem in the
use of such marker genes was encountered when a marker gene itself had a
larger effect on the quantitative character than the linked polygene,
preventing its detection or an over/under estimation of its effect. For
example, in plants a common monogenic marker is dwarfism. It would not be
possible to use a dwarfism marker to study the polygenic inheritance of plant
height since the effect of the marker gene on plant height would be much
greater than that of an individual polygene. Other problems associated with
the early use of marker genes were epistasis (whereby one gene interferes
with the phenotypic expression of another, non-allelic gene) and lack of
polymorphism in natural populations (Tanksley, 1993).
An advancement in quantitative trait loci mapping came with the discovery
that allelic forms of enzymes (isoenzymes) could be electrophoretically
distinguished from one another (Hunter and Marked, 1957). Such
polymorphic markers allowed polygenes to be genetically mapped with
greater independence from the phenotypic changes incurred with the use of
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marker genes. This change in the nature of the marker used to map
polygenes considerably increased the success of QTL mapping studies.
With the introduction of DNA-based genetic markers (Botstein et al., 1980), it
became possible to survey genetic variation directly at the DNA level. The
use of restriction fragment length polymorphisms (RFLPs) and simple
sequence length polymorphisms (SSLPs), greatly increased the level of
polymorphic variation which could be studied. With the creation of high-
density genetic linkage maps, the inheritance of markers spanning an entire
genome can now be simultaneously followed to identify chromosomal
regions linked to a varying trait. As with isoenzymes, polymorphism for DNA
markers usually has no phenotypic affect. Today molecular linkage maps
covering the entire genome are available for quantitative trait studies in a
number of species including human (Weissenbach et al., 1992), mice
(Copeland et al., 1993) and rats (Serikawa et al., 1992).
5.1.2 Strategies for detecting polygenes
A variety of statistical techniques have been proposed for estimating the
minimum number of genetic loci contributing to the difference in a
quantitative trait between two inbred lines grown in a common environment
(Castle, 1921; Wright, 1968). Wright's method assumes that, with respect to
all relevant loci, one line is fixed with alleles increasing the character of
interest, and the other line is fixed with alleles decreasing it. This is most
likely when the divergence of the populations was caused by sustained
artificial selection on the trait of interest or on some character(s) highly
correlated with it genetically. Estimates of the minimum number of genes
influencing such a trait are obtained by comparing the phenotypic means and
variances of the character in the F,, F2 and backcross populations. The
requirement of inbred lines, however, can produce complications through
inbreeding depression on the mean and developmental instability associated
with inbred lines. More recent interpretations of Wright's formulae (Lande,
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1981) have shown that his method can still be applied to crosses between
heterogenous (or wild) populations.
The use of marker loci to detect polygenes relies on the assumption that
linkage disequilibrium (the non-random association of alleles) exists between
alleles at the marker locus and alleles of the polygenes. Although linkage
disequilibrium can be caused by factors such as selection and genetic drift,
its predominant cause, in crosses between different strains, is the physical
linkage of loci. The use of linkage disequilibrium can be very powerful in
populations derived from controlled matings, such as backcross or F2/F3
populations. QTL mapping in these populations is more powerful than in
human pedigrees because genetic noise can be reduced through the use of
recombinant inbred and congenic strains of mice. The use of experimental
crosses with large numbers of offspring, also greatly increases the power of
the statistical tests which can be used to analyse linkage data (Lander and
Schork, 1994).
Statistical procedures used to determine whether a polygene is linked to a
marker gene share a basic principle, that is to group a population into
genotypic classes based on the genotype at the marker locus and then use
correlative statistics to determine whether the individuals of one genotype
differ significantly compared with individuals of other genotypes with respect
to the trait being measured. If the phenotypes differ significantly, it can be
interpreted that a gene (or genes) affecting the trait is linked to the marker
locus used to haplotype the population. This procedure can be repeated for
additional marker loci throughout the genome to detect as many QTL as
possible. This type of analysis does not determine whether an effect
detected with a marker is due to one or more linked genes, but defines a
chromosomal region that has a significant effect on a quantitative trait.
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There are three approaches which can be used in the mapping of a QTL:
single point analysis (Edwards et at., 1987), interval mapping (Lander and
Botstein, 1989) and the analysis of phenotypic extremes (Lander and
Botstein, 1989; Taylor et al., 1994).
Single point analysis
Single point analysis employs one marker at a time in the detection of a QTL
and does not, therefore, require a complete molecular marker linkage map
(Tanksley, 1993). The problem with the use of this type of analysis is that the
magnitude of the QTL effect revealed by the marker is the actual allelic effect
devalued by the map distance to the marker. Since this analysis does not
take into account recombination between the marker and QTL, it can often
result in misclassification of QTL genotype.
Interval mapping
With the availability of high density molecular linkage maps covering entire
genomes, some of the problems associated with single point analysis have
been overcome with the use of interval mapping (Lander and Botstein,
1989). Interval mapping uses phenotypic and genetic marker information to
estimate the probable genotype and the most likely QTL effect at every point
in the genome, by means of a maximum-likelihood linkage analysis.
Maximum likelihood linkage analysis uses known parameters (such as
phenotype) along with unknown, estimated parameters (such as the location
of the trait-causing locus) to produce a model that best explains the data
being analysed. By using linked markers it is possible to compensate for
recombination between the markers and the QTL, increasing the probability
of QTL detection. The maximum benefit of interval analysis versus point
analysis is found when linked markers are 20-35cM apart, since there are
likely to be more crossovers between the marker and the QTL which interval
analysis can compensate for.
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Analysis of phenotvpic extremes
A cost efficient and rapid means of detecting QTL is to perform marker
analysis on only those individuals at the extreme tails of a phenotype's
spectrum i.e. on those individuals which are phenotypically the most or the
least affected by modifying QTL. In a segregating backcross, this analysis
would be possible by measuring the trait in each of the backcross progeny
and then subdividing the population into two phenotypic extremes. If the
allele frequency at any marker locus differs significantly between the two
sub-populations, it could be inferred that a QTL controlling the measured trait
is located near that marker.
Recently, Taylor et al. (1994) introduced a method with the potential to
further reduce the effort to map trait-modifying loci, termed phenotypic
pooling. Phenotypic pooling refers to the pooling of DNA from the progeny of
a segregating population, on the basis of similar phenotype, prior to marker
analysis. Using this approach makes it unnecessary to individually type each
animal in a phenotypic sub-population with genome-wide markers, since the
marker analysis can be carried out using a single sample of pooled DNA,
made up of equal amounts of DNA from each animal within a phenotypic
sub-class. In the absence of linkage, such an analysis would show a 50:50
ratio of each allele at any given marker. Markers that are linked to a QTL
show an enrichment for a particular allele on amplification of the pooled DNA
by PCR. This enrichment can be visualised when the PCR product is
electrophoresed and one allele-derived band is of greater intensity than the
other. With the use of careful controls, it is possible to gauge from this
technique which chromosomal regions show linkage to QTL for a single trait.
Although this method was originally developed to facilitate the mapping of
single locus mutations, findings presented in this thesis support the proposal
that this method can also be used in the rapid mapping of quantitative trait
loci.
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One of the main disadvantages in the analysis of phenotypic extremes, and
in the use of phenotypic pooling, is that more segregating individuals must
be analysed for the quantitative phenotype, in order to collect enough
individuals in the phenotypic extremes. Due to differences in breeding, this is
not possible for every organism, but is one of the advantages of using mice
for this type of analysis. It is also not possible to use this analysis to map
more than one quantitative character, since individuals with extreme
phenotypes for a particular trait are not likely to represent the extremes for
another.
5.1.3 Gene action
Gene action is a term used to describe the ways in which two alleles at a
genetic locus can interact to produce the phenotype of an individual
(Tanksley, 1993). In classical genetics, the phenotypes of macromutations'
alleles are usually described as being either dominant or recessive.
However, phenotypes are seldom absolutely recessive or dominant in loci
underlying quantitative variation. The gene action for quantitative trait alleles
can range from complete dominance to complete recessiveness, to
overdominance, where offspring exceed the phenotype of either parent, to
anything in between. In order to describe such continuous gene action,
quantitative geneticists have devised a number of statistical parameters. The
dominance/additivity statistic (d/a) is commonly used, and describes the
degree to which an offspring, genotypically heterozygote for a QTL,
resembles the parental homozygotes. Values assigned to the d/a statistic
describe whether a QTL has a dominant, recessive or over/underdominant
gene action. Additive gene action is used to describe a heterozygote QTL
which is phenotypically intermediate between the parental homozygotes, and
dominant gene action describes an individual more phenotypically similar to
one parent than the other. In this way, similarity of phenotype can be used to
infer similarity to parental genotype, with reference to the genotype of a
known marker.
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5.1.4 Variation in the phenotype of Sd
The two phenotypic manifestations of the Sd mutation, the shortening in tail
length and the urogenital anomalies, are strongly influenced by genetic
background (Dunn et al., 1940; Gluecksohn-Schoenheimer, 1943). For
example, breeding Sd mice onto a BALB/C background increases the
expression and dominance of the Sdmutation to the point where the affect of
Sd approaches that of a lethal dominant (Dunn et al., 1940). In a recent
study, Sd+ mice (on a RSV/Le background) were outcrossed to NMRI and
C57BI/6 mice. When the number of vertebra in each Sd+ mouse were
counted, those on a NMRI background developed 30-37 vertebrae, whilst
those on the C57BI/6 background developed 37-42, displaying a less severe
phenotype than in the NMRl-crossed mice (Dietrich et al., 1993a). In early
selection experiments, the two phenotypes were found to vary independently
of each other (Dunn, 1942), as was found in this backcross. However, on
some genetic backgrounds the severity of the spinal phenotype and has
been found to correlate with that of the renal phenotype (Mesrobian and
Sulik, 1992).
5.2 Analysis of tail length variation in the Sd backcross
As described in chapter 3, tail lengths of all the backcross offspring were
measured and recorded (see table 3.3.1). In 24 day old Sd progeny, tail
lengths varied from 0cm to 4.5cm. In the 24 day old wild type (WT) progeny,
tail lengths varied from 5cm to 8.5cm. The distribution of tail length variation
for both populations is shown in figure 5.2. This figure shows that the longest
Sd tail is smaller than the shortest WT tail and, therefore, that the two tail
length distributions do not overlap. It was noted at this time that the tail
lengths of the Sd backcross progeny were, on average, smaller in length
than those of their (CAST/Ei X CBA) Sd parents (see table 3.3.2) (taking into
account the differences in age). This led to the hypothesis that the
M.m.castaneus genome could be carrying quantitative trait loci which were
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Figure 5.2: Tail length distribution of wild type and Sd mice in the backcross.
The number of mice with a given tail length is shown on the Y axis and tail
length is shown in centimetres (cm) on the X axis. The dark bars show tail
lengths in the Sd progeny, and the light bars show tail lengths in the wild
type (WT) progeny of the backcross.
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In order to ascertain whether the variance of tail length in the Sd progeny
was significantly different to that of the WT progeny, statistical analysis was
carried using the F test (appendix D). This showed that difference in tail
length variation between Sd and WT mice was highly significant (p<0.001).
5.3 Phenotypic pooling of Sd backcross progeny
The work in this section of the chapter was carried out in collaboration with
S. Phillips and B. Taylor at the Jackson Laboratory, using the phenotypic
pooling technique previously described (Taylor et ai, 1994).
From each extreme of the tail length distribution, 30 Sd mice with the
shortest, and 30 with the longest tails were picked for phenotypic pooling.
500ng of DNA from each mouse was used to make up the pools for marker
analysis: pool A was made up of DNA from mice with the shortest tails and
pool B was made up of DNA from those with the longest. WT mice were not
used in this analysis (table 5.3.1).
Based on the hypothesis that the M.m.castaneus genome is carrying QTL
which increase tail length in Sd mice, if a marker is physically linked to a tail-
length modifying locus, one would expect to see an excess of the CAST/Ei
allele in the long-tail pool and a reduction in the short-tail pool. Likewise,
excess of the CBA allele in the short tail pool and a reduction in the long-tail
pool would also be expected if this hypothesis were true, since non-linked
loci would normally show a 50:50 distribution of alleles. An enrichment for the
CAST/Ei allele in the long tail pool at a given marker implies that the majority
of long-tailed Sd mice at that locus are positive for the trait-modifying
genotype, and vice versa for the CBA allele in the short-tail pool. Results
showing the enrichment of alleles from the relevant pooled sample would
give credence to the hypothesis that the M.m.castaneus genome carries
modifiers which favour long tails, and would identify chromosomal regions
requiring more detailed analysis for the identification of QTL.
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107 0 85 2.8
220 0 322 2.8
121 0.1 3 3.0
204 0.2 40 3.0
276 0.2 76 3.0
21 0.3 95 3.0
82 0.4 130 3.0
244 0.4 142 3.0
245 0.4 161 3.0
36 0.5 194 3.0
61 0.5 209 3.0
158 0.5 210 3.0
270 0.5 211 3.0
302 0.5 224 3.0
320 0.5 240 3.0
313 0.6 263 3.0
115 0.7 292 3.0
8 0.8 297 3.0
37 0.8 7 3.5
318 0.8 103 3.5
81 0.9 135 3.5
203 0.9 145 3.5
258 0.9 188 3.5
4 1.0 189 3.5
56 1.0 193 3.5
86 1.0 298 3.5
128 1.0 214 4.0
237 1.0 9 4.4
299 1.0 155 4.5
2 1.5 205 4.5
Table 5.3.1 Sdmice used to generate phenotypic pools A and B
Pool A was generated from Sd mice with the smallest tails in the backcross
and Pool B was generated from Sd mice with the longest tails in the
backcross. In Pool A, tail lengths ranged from 0-1 cm, and in Pool B tail
lengths ranged from 2.8-4.5cm.
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5.3.1 Marker analysis of phenotypically pooled DNA
Phenotypic pools, A and B, were used in a genome-wide marker analysis to
identify chromosomal regions showing linkage to tail length modifying genes.
Sixty five simple sequence repeat (SSR) markers, which can be amplified by
PCR, were utilised in this analysis (figure 5.3.1). SSR markers that amplified
M.m.castaneus and M.m.musculus alleles equally well from N1 hybrid DNA,
and which gave strong, well-separated bands in agarose gels, were chosen
for use in this study. They were also selected such that any autosomal locus
would be no more than 20cM from the nearest marker (the MIT Genome
Centre map was used to ascertain both the genetic length of the
chromosomes and the positions of SSR markers along them). A control
sample of N1 hybrid DNA was used in the PCR reactions to ensure that
differences in the allele amplification were not artefactual. The results of the
marker analysis are given in table 5.3.2 and figure 5.3.1.
From figure 5.3.1 and table 5.3.2 it can be seen that a number of markers
show skewing from the 50:50 random distribution of alleles. An indication of
the sensitivity of this technique can be seen in the results for chromosome 2,
where a deficiency of the CAST/Ei product, in both phenotypic pools, was
found in the markers which flank Sd (D2Mit1, at a distance of 10cM proximal
to Sd, and D2MH7, approximately 13cM distal to Sd). Since Sd is present on
the M.m.musculus allele and is the phenotype that has been selected for in
all the mice, one would expect to see a deficiency of the M.m.castaneus
allele in this region of chromosome 2 if the markers were detecting linkage
from the phenotypic pools. This confirmed to us that the pooling technique
could detect linkage to a mutant allele over a 20cM distance. However, some
regions, such as chromosome 7, proved difficult to analyse due to lack of
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Where isolated regions displayed allele enrichment in only one of the
phenotypic pools, evidence of linkage could not be assumed since these
results could not be explained by the hypothesis and could be due to
chance. An example of this can be seen at the marker D4MH56, where less
CAST/Ei product was seen in the long-tail pool and more in the short-tail
pool. Because the remaining markers on chromosome 4 showed no skewing
in allele amplification, it is unlikely that the result for D4Mit56 is significant.
Stronger proof of linkage arises where evidence of allele enrichment can be
seen with 2 or more markers across a chromosomal region. Results for
chromosomes 9, 10 and 18 provide the strongest proof of linkage to tail-
length modifying genes, since allele enrichment in one or both pools has
been detected with more than one marker. In chromosome 9, linkage to all 4
markers in either one or both phenotypic pools was seen (table 5.3.2), and in
chromosome 10, only D10MH44 and D10Nds2 failed to show linkage out of
the 6 markers analysed (table 5.3.2). In chromosome 18, evidence of linkage
is less well founded, since only 2 markers, D18Mit17 and D18Mit50 showed
distortion in the distribution of CAST/Ei and CBA alleles.
5.3.2 Discussion
This technique, designed for the detection of single mutant loci, allowed for
the rapid and efficient identification of three regions which could be positive
for tail-length modifying loci on chromosomes 9, 10 and 18. To confirm these
findings, it was necessary to singly haplotype the individual mice in each
phenotypic pool with a panel of closely spaced markers on each
chromosome. This was done to increase evidence of linkage and to identify
markers more closely linked to putative QTL for use in the analysis of the
entire backcross.
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5.4 Chromosome 10 marker analysis
In order to analyse more closely the evidence of linkage on chromosome 10,
a panel of 8 SSR markers spaced between 10-20cM apart (table 5.4.1) were
selected and used to individually haplotype by PCR, the Sd progeny
comprising the two phenotypic pools. The results of this analysis are shown
in tables 5.4.2 (short-tail pool) and 5.4.3 (long-tail pool). The inclusion of the











D10Mit80 2.2 144 172
D10MH105 13.4 145 182
D10Mit31 18.4 154 134
D10MH21 39.4 132 160
D10MH121 60.7 190 217
D10Mit164 68.5 130 108
D10MH145 73.0 141 101
Table 5.4.1 Chromosome 10 markers used for the haplotyping of the long
and short-tailed Sdmice from the backcross.
The distance of each marker from the top of chromosome 10 is given in
centiMorgans (cM) and was obtained from the microsatellite map distributed
by the MIT Genome Centre. Allele sizes are given in basepairs (bp).
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Tail D10 D10 D10 D10 D10 D10 D10
No. Sex length Mit Mit nodal Mit Mit Mit Mit Mit
(cm) 80 105 31 21 121 164 145
107 F 0 M M M C C C C C
220 F 0 M M M M M M C C
121 M 0.1 M M M M M M M M
204 F 0.2 C C C C C M M M
276 M 0.2 M M M M M C C C
21 F 0.3 M M M M C C C C
82 M 0.4 C C M M M c C C
244 M 0.4 M M M M M c C c
245 M 0.4 M M M M M M M c
36 M 0.5 M M M M M M M M
61 F 0.5 C C C C C C C M
158 F 0.5 M M M M M M M M
270 F 0.5 M M M M M M C C
302 M 0.5 C C C C C C C c
320 M 0.5 M M M M M M M M
313 M 0.6 C C C M M M M M
115 F 0.7 M M M M M M M M
8 F 0.8 M M M M M M M M
37 M 0.8 M M M M M M M M
318 M 0.8 C C C C C M M M
81 M 0.9 M M M M M M M M
203 F 0.9 M M M M M C C C
258 M 0.9 M M M M M M M M
4 M 1.0 M M M M M M M M
56 M 1.0 C C C C C C C C
86 F 1.0 C C C C C M M M
128 M 1.0 M M M M M M M M
237 M 1.0 C C C C C C C M
299 F 1.0 M M M M M M M M
2 M 1.5 M M M M M C C C
% CBA allele 70% 70% 73% 73% 67% 63% 56% 60%
Table 5.4.2 Chromosome 10 haplotyping of mice in the short-tail pool
F stands for female and M for male in column 2. Tail lengths are in
centimetres (cm). Mice haplotyped as C were heterozygous for the CAST/Ei
and CBA alleles. Mice haplotyped as M were homozygous for the CBA allele.
The final row indicates the percentage of mice at each marker which were
genotyped as being homozygous for the CBA allele (M). Markers are given in
a centromeric (left) to telomeric (right) order. The map positions of the MIT
markers were obtained from the MIT Genome Centre map. The relative
position of nodal was obtained from the Jackson Laboratory's Encyclopaedia
of the Mouse.
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Tail D10 D10 D10 D10 D10 D10 D10
No Sex length Mit Mit nodal Mit Mit Mit Mit Mit
(cm) 80 105 31 21 121 164 145
85 F 2.8 C C C M L M M M M
322 F 2.8 c c C C C C C C
3 F 3.0 c c c C C C C C
40 F 3.0 c c c
t c M M M M
76 M 3.0 c c !_ C c C C C C
95 F 3.0 c c L C M M M M M
130 M 3.0 c c C C C C C C
142 M 3.0 M c C C C C C C
161 M 3.0 c c C M M M M M
194 M 3.0 M M M M M M M M
209 M 3.0 M c C C C C C C
210 M 3.0 C c C C C M M M
211 M 3.0 C c c C C C C C
224 F 3.0 C c M M M C C C
240 F 3.0 c c M M M M M M
263 F 3.0 c c M M M M M M
292 F 3.0 c c C C C C C C
297 F 3.0 M c C C C C C C
7 F 3.5 M M M M M M M M
103 M 3.5 C c C C C M M M
135 F 3.5 M c C C C C C C
145 F 3.5 C c c C C C c C
188 F 3.5 M M M M M M M M
189 F 3.5 C C C C C M M M
193 M 3.5 M C C c C C C M
298 F 3.5 M C C c c C C C
214 M 4.0 C C C c c C c C
9 F 4.4 C c c c c C c C
155 F 4.5 c c c c c C c C
205 F 4.5 c c J c c c C j c C
% CAST/Ei allele 66% 87% 80% 70% 66% 60% 60% 56%
Table 5.4.3 Chromosome 10 haplotyping of mice in the long-tail pool
F stands for female and M for male in column 2. Tail lengths are in
centimetres (cm). Mice haplotyped as C were heterozygous for the CAST/Ei
and CBA alleles. Mice haplotyped as M were homozygous for the CBA allele.
The final row indicates the percentage of mice at each marker which were
genotyped as being heterozygous for the CAST/Ei and CBA alleles (C).
Markers are given in a centromeric (left) to telomeric (right) order. The map
positions of the MIT markers were obtained from the MIT Genome Centre
map. The relative position of nodal was obtained from the Jackson
Laboratory's Encyclopaedia of the Mouse.
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From table 5.4.2, it can be seen that over 50% of the mice in the short-tail
pool are genotypically CBA when haplotyped using the chromosome 10
markers. D10Mit80 and D10Mit105 show the CBA genotype in 70% of the
mice, with the skew in allele distribution peaking at 73% at D10Mit31. The
number of mice with the CBA genotype decreases to 67% at D10MH21. The
incidence of the CBA allele at markers more telomeric (at D10MH121,
D10MH164 and D10MH145) ceases to follow a genotypic pattern indicative of
linkage to a QTL. From these preliminary results, it is possible to infer that
the markers D10Mit80\o D10Mit31 define a region of chromosome 10 which
is in linkage disequilibrium with tail-length modifying QTL.
The chromosome 10 haplotyping results from the mice in the long-tail pool
(table 5.4.3) shows that linkage to the CAST/Ei allele increases from 66% at
D10Mit80 to a peak at D10MH105, where 87% of the mice are of the
CAST/Ei genotype. Linkage reduces slightly to 70% at D10MH31, and then
the incidence of the CAST/Ei allele decreases the further down the
chromosome the markers are situated, with D10MH21, D10MM21,
D10Mit164 and D10Mit145 showing similar slight skews in allele distribution
as those seen in the short-tail pool (tables 5.4.2 and 5.4.3). These results
support the data produced from marker analysis of the short-tail pool,
suggesting the presence of a tail-length modifying QTL between the markers
D10Mit80 and D10MH31 on chromosome 10.
Using the chromosome 10 mapping data produced from the long and short-
tailed mice, the search for genes mapping in the region of D10Mit105 to
D10MH31 identified nodal as a potential candidate gene on the basis of its
map position and biological function. Nodal belongs to the TGF(3 superfamily
of genes and encodes a signalling molecule thought to be essential for
mesoderm formation and the organisation of axial structures in early mouse
development (Zhou et al., 1993). Mapping data obtained from the Jackson
Laboratory's Encyclopaedia of the Mouse positions nodal 14.5cM distal to
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D10Mit105 and 6.5cM proximal to D10Mit31. Since nodal maps to the
appropriate region of chromosome 10, and has a biological function which
could be used to explain the variation in the expressivity of Sd, primers were
designed (table 2.10.4) to amplify over an intron, the size of which varied
between M.m.musculus and M.m.castaneus DNA. Using this variant, mice in
the long and short-tail pools were genotyped at nodal (see tables 5.4.2 and
5.4.3).
The results of mapping nodal onto the panel of long and short-tailed mice are
shown in tables 5.4.2 and 5.4.3. In the long-tail pool (table 5.4.3), nodal was
genotyped as being CAST/Ei in 80% of the mice. This shows a decrease in
the number of mice of the CAST/Ei genotype between D10Mit105 and nodal.
In the short-tail pool, nodal was genotyped as being CBA in 73% of the mice
(table 5.4.2), showing an increase in the number of mice of this genotype
between D10Mit105 and nodal. These results show that nodal maps within
the region of linkage disequilibrium defined by the markers D10Mit105 and
D10MH31. Data from the long-tail pool, showing a decrease in the number of
mice with the CAST/Ei genotype between D10Mit105 and nodal, could be
due to recombination occurring between the marker and QTL. However, it
was not possible to statistically confirm the presence of a tail-length
modifying gene on this region of chromosome 10 by using data from such a
small number of mice.
5.5 Chromosome 10 backcross analysis
In order to have sufficient data to statistically identify a tail-length modifying
locus on chromosome 10, backcross progeny were haplotyped with the
markers D10Mit80, D10Mit105, D10MH31 and nodal. Only those mice which
were 24 days old when assayed were used in this analysis (300 out of the
336 backcross progeny). Figure 5.5.1 shows the results of chromosome 10
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Figure 5.5.1 Chromosome 10 haplotyping of the Sd backcross
152 Sd mice (figure A) and 148 wild type (figure B) were haplotyped. The
number at the base of each column indicates the number of animals
recombinant between the markers shown. The filled in box pi) denotes the
CAST/Ei allele and the unfilled box P) denotes the CBA allele.
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5.5.1 Statistical analysis of chromosome 10 mapping data
The statistical analysis in this section of the thesis was carried out in
collaboration with K. Ranee and P. Keightley at the Institute of Cell and
Animal Population Biology, University of Edinburgh.
The statistical method used to analyse the chromosome 10 mapping data
was based on that of Haley and Knott (1992), where a regression analysis is
used in place of a maximum likelihood method (the two methods have been
found to give comparable results). A statistical programme based on this
method which took into account variation arising from sex, parity, litter
number and litter size was devised. Sex and parity were found to be
insignificant in the analysis of variance and were therefore excluded from the
regression analysis. The chromosome 10 mapping results from backcross
Sdand wild type mice were analysed as two separate data sets.
In the regression analysis employed, the putative QTL is positioned at 1cM
intervals along the chromosome and the statistical model is fitted at each
point. The test statistic is calculated in log10 and is comparable with a LOD
score (Haley and Knott, 1992). The likelihood profiles which are generated
show a peak in the test statistic where a QTL is most likely to be located on
the chromosome. A drop in the test statistic of more than 2 defines a 95%
confidence interval for the presence of a QTL in that region.
Figures 5.5.2 and 5.5.3 show the likelihood profiles generated from the
chromosome 10 mapping data of the Sd and WT progeny of the backcross
(respectively). Figure 5.5.3 shows that there is no evidence of linkage to a
tail-length modifying gene in the WT progeny, as the test statistic fails to
reach over a value of 2 at most positions along the chromosome. There is
also no peak in the test statistic to indicate linkage to a modifying gene over
a particular region of chromosome 10. Conversely, figure 5.3.2 shows that
the test statistic peaks significantly at a number of points along the
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chromosome in the likelihood profile of the Sd backcross progeny. The test
statistic peaks at a value of 13.37, equivalent to a LOD score of the same
value, 12cM distal to D10Mit80. This peak defines the region of maximum
linkage to a tail length modifying gene on chromosome 10. Either side of this
peak, between 7.5 to 22cM away from D10Mit80, the 95% confidence
interval spans a 14.5cM stretch of chromosome 10. This model suggests,
therefore, that a tail length modifying gene in Sd progeny could be found
within this region. Since D10Mit105 maps 9.2cM (+/-2.3) distal to D10MH80
in the Sd+ population, it maps within this region, close to the peak of
maximum linkage. However, the candidate tail-length modifying gene nodal,
maps 23cM (+/-3.8) from D10Mit80, and is outwith the region of chromosome
10 defined by the 95% confidence interval. Nodal is unlikely, therefore, to be
responsible for tail length variation in the Sd progeny of the backcross.
Nevertheless, this analysis has shown that a tail-length modifying gene is
most likely to be present on the region of chromosome 10 between the
markers D10Mit80 and D10Mit105. Calculating the percentage of the mean
(appendix E), indicates that this locus could be responsible for at least 21.2%
of the genetic variance affecting tail lengths in Sdmice.
5.5.2 Discussion
These data indicate that a tail length modifying locus is present on
chromosome 10, approximately 12cM distal to the marker D10Mit80, and in
the vicinity of D10Mit105. The location of a tail length modifying gene to this
region of chromosome 10 excludes the gene nodal as a candidate modifier.
There are other genes in this region of the chromosome, such as the
interferon gamma receptor gene (Kozak et al., 1990), which are not as
strong candidates as nodal, but which may warrant further investigation. It is
likely that this gene is not the only locus affecting tail length in the presence
of Sd, since markers on chromosomes 9 and 18 also showed linkage to the
variable phenotype, and contribution of this locus to overall tail length
variation may be only 21.2%.
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Position on chr. 10 from D10Mit80 (cM)
Figure 5.5.2 Regression analysis of chromosome 10 mapping data (Sd
progeny)
The likelihood profile was produced using regression methods to fit a model
for a single QTL at 1cM intervals along the chromosome (solid line). The
height of the curve (X axis) was calculated in log10. Distance in centiMorgans
(cM) is shown on the Y axis. The 95% confidence interval, defined by a drop
of 2 in the test statistic, is indicated by the broken line. With markers placed
in a telomeric (left) to centromeric (right) order: D10Mit80 is positioned where
the X and Y axes intersect; D10Mit105 is positioned 13.2cM (+/-2.7) from
D10Mit80, nodal is 9.9cM (+/-2.4) from D10Mit105, and D10Mit31 is 7.2cM
(+/-2.1) from nodal. Arrows indicate the approximate position of these
markers. Map distances were calculated from the Sd progeny of the
backcross (see figure 5.5.1), and cM and standard error values as in section
2.12. The data used to generate this likelihood profile is detailed in appendix
A.
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Position on chr.10 from D10Mit80 (cM)
Figure 5.5.3 Regression analysis of chromosome 10 mapping data (WT
progeny)
The likelihood profile was produced as in figure 5.3.2 using mapping data
from the wild type (WT) progeny of the backcross (solid line). The height of
the curve (X axis) was calculated in log10. Distance in centiMorgans (cM) is
shown on the Y axis. The 95% confidence interval is indicated by the broken
line. With markers placed in a telomeric (left) to centromeric (right) order:
D10Mit80 is positioned where the X and Y axes intersect; D10Mit105 is
positioned 7.4 (+1-2.2) from D10Mit80, nodal is 7.4 (+1-2.2) from D10MH105,
and D10Mit31 is 10.8 (+/-2.5) from nodal. Arrows indicate the approximate
position of these markers. Map distances were calculated from the WT
progeny of the backcross (see figure 5.5.1), and cM and standard error
values as in section 2.12. The data used to generate this likelihood profile is
detailed in appendix B.
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Chapter 6: In vitro development of embryonic
kidneys from Sd mice
6.1 Introduction
There are three spatially and temporally discrete embryonic excretory
organs: the pronephros, the mesonephros and the metanephros (Saxen,
1987). The pronephros is the most primitive of these organs and is functional
in embryogenesis only in some of the lower vertebrates. The mesonephros,
located caudal to the pronephros, is functional during embryogenesis and
throughout life in higher fishes and amphibians. The metanephros, located
most caudally, serves as the permanent kidney of the amniotes. The
pronephros, mesonephros and metanephros consist of paired organs
derived from the intermediate mesoderm located immediately lateral to the
somites. Pronephric tubules empty into the primary nephric ducts, which are
adopted by the mesonephros after degeneration of the pronephric tubules to
become the mesonephric ducts. The mesonephric ducts empty into the
cloaca and, at a later stage in development, are induced by the metanephric
mesenchyme to develop into outgrowths called the ureteric buds. The
ureteric buds then invade the metanephric blastema to set in motion the
cascade of inductive interactions which give rise to the mature metanephric
kidney.
6.1.1 kidney organogenesis
Differentiation of the metanephric blastema and of the ureteric bud is
dependent on an inductive event (or events) that takes place when the
ureteric bud encounters the metanephric blastema. The exact nature of this
event is unknown, but the induction between the ureteric bud and
metanephric blastema is known to be reciprocal (Grobstein, 1955).
On invasion of the metanephric mesenchyme by the ureteric bud, the bud
induces the metanephric mesenchyme to undergo nephrogenic
differentiation. For this, mesenchymal stem cells condense into small
aggregates whilst others differentiate into stromal cells which remain located
in the medulla. Each aggregate undergoes a mesenchymal to epithelial
139
conversion and a sequence of histologically definable growth stages. The
cells in the condensed aggregate proliferate as part of a mitotic stage, after
which mitotic activity decreases and the condensate assumes a comma
shape. Cells farthest from the tip of a ureteric branch become elongated and
funnel shaped, resulting in the formation of a slit which develops into the
glomerular crevice. While glomerulogenesis is taking place, a second slit
forms at the distal pole of the developing nephron giving rise to an S-shaped
body (Saxen, 1987). This pole of the developing nephron fuses with the tip of
a collecting duct and forms the distal tubule of the mature nephron, whilst the
proximal pole gives rise to the glomerulus and proximal tubule. The
metanephric blastema differentiates into all of the tubular structures of the
adult nephron with the exception of the collecting duct system.
On encountering the metanephric mesenchyme, the ureteric bud is induced
to grow and bifurcate. In humans and mice, the first branching of the bud in
the mesenchymal blastema is dichotomous and symmetric, creating two
branches that grow in opposite directions at an angle of 180° (Saxen, 1987).
As each new ureteric branch is capped by a mesenchymal condensate,
serial, dichotomous branching is induced giving rise to a network of branches
which form the collecting duct system of the metanephros. Whilst the distal
tips of the ureteric bud divide and grow to the periphery of the metanephric
mesenchyme, the proximal ends give rise to the ureter and renal pelvis.
6.1.2 Molecular and genetic events in kidney induction
Although the actual signalling molecules responsible for induction remain
elusive, a number of growth factors and receptors are known to be
expressed in the kidney at the time of induction; and although the nature of
the primary mesenchymal induction signal is still unknown, an understanding
of the molecular mechanisms underlying the induction of the ureteric bud
may be closer at hand.
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The proto-oncogene c-ret is a receptor tyrosine kinase expressed in the
developing kidney at the tips of the branching ureteric bud (Pachnis et al.,
1993). Mice with a truncated form of Ret protein which fails in its biological
function, are born with multiple defects of the urogenital system (Schuchardt
et al., 1994). Phenotypes in these mice range from renal agenesis to small,
severely dysplastic kidney rudiments, abnormalities which occur primarily
because the ureteric bud fails to proliferate and branch. Surrounding the tip
of the growth retarded ureteric buds, nephrogenic tissue composed of
glomeruli and tubules is found, indicating that the differentiation potential of
the mesenchyme is not affected by the loss of Ret. The c-ret gene product
may therefore be responsible for transducing the signals from the
mesenchyme that induce growth and branching of the ureteric bud. Since an
endogenous ligand for c-ret has yet to be identified, the nature of the
mesenchymal-derived signal remains unknown.
The expression patterns of the proto-oncogene c-met and its ligand,
hepatocyte growth factor (HGF) are indicative of their involvement in kidney
induction and branching morphogenesis (Sonnenberg et al., 1993). In the
developing kidney, c-met is expressed and transcribed in both the ureter
epithelial and mesenchymal cells. HGF is synthesised by the surrounding
mesenchyme and is known to stimulate branching and tubulogenic
morphogenesis in Madine-Darby canine kidney (MDCK) cells (Montesano et
al., 1991; Santos and Nigram, 1993). Co-culturing mouse 11.5d kidney
rudiments with MDCK cells seeded in Type I collagen, induces the cells to
undergo a branching morphogenesis which can be partially inhibited by
monospecific antiserum against HGF. This suggests that the action of
soluble branching morphogens released by the embryonic kidney can be
partly blocked by inhibiting the binding of HGF. Inhibition of the HGF/ c-met
interaction with anti-HGF antibodies, also reduces the growth of kidney
rudiments in culture (Santos et al., 1994). Nevertheless, mice lacking HGF
fail to survive due to placental and liver defects (Schmidt et al., 1995; Uehara
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et al., 1995). Abnormalities in the development of excretory system were not
reported, suggesting that HGF is probably not the only branching morphogen
in the developing kidney.
Mice lacking the Wilms' tumour suppresser gene, WT1, have recently been
generated (Kreidberg et al., 1993). This gene was initially identified by a loss
of heterozygosity in human embryonic kidney tumours and is expressed in a
variety of cell types in the urogenital system (Armstrong et al., 1992). The
WT1 knockout mouse shows a complete absence of ureteric bud outgrowth
despite the fact that WT1 is normally expressed in the uninduced
mesenchyme, and not in the ureter epithelium or nephric duct. The WT1
mutant mesenchyme is unable to respond to induction when co-cultured with
wild type inducer, such as spinal cord, but instead undergoes apoptosis
(Kreidberg et al., 1993). This suggests that WT1 is important in early kidney
development, and is required for both the primary induction signal of the
ureteric bud and in the differentiation events of the metanephric blastema.
WT1 is likely to play an important role in the regulation of Pax2, a
transcription factor which is activated during early kidney morphogenesis and
down regulated as the tubular epithelium matures (Dressier and Douglass,
1992). Pax2 is expressed in condensing metanephric mesenchyme and in
early epithelial structures derived from the mesenchyme. Repression of Pax2
by antisense oligonucleotides inhibits condensation of the mesenchyme and
its subsequent conversion to epithelium (Rothenpieler and Dressier, 1993);
whilst persistent and ectopic expression of this gene in transgenic mice,
results in renal abnormalities similar to those found in human nephrotic
syndromes (Dressier et al., 1993). The properly timed activation and down-
regulation of Pax2 is therefore essential for normal kidney development.
Persistent expression of Pax2 in the epithelial components of human Wilms'
tumours (Dressier and Douglass, 1992) suggested that negative regulators
of the gene were absent in these tissues. Expression analysis of WT1
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revealed that its protein levels were markedly increased in individual
precursor cells of the glomerular epithelium during periods of Pax2 down-
regulation in these cells. Binding studies and CAT assays demonstrated that
WT1 is able to bind to three high affinity sites in the 5' untranslated region of
Pax2 to repress its transcription (Ryan et al., 1995). These data indicate that
WT1 acts upstream of Pax2 in the metanephric induction pathway.
Evidence exists to suggest that the signalling glycoprotein Wnt-4 is essential
for normal kidney development (Stark et al., 1994). Wnt-4 expression is first
seen in 11.5 day embryos where the first pre-tubular condensates form. It is
later expressed in the comma shaped bodies, and is then restricted to the
region in the S-shaped body where fusion of the tubular epithelium to the
collecting duct occurs. Once this fusion is complete, Wnt-4 expression is lost.
Mice lacking Wnt-4 activity develop severely growth retarded kidneys with
morphologically undifferentiated mesenchyme. Pretubular aggregates were
absent in the majority of 15 day embryos examined, although ureteric
branching was found to be unaffected (Stark et al., 1994). When the
expression of kidney markers in Wnt-4 null mice was examined, the initial
expression of WT1 in undifferentiated mesenchyme was found to be
unchanged, indicating that the early activation of WT1 remains unaffected by
the loss of Wnt-4. Pax2 and N-myc expression patterns were also normal to
day 14.5 of gestation, but in embryonic rudiments where the mesenchyme
had failed to undergo tubulogenesis, the expression of these genes was
absent. These data suggested that the mesenchymal cells fated to form
tubules were induced but failed to convert to epithelial structures in the
absence of Wnt-4. Wnt-4 was also found to be necessary for the activation
and/or maintenance of Pax8 expression. Pax 8 is a transcription factor which
is expressed in condensing metanephric mesenchyme and which could be
involved in the regulation of other genes essential for tubule formation
(Plachov et al., 1990). It is likely therefore that the development of the
ureteric bud, from 12.5 days of development, is independent of both Wnt-4
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expression and tubule formation, as supported by the normal expression of
c-ret and c-ros, genes which are markers for the differentiation and
development of the ureteric bud. These data indicate that although the early
expression of WT1 and Pax2 is induced in the absence of Wnt-4, the
expression of this gene is vital for the mesenchymal to epithelial conversion
of the metanephric mesenchyme.
There are many other genes known to be active in kidney morphogenesis.
Cell proliferation and differentiation are intimately linked to ensure that the
correct numbers of cells and cell types develop accurately. The insulin-like
growth factors (IGFs) and their receptors (IGFrs) mediate proliferation and
morphogenesis of the kidney epithelium (Patterson and Dressier, 1994). IGF-
2 is expressed in undifferentiated metanephric mesenchyme and human
Wilms' tumour (Yun et al., 1993) and its expression is possibly controlled by
WT1 (Drummond et al., 1992). Mice lacking IGF-2 are dwarfed in
development (Dechiara et al., 1990), as are those lacking IGF-1 (Powell
Braxton et al., 1993). Both IGFs bind to IGF1 r, which is expressed in the
ureteric bud and its branches (Wada et al., 1993). However, since double
mutants lacking both the receptor and the IGF-1 gene develop histologically
normal, but proportionately smaller, kidneys (Liu et al., 1993a), it is likely that
the IGFs do not act primarily as renal morphogens but as mitogens,
stimulating cell proliferation during kidney development.
Mutations exist for a number of extracellular matrix components, proteins
which provide the scaffold for the developing kidney epithelium. Collagen IV,
which is expressed in the basement membranes of a developing kidney, is
mutated in the human disorder Alport's syndrome, resulting in nephritis which
leads to eventual renal failure, and sensorineural hearing loss (Barker et al.,
1990). With the exception of electron microscopic abnormalities in the
basement membrane of affected individuals, renal morphology is normal and
kidney failure develops only in later life, indicating that this matrix protein is
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not required for kidney development but for postnatal renal function. Mutant
mice with null alleles for tenascin (Saga et al., 1992) and vimentin (Colucci-
Guoyon et ai, 1994) develop normally without any renal histological
abnormalities, indicating considerable functional redundancy in the biological
activity of these proteins. An insertional mutation in collagen I, which is
expressed in undifferentiated mesenchyme prior to induction, does result in a
lethal phenotype, although the kidneys from such mutants develop normally
when cultured in vitro (Kratochwil et at., 1986).
Recently, the biological activities of sulphated proteoglycan have been found
to be essential for normal kidney development (Davies et al. 1995). Some
sulphated proteoglycans are biologically active through their core proteins,
whilst the others function through their sulphated glycosaminoglycan (GAG)
sidechains (Kjellen and Lindahl, 1991). An early extracellular marker of
induction is the proteoglycan, syndecanl (Vainio et al., 1989). Syndecan 1
upregulation is reported to be necessary for mesenchymal condensation, the
first morphological event in nephrogenesis (Vainio et al., 1992). This
syndecan 1-induced condensation can be severely impaired in vitro by
heparin and heparan sulphate (Piatt et al., 1990). The timing of syndecan 1
elevation would suggest it has a role in nephrogenesis that is essential for
proper mesenchymal condensation and differentiation. Impairment of
sulphated proteoglycan function would therefore be expected to affect the
development of nephrogenic condensates. However, in vitro cultivation of
embryonic kidney rudiments with sodium chlorate (a specific inhibitor of GAG
sulphation), and with the GAG-degrading enzymes heparitinase and
chondroitinase ABC, showed that these inhibitors of GAG sidechain
sulphation, did not prevent nephron development (Davies et al., 1995).
Unexpectedly, the inhibitors affected the growth and branching of the ureteric
bud, in a reversible manner. Interestingly, the in vitro affect of sodium
chlorate was partially overcome by two agents: the protein kinase C
activator, phorbol 12-myristate acetate (PMA), and HGF. Whilst PMA was
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able to restore the initial branching morphogenesis of the ureteric bud
without improving its growth in the presence of sodium chlorate, HGF was
able to restore bud growth without stimulating branching morphogenesis.
This strongly indicates the presence of two independent pathways which
control the growth and the branching morphogenesis of ureteric buds.
6.2 Analysis of kidney development in Sd mice
Renal abnormalities commonly seen in Sd mice are thought to occur
primarily through the failure of the ureteric bud to branch and ramify through
the metanephric blastema (Gluecksohn-Waelsch and Rota, 1963). To
investigate more closely the development of Sd kidneys, an in vitro organ
culture assay was used (section 2.2.3-2.2.5) to culture kidney rudiments from
12.5 day homozygous (SdSd), heterozygous (Sd+) and wild type (WT)
embryos (section 2.2.3-2.2.4). Kidney rudiments were cultured in IMEM
alone (section 2.2.1), or in the presence of HGF or a protein kinase C
activator, beta-phorbol-12, 13-dibutyrate (section 2.2.1). Fluorescently-
tagged secondary antibodies were used in this analysis, so that laser-
scanning confocal microscopy could be employed to section optically
through intact rudiments, making histological analysis quicker and simpler
than in the use of paraffin embedded sections. Work presented in this
chapter of the thesis was carried out in collaboration with S. Larsson at the
MRC Human Genetics Unit.
6.2.1 In vitro development of kidney rudiments
Figure 6.2.1 shows an image generated by laser scanning confocal
microscopy (section 2.2.7) of wild type (WT) kidney rudiments originating
from the left side (LHS) and right side (RHS) of the body, which have been
cultured for 48 hours (section 2.2.5), and then immunohistochemically
stained (sections 2.2.2 and 2.2.6). The red signal is generated by the
conjugation of a fluorescently-tagged (Texas Red) secondary antibody to a
mouse monoclonal anti-calbindin antibody (section 2.2.2). Calbindin is a
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calcium binding protein which is expressed in the ureteric bud during the
early stages of collecting duct morphogenesis, but is not expressed in the
metanephric mesenchyme (Liu et al., 1993b). For this reason, anti-calbindin
antibody is a good marker for the ureteric epithelium. The green signal is
generated by the conjugation of a fluorescently-tagged (FITC) secondary
antibody (section 2.2.2) to a rabbit polyclonal, anti-mouse-laminin antibody
(section 2.2.2). The laminin glycoproteins are a major component of the
epithelial basement membrane (Abrahamson and St. John, 1993), and their
expression is confined to the basement membrane as the metanephric
mesenchyme aggregates and epithelialises. Laminin is not greatly expressed
in undifferentiated metanephric mesenchyme (Saxen, 1987), but its
expression intensifies in epithelium generated from condensed mesenchyme
and the ureteric bud. These antibodies were used throughout the analysis of
the in vitro development of WT and Sd rudiments.
Figure 6.2.1 shows the considerable development of WT kidney rudiments
following 48 hours in culture. When dissected, by day 12.5 of gestation
kidney rudiments have undergone the first stage in branching
morphogenesis, giving the ureteric bud a characteristic T-shape surrounded
by undifferentiated mesenchyme. All development subsequent to this occurs
in culture. Figure 6.2.1, shows how the ureteric branches have grown and
ramified through the metanephric blastema. Laminin-stained condensates
have epithelialised and differentiated into comma and S-shaped bodies.
Some nephrogenic tubules have reached an advanced stage of maturation
and have become fused to the epithelia of the collecting duct. Both kidneys
show an approximately equal number of branching events on either side of
the initial T-shaped bud. In addition, both rudiments are at a similar stage of
development.
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Figure 6.2.1 In vitro development of WT kidney rudiments
Rudiment A (from the RHS of the body) and rudiment B (from the LHS of the
body) were cultured for 48 hours. The images were generated by laser-
scanning confocal microscopy by the simultaneous collection of FITC (green)
and Texas Red signals against laminin and calbindin, respectively.
Nephrogenic condensates are shown in green and the collecting duct system
in red. On figure B, the asterix denotes the development of a comma-shaped
body and the arrow, that of a S-shaped body. Magnification was 6.3X and
the scale bar represents 250 microns.
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Figure 6.2.2 In vitro development of Sd+ kidney rudiments
Rudiment A (from the RHS of the body) and rudiment B (from the LHS of the
body) were cultured for 48 hours. The image was generated by laser-
scanning confocal microscopy as in figure 6.2.1. Magnification is 6.3X and
the scale bar represents 250 microns.
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Figure 6.2.3 In vitro development of SdSkidneyrudiments
Rudiment A (from the RHS of the body) and rudiment B (from the LHS of the
body) were cultured for 48 hours. The image was generated by laser
scanning confocal microscopy as in figure 6.2.1. Magnification is 6.3X in
figure A (scale bar represents 250 microns), and 10X in figure B (scale bar
represents! 58 microns)
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Figure 6.2.2 shows the in vitro development of kidney rudiments from a
heterozygous (Sd+) Danforth short-tail mouse after 48 hours in culture. The
image was generated from the anti-laminin and anti-calbindin fluorescent
signals, and shows condensate development and the branching pattern of
the ureteric bud in mutant mice. Figure 6.2.2 is an example of a
phenomenon that was commonly seen in Sd+ rudiment cultures: the
retarded development of the LHS kidney in comparison to that of the RHS
kidney, where both organs have been cultured under the same conditions
and have originated from the same mouse. This phenomenon has been
previously reported (Glueckson-Schoenheimer, 1943).
Figure 6.2.2 shows that the RHS kidney (A) has a WT pattern of branching
morphogenesis, whilst branching in the LHS kidney (B) is poorly developed
and dysmorphic. This variation in the development of the RHS and LHS
kidneys supports the phenotypic data generated from the backcross
(detailed in table 3.3.1), where it was found that of the 73 Sd+ mice with one
larger kidney, in 96% it was the RHS kidney which was the larger of the pair.
This variation is reflected in the development of heterozygote rudiments in
culture.
Despite the decrease in ureteric branching, the metanephric mesenchyme in
Sd+ rudiments is still able to condense and form comma and S-shaped
bodies, indicating that mesenchymal induction and differentiation remain
unaffected by the mutation. It was noted, however, that in Sd+ rudiments
with dysmorphic ureteric branching, fewer condensates were able to form
than in rudiments obtained from WT littermates (see figures 6.2.1, 6.4.2 and
6.4.3), and that their progress through the different stages of nephrogenesis
(section 6.1.1) was retarded.
Figure 6.2.3 shows the in vitro development, after 48 hours in culture, of
kidney rudiments dissected from a 12.5d homozygous (SdSd) embryo.
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Kidney rudiments from SdSd embryos were difficult to dissect as the ureteric
bud was retarded in development by day 12.5. The characteristic T shape of
the ureteric bud, which indicates that the initial branching of the bud has
occurred, was frequently absent in SdSd mice. Ureteric buds were often
dissected in the form of a single-tip bud, surrounded by undifferentiated
mesenchyme, and were usually smaller in size than rudiments dissected
from WT and Sd+ littermates.
The RHS rudiment (figure 6.2.3a) shows a dysmorphic ureteric bud that has
failed to undergo the initial, dichotomous branching step needed to form a T-
shaped bud. Laminin expression is visible in the ureteric bud epithelium, but
is not present in the metanephric mesenchyme immediately adjacent to the
ureteric bud, showing the absence of differentiating condensates. In the LHS
kidney (figure 6.2.3b), the ureteric bud has undergone the primary branching
step to form a T-shaped ureteric bud. Laminin staining shows the presence
of two maturing condensates on either side of the branch, which are
expressing laminin and which have therefore epithelialised.
Unexpectedly, the condensates in figure 6.2.3b are at an advanced, S-
shaped, stage of development and have fused to the tips of the ureteric
ducts. These data strongly indicate that when branching of the ureteric bud
occurs, mutant metanephric mesenchyme is able to respond to inductive
signals provided by the ureteric bud, to undergo condensation and
nephrogenesis. The number of nephrons able to form appears to be a
consequence of branching: the less well branched the ureteric bud is, the
fewer the number of nephrogenic condensates which are able to form.
6.2.2 Discussion
Data presented here strongly suggests that the Sd mutation primarily affects
the branching capacity of the ureteric bud, since when ureteric branching has
occurred, the mutant mesenchyme appears able to undergo proper
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tubulogenic differentiation (figure 6.2.3b). This does not concur with the
findings of Gluecksohn-Waelsch and Rota (1963), which were unable to
confirm the responsive capability of the metanephric mesenchyme in Sd
mice. The retardation of mutant metanephric responsiveness in this study
could have been due to the nature of the assay used. Kidney organ culturing
was in its infancy when this work was carried out, and the use of plasma
clots may have had adverse affects on the in vitro development of rudiments.
The fact that only 53% of their control cultures developed suggests that it
was not an ideal in vitro system. In addition, the use of undefined horse
serum introduced unquantified substances into the culture media, the affects
of which would have been unknown. In contrast, this study used defined
media.
6.3. Analysis of the in vitro effects of HGF
Hepatocyte growth factor (HGF) is synthesised by the metanephric
mesenchyme, and is the ligand for the c-met tyrosine kinase receptor, a
receptor which is expressed in the epithelium of the ureteric bud and which is
associated with the formation and maintenance of epithelial lumenal
structures (Tsarfarty eta/., 1994). Madine-Darby canine kidney cells (MDCK)
undergo tubulogenesis and branching morphogenesis when grown in Type I
collagen in the presence of HGF (Santos and Nigram, 1993). Since HGF is
able to induce branching morphogenesis in MDCK cells, and in cell lines
derived from murine inner medullary collecting duct epithelial cells (Cantley
et ai, 1994), Sd rudiments were cultured with HGF to investigate whether it
could induce improved branching morphogenesis in Sd kidneys.
6.3.1 Sd kidney development in the presence of HGF
HGF (section 2.2.1) was used in the culturing of 12.5 day embryonic kidney
rudiments. Culture times varied from 48-54 hours, to a maximum culture time
of 62 hours. Kidney rudiments were immunohistochemically stained (section
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2.2.6) using the fluorescent secondary antibodies described in section 6.2.1
Whole mount rudiments were histologically analysed using laser-scanning
confocal microscopy (section 2.2.7). In all culture assays, it was noted which
side of the body each kidney originated from. Confocal microscopy images
were generated from the anti-calbindin (Texas Red) fluorescent signal only,
to facilitate the counting of branches.
From figure 6.3.1, it can be seen that the presence of HGF did not affect the
growth or development of wild type (WT) rudiments (figure 6.3.1), following
54 hours in culture, since the development of the kidney originating from the
LFIS of the body, which was cultured in the presence of HGF, is comparable
to that of the control kidney.
Figure 6.3.2 shows kidney rudiments from a heterozygous (Sd+) mouse
cultured in the presence and absence of HGF for 48 hours. The RHS control
kidney has a WT pattern of branching morphogenesis, with the ureteric
system well developed. When the image was generated from the FITC (anti-
laminin) fluorescent signal, mature condensates surrounding the tips of the
collecting ducts were visible (data not shown). The LHS kidney shows a
dysmorphic pattern of branching that is less well developed than that of the
RHS kidney, despite the presence of HGF in the culture media. Since HGF
failed to induce branching morphogenesis in other Sd+ rudiment cultures
(see table 6.3.2), it was concluded that under these culture conditions, and at
a concentration of 80ng/ml, HGF was unable to induce improved branching
morphogenesis in Sd+ rudiments.
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Figure 6.3.1 In vitro affect of HGF on the development of WT kidneys
Rudiment A (from the RHS of the body) and rudiment B (from the LHS of the
body) were cultured for 54 hours. The image was generated by laser-
scanning confocal microscopy, from the Texas Red signal against calbindin.
HGF was used at a concentration of 80ng/ml. Magnification is 10X and the
scale bar represents 158 microns.
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Figure 6.3.2 In vitro affect of HGF on the development of Sd+ kidneys
Rudiment A (from the RHS of the body) and rudiment B (from the LHS of the
body) were cultured for 48 hours. The image was generated by laser-
scanning confocal microscopy as in figure 6.3.1. HGF was used at a
concentration of 80ng/ml. Magnification is 10X and the scale bar represents
158 microns.
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Figure 6.3.3 In vitro affect of HGF on the development of kidneys
Rudiment A (from the RHS of the body) and rudiment B (from the LHS of the
body) were cultured for 48 hours. The image was generated by laser-
scanning confoca! microscopy as in figure 6.3.1. HGF was used at a
concentration of 80ng/ml. Magnification is 10X and the scale bar represents
158 microns.
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Figure 6.3.3 shows that HGF is not able to rescue the branching phenotype
of SdSd kidney rudiments following 48 hours in culture, since despite the
presence of HGF, the LHS kidney is still not able to proceed beyond the first
step in branching morphogenesis. In comparison, the RHS rudiment has
proceeded through 3 more branching events in the absence of HGF,
indicating that SdSd kidneys have some residual branching ability which is
retarded in development.
Culturing Sd+ and SdSd rudiments in the presence of HGF for 54 and 62
hours produced similar results (confocal microscopy data for this is not
shown), in that HGF was unable to induce improved branching
morphogenesis in Sd kidneys, under the culture conditions used.
6.3.2 Branching analysis
In order to perform a preliminary analysis of the in vitro effect of HGF on
branching morphogenesis, rudiments from WT, Sd+ and SdSd mice were















branches 32 26 18 14 5 3
No. of
rudiments 4 2 4 3 3 3
SEM 6.3 16 2.75 4.3 1.45 0.7
Table 6.3.2 Branching analysis of wild type (WT), heterozygous (Sd+) and
homozygous (SdSd) rudiments.
HGF indicates those rudiments cultured with 80ng/ml HGF; cont. indicates
control rudiments cultured without HGF. SEM (standard error of the mean)
was calculated using the statistical analysis program on Excel 5.0
(Microsoft). Rudiments were cultured for 48 hours.
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The Mann Whitney U Test (appendix C) was used to compare the mean
number of branches from rudiments cultured in HGF, with the mean number
of branches in the control rudiments. Probability values generated by this
test indicate the degree to which samples from an identical population would
be expected to overlap. For the WT rudiments, p=0.314; for the Sd+
rudiments, p=0.35 and for the SdSd rudiments, p=0.1. These probability
values indicate that there is no significant difference in the number of
branches which form when the rudiments are cultured with or without FIGF.
Similar findings were observed in rudiments that were cultured for 54 and 62
hours in the presence of HGF (data not shown).
6.3.3 Discussion
From these data it was concluded that HGF was unable to induce improved
branching morphogenesis in in vitro cultured Sd kidney rudiments. It was not
investigated whether the use of HGF at other concentrations would have
been affective, but since HGF has been reported to be biologically active at
concentrations ranging from 30-100ng/ml in kidney culture assays (Davies et
al., 1995), a concentration of 80ng/ml should have been sufficient to produce
a biological response. Nevertheless, it is not possible to definitively exclude
HGF efficacy in the absence of positive controls. Future experiments could
include a control to assay for the biological activity of HGF at different
concentrations by BrdU incorporation, since HGF has known mitogenic
activity. Preliminary data presented here suggests that Sd could affect a
component of the HGF/c-met signalling pathway, preventing the ureteric
epithelium from responding to the inductive signal provided by HGF.
Alternatively, since HGF is not the primary branching morphogen of the
mature kidney (Uehara et al.), Sd may affect an alternative signalling
pathway.
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6.4. Analysis of the in vitro effects of protein kinase C activation
It has been proposed that the activity of HGF, in inducing tubulogenesis and
branching morphogenesis in MDCK cells, can be modulated by several
different protein phosphorylation mechanisms, including those mediated by
tyrosine kinases, protein kinase C and protein kinase A (Santos et al., 1993).
Protein kinase C activation has also been found to induce branching
morphogenesis in sodium chlorate-inhibited rudiments (Davies et al., 1995).
To investigate whether protein kinase C (PKC) activation could induce
branching morphogenesis in Sd kidneys, rudiments were cultured in the
presence of beta-phorbol-12, 13-dibutyrate (PDBu), a phorbol ester known to
activate PKC (Chiu et al., 1987).
6.4.1 In vitro culture of kidney rudiments in the presence of PDBu
Figure 6.4.1 shows WT rudiments cultured for 48 hours in the presence of
10nM (B), 20nM (C) and 200nM (D) PDBu. Rudiment A was cultured in the
absence of PDBu as a control. Rudiments A and B originated from the RHS
of the body, and rudiments C and D from the LFIS. PDBu appears not to
affect the in vitro development of WT kidneys at these concentrations, over a
48 hour culture period, as rudiments B ,C, and D have developed to the
same degree as that of the control rudiment, A.
Figure 6.4.2 shows heterozygous (Sd+) rudiments cultured in the presence
and absence of PDBu for 48 hours. Rudiments A and B , cultured in the
absence of PDBu, are an example of the variability seen in the renal
phenotype of Sd+ mice. The kidney dissected from the RHS of the body has
developed poorly in comparison to that of the WT rudiments (figure 6.4.1).
The branching pattern is not as extensive in this rudiment as it is in the WT
rudiments, and branching appears to have failed at a number of ureteric tips.
The rudiment dissected from the LHS of the body (figure 6.4.2B) has a more
severely affected branching pattern. Branching appears retarded, and the
branch on the right hand side of the T has failed to undergo a second
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branching event, which has occurred normally on the left hand side of the T.
The failure in proper branching at this point gives the ureteric branches a
dysmorphic appearance. Where branching morphogenesis has occurred in
rudiments A and B, condensates undergoing nephrogenesis are visible. It
can be seen from these rudiments that the number of condensates which
form is dependent on the number of duct tips available for the induction of
mesenchymal differentiation.
Heterozygous (Sd+) rudiments C and D, in figure 6.4.2, were cultured in the
presence of 20nM PDBu for 48 hours. Rudiment C was dissected from the
RHS of the body and has a branching pattern which is indicative of a failure
in ureteric branching. Culturing rudiment C with 20nM PDBu has not altered
the rudiment's inability to branch normally. Rudiment D, dissected from the
LHS of the body, is severely retarded in its development, and has not
progressed much beyond the initial branching event which forms the
immature ureteric bud's characteristic T-shape. Culturing the rudiment with
20nM PDBu has failed to rescue the retarded and dysmorphic development
of this kidney. It was concluded from these data that PDBu, at a
concentration of 20nM and over a culture period of 48 hours, was not able to
improve the branching morphogenesis of Sd+ kidneys in vitro.
Figure 6.4.3 shows heterozygous (Sd+) rudiments cultured in the presence
of 100nM (rudiments A and B) and 200nM (C and D) PDBu, for 48 hours.
Rudiment A, dissected from the RHS of the body, has a pattern of branching
morphogenesis which is retarded in development but not severely
dysmorphic. Culturing it in the presence of 100nM PDBu could be
responsible for this improvement in ureteric branching, however, this affect
could also be attributable to the variability of phenotype seen in rudiments
originating from the RHS of the body. The fact that rudiment B, dissected
from the LHS of the body, still has a severely retarded and dysmorphic
pattern of branching morphogenesis, despite having also been cultured in
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100nM PDBu, suggests that the latter is so. If an improvement in branching
morphogenesis was due to the biological activity of PDBu, it would be
evident in both RHS and LHS rudiments. Since no such improvement was
evident, it was concluded that PDBu was not able to induce normal
branching morphogenesis in Sd+ kidneys at a concentration of 100nM and
over a culture period of 48 hours.
Rudiments C and D (figure 6.4.3) were cultured in the presence of 200nM
PDBu for 48 hours. Rudiment C, which originates from the RHS of the body,
has an almost WT pattern of ureteric branching, with many condensates
fused to collecting duct epithelia. Rudiment D, originating from the LHS of
the body, has failed to undergo branching morphogenesis on the LHS
branch of the T. The presence of 200nM PDBu in the culture was not
sufficient to induce normal ureteric branching in this part of the rudiment. For
this reason, it was concluded that PDBu, at a concentration of 200nM and
over a culture time of 48 hours, was not able to induce normal ureteric
branching in Sd+ kidneys.
In figure 6.4.4, homozygous (SdSd) rudiments A (RHS of origin) and B (LHS
of origin) were cultured in the absence of PDBu for 48 hours. Rudiment A
has not progressed beyond the primary branching stage which divides the
ureteric bud into a T. Nevertheless, nephrogenic condensates are visible at
either end of the bud, confirming that the mutant metanephric mesenchyme
is able to respond to ureteric bud-derived inductive signals, but only when
branching of the bud has occurred. Rudiment B has undergone further
ureteric branching than A, and mesenchymal condensates are visible where
branching morphogenesis has occurred.
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Figure 6.4.1 In vitro affect of PDBu on the development of WT kidneys
The figure is continued over page.
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Figure 6.4.1 /n vitro affect of PDBu on the development of WT kidneys
(continued)
Rudiments A and B originated from the RHS of the body. Rudiment A was
cultured without PDBu and rudiment B was cultured with 10nM PDBu for 48
hours. Rudiments C and D originated from the LHS of the body. Rudiment C
was cultured with 20nM, and rudiment D with 200nM PDBu for 48 hours. The
images were generated from FITC (anti-laminin) and Texas Red (anti-
caibindin) fluorescent signals using laser-scanning confocal microscopy.
Magnification is 6.3X and the scale bar represents 250 microns.
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Figure 6.4.2 Invitro affect of PDBu on the development of kidneys
(Continued over page)
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Figure 6.4.2 In vitro affect of PDBu on the development of kidneys
Rudiments A (from the RHS) and B (from the LHS of the body) were cultured
without PDBu, rudiments C (from the RHS) and D (from the LHS) were
cultured in the presence of 20nM PDBu, for 48 hours. The images were
generated by laser-scanning confocal microscopy as in figure 6.4.1.
Magnification is 6.3X and the scale bar represents 250 microns.
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Figure 6.4.3 Invitro affect of PDBu on the development of Sd+ kidneys
Rudiments A (from the RHS) and B (from the LHS of the body) were cultured
in the presence of 100nM PDBu, rudiments C (from the RHS) and D (from
the LHS of the body) were cultured in the presence of 200nM PDBu, for 48
hours. The images were generated by laser-scanning confocal microscopy
as in figure 6.4.1. Magnification is 6.3X and the scale bar represents 250
microns.
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Figure 6.4.4 PDBu affect on the in vitro development of kidneys
Rudiments A and B were cultured without PDBu. Rudiment C was cultured
with 20nM PDBu and rudiment D with 100nM PDBu, for 48 hours. The
images were generated by laser-scanning confocal microscopy, as in figure
6.4.3. Magnification is 6.3X and the scale bar represents 250 microns.
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Rudiments C (RHS of origin) and D (LHS of origin), from homozygous
mutants, were cultured in the presence of 20nM and 100nM PDBu,
respectively, for 48 hours. From the severely retarded development of both
rudiments, and from the similarity they bear to the control rudiments A and B,
it is evident that PDBu is not able to induce branching morphogenesis.
6.4.2 Discussion
Protein kinase C (PKC) activation, by PDBu, was not able to induce
branching morphogenesis in Sd rudiments, in the concentration range (10-
200nM) used. Due to the inhibitory affect which phorbol esters are known to
have on PKC, over extended periods of time, it cannot be ruled out that
PDBu was acting to inhibit PKC over the 48 hour culture period. Culturing
WT rudiments, for 48 hours in different concentrations of PDBu (figure 6.4.1),
appeared not to affect WT development, this does not exclude the possibility,
however, that PDBu failed to induce branching morphogenesis because it
was inhibiting, and not activating, PKC over the culture period used.
The inhibition and activation of PKC has been reported to have different
affects on renal morphogenesis depending on the biological assay used. In
collagen type l-seeded MDCK cells, the branching activity of HGF is reported
to be enhanced by inhibitors of PKC, suggesting that PKC activity may
negatively modulate HGF-induced branching and tubulogenic processes in
this system (Santos et at., 1993). Because Sd rudiments were cultured in the
absence of an appropriate positive control, such as the use of sodium
chlorate branch-inhibited rudiments, it was not possible to define the degree
to which PDBu was activating or inhibiting PKC. If it was inhibiting PKC, and
if these two systems were considered to be analogous, one might expect to
see an increase in ureteric branching. Recent data does exist to suggest,
however, that the MDCK system and the rudiment culture assay are not
strictly comparable systems. In the development of wild type rudiments
cultured in the presence of sodium chlorate, PKC activation by phorbol 12-
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myristate acetate (PMA) was reported to partially restore the branching
ability of chlorate-inhibited ureteric bud (Davies et al., 1995). The
development of PMA-induced swellings, indicative of branch initiation, that
were seen in these cultures were not evident in Sd rudiments cultured in the
presence of PDBu, despite the fact that both chlorate-inhibited rudiments
and Sd kidneys fail to develop primarily through the failure of the ureteric bud
to branch normally. Thus, simple conclusions cannot be drawn from either
system as to why PDBu failed to induce branching morphogenesis in Sd
kidneys. The Sd mutation may affect a signal transduction pathway which
does not result in the activation of PKC, alternatively, it could affect the
mesenchymal derived signal itself or the ureteric receptor upon which the
signal acts.
Of interest was the finding that mice heterozygous for the Sd mutation share
a common phenotypic feature, where the kidney originating from the left side
of the body was frequently more severely affected by the mutation than the
kidney originating from the right side. From table 3.3.1 it can be seen that
only 5 wild type mice from the backcross had a RHS kidney which was
bigger than the LHS one, compared to 73 heterozygous mice. This indicates
that the degree of asymmetry seen in the renal development of heterozygous
Sc/mice is higher than that seen in the wild type population. This feature has
been previously reported (Glueckson-Schoenheimer, 1943; Mesrobian and
Sulik, 1992).
Whilst the action of modifying genes could explain renal phenotypic variation
between individuals in a backcross population, such a genetic action would
not explain the asymmetrical development of kidneys arising from a single
mouse which are genotypically identical. However, left-right asymmetries are
common in vertebrates. The consistent handedness of left-right asymmetric
organs relative to the dorsoventral and anteroposterior axis is evolutionarily
conserved. For example, the heart tube loops to the right in all chordates
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(Yost, 1995). A number of mouse mutations exist which alter the
development of left-right asymmetric organs, such as iv (Hummel and
Chapman, 1959), in which 50% of the offspring are phenotypically situs
invertus, and /'nv (Yokoyama et al., 1993), in which 100% of the offspring are
situs invertus, with respect to the left-right axis. These mutations strongly
suggest that left-right asymmetry has an underlying genetic basis. Recently,
a number of RNAs, including those for sonic hedgehog and acitvin, were
found to be asymmetrically distributed along the left-right axis in chick
embryos, during gastrulation and neurula stages (Levin et al., 1995), strongly
implicating these genes in the establishment of left-right asymmetry. It is
therefore possible that the asymmetry seen in Sd mice, in the development
of their kidneys, could be due to alterations in gene expression and RNA
distribution brought about by the loss of the Sd gene product. The possibility
that Sd might be a gain of function mutation can also not be excluded, and
as such, its misexpression or inappropriate biological activity could also
underlie renal left-right asymmetry. Until the Sd gene itself is identified the
question of this asymmetry in Sd mice will be difficult to investigate further.
In conclusion, this study has shown that mutant metanephric mesenchyme is
able to respond to ureteric branching by undergoing condensation and
nephrogenesis. This suggests that whilst we do not know the biological
function of Sd, it is likely that the ability of the mesenchyme to respond to
ureteric inductive signals is unaltered by the mutation, and that upon
branching, the ureteric bud is still able to induce the mesenchyme to
respond. Hepatocyte growth factor and the protein kinase C activator, beta-
phorbol-12, 13-dibutyrate, have been shown to be unable to induce in vitro
branching morphogenesis in mutant kidney rudiments.
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Chapter 7: Future Work
Since a discussion of results has been presented at the end of each results
section, this chapter will focus on plans for future work.
The primary objective is to isolate the gene for Sd using a positional cloning
strategy. The rate-limiting step in positional cloning is the identification and
characterisation of genes in a genomic region, thus, it is important that the
region of linkage has been well defined by mapping, and a number of
strategies are available for the isolation of candidate transcripts. Since the
physical size of the region in the vicinity of Sd remains unknown, it is
possible that an additional backcross may need to be set up if this region is
large (>1Mb). If additional backcrosses are needed, the mouse species of
choice for the backcross could be the Mus musculus sub-species
M.m.molossinus. The advantage of using M.m.molossinus over Mus spretus
would be that F1 mice of both sexes are fertile. This allows the quicker
accumulation of informative recombinants. In addition, it is thought that
recombinants in a backcross can cluster in a particular region, thus by using
a different strain or subspecies of mouse it may be possible to avoid clusters
in the same regions. Furthermore, markers that were not informative in one
strain may be informative in another.
Genes can be isolated from a specific region of mammalian genomic DNA by
a number of methods. These include the identification of CpG islands as
potential sign posts for the ends of 50% of transcription units (Lavia et al.,
1987) and the use of "zoo blots" to detect cross-species conservation of
genomic sequences (Rommens et al., 1989). Random cloning of genomic
segments, followed by sequence analysis, can also be used where mapping
studies have defined a candidate interval (Flarshman et al., 1995). More
technically sophisticated methods include the use of exon trapping
techniques, to capture expressed sequences from large genomic regions
(Duyk et al., 1990), and the screening of cDNA libraries with complex probes
(Lovett et al., 1991). The degree of success in a positional cloning strategy
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may depend upon the combined use of a number of these techniques, since
each method has inherent problems (Harshman et al., 1995). For example,
exon trapping increases the likelihood of isolating genes composed of a
number of exons, whilst decreasing the chances of identifying those
composed of a few exons, and, depending on the vector, is unable to trap
genes with only one or two exons. Nevertheless, exon trapping alone has
proved to be efficient in the identification of novel genes, as in the cloning of
the obese (ob) gene in the mouse (Zhang et al., 1994). It is likely that a
number of these strategies will be used in the Sd project.
As Sd is flanked on only one side by close polymorphic markers, it will be
necessary to delineate close recombinants on the other side in order to
define a candidate interval. To do this, YAC libraries will be screened with
the YAC end fragment marker, LnlLAT. This marker is non-recombinant with
Sd in the backcross making it the closest marker to Sd that has been
isolated to date. YACs identified with this marker will be used to generate
end fragments, which will in turn be mapped onto the backcross. Once a
region of the contig has been identified which crosses recombinants either
side of Sd, it will be possible to determine which YAC (or YACs) contain Sd.
Markers generated from this YAC can be used in the screening of mouse P1
(Pierce et al., 1992) or BAC (bacterial artificial chromosome) (Shizuya et al.,
1992) libraries. The advantage of using these cloning vectors over YACs is
that they have a reasonable insert size (an average of 150kb for BACs and
85kb for P1s), without the problems of insert instability and chimerism
common to YACs.
Once an interval has been established, YAC or P1 clones positive for Sd will
be analysed by restriction digestion to identify rare cutter sites (such as A/ot1)
which are indicative of the presence of CpG islands, and to generate
physical maps of the inserts. YAC and P1 clones will also be subjected to
exon trap analysis, for this a recently described phage vector 1GET (Nehls et
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al., 1994) will be used. This vector accommodates 6.5-19kb of DNA and
allows inserts to be automatically subcloned as multi-copy plasmids
containing splice donor and acceptor sites which flank the genomic insert.
Transfection of COS cells with this plasmid allows exons within the coding
region to be in vivo processed, or "trapped". In addition, cDNA selection can
be used to enrich for cDNAs which are encoded in the region of Sd. This can
be done by hybridising a library of cDNA's (for example from a mouse foetal
kidney library) to an immobilised YAC or P1 clone (Lovett et al., 1991). It is
also possible to carry out cDNA selection without first purifying YAC DNA
from total yeast DNA, which makes the technique simpler and faster to use
(Parimoo et al., 1993). Once candidate transcripts have been isolated and
sequenced, database searches will identify transcripts which have already
been isolated and cloned. Some of these may be genes whose expression
and function is well established. Matches will also be expected to ESTs
(expressed sequence tags), which are the result of large scale random cDNA
sequencing projects. Expression patterns for ESTs are not usually known.
The expression of ESTs and novel transcripts during development could be
studied using in situ and RT-PCR techniques.
The size of the Sd transcript will determine the approach to mutation
analysis. In the event of the transcript being particularly large, direct
sequencing of the region would not be practical. An alternative approach
would be to PCR-amplify smaller fragments from the region (1-1.5kb) and
use these in the detection of mismatched heteroduplexes of mutant versus
wild type DNA. Since DNA from the original strain on which Sd arose is not
available for the wild type control, a number of different wild type DNAs
would need to be used in its place. Heteroduplexes formed between wild
type and mutant cDNA, identify regions of interest for direct analysis by
sequencing. Alterations in the mutant sequence will need to be analysed in a
number of inbred strains to ensure that a polymorphism is not mistaken for
the mutation. In the absence of any obvious structural changes to the coding
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sequence, such as a frame shift causing a premature stop codon, transgenic
methods could be used to confirm the identification of the mutation. If the
introduction of an Sd transgene into mutant mice were to rescue the
phenotype, it would indicate that Sd is a loss of function mutation which
arises through haploinsufficiency. If the phenotype fails to be rescued it could
indicate one of two possibilities: i) that the mutant transcript identified is not
Sd, or ii) that Sd is a gain of function mutation.
Based on the present knowledge of the mutation, it is difficult to predict the
nature or biological function of the Sdgene. The semi-dominant mode of the
inheritance of Sd suggests that it could be a loss of function mutation. If this
were so, one would expect to find the gene normally expressed in the
developing kidney and notochord/neural tube, where the loss of its function
would most severely impair development. In these systems, Sd could act as
a regulator of transcription or as a component of an intracellular signalling
pathway. Interestingly, no other alleles of Sd have been identified, and
despite its easily recognisable phenotype, neither chemical nor radiation-
induced mutagenesis programs have identified a mutation with a similar
phenotype, although this could be because tail mutations are commonly
generated and not always tested, or because Sd represents a "mild" allele,
the complete loss of which could be lethal in heterozygotes. The possibility
nevertheless exists that Sd may not be a loss of function, but a gain of
function mutation. Gain of function mutations are less common in mice than
loss of function mutations, but several are known to exist. One such mutation
is disorganization (Ds), which causes a wide range of sporadic
developmental anomalies including supernumerary limbs, body wall defects
and abnormalities of the viscera (Crosby et al., 1992). The Ds locus exhibits
low pleiotropism, low penetrance and variable expressivity. Although the
locus has yet to be cloned, it was found to be a gain of function mutation
when trisomic fetuses had the same phenotype as heterozygote and
homozygote Ds mice (Crosby et al., 1992). The question then arises as to
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what mechanism could Sd be a gain of function mutation, when it is inherited
in a semi-dominant manner? A semi-dominant pattern of inheritance
suggests that reduced gene dosage is responsible for the mutant phenotype,
a mechanism which is usually associated with loss of function mutations.
Increased gene dosage, ectopic or temporally altered mRNA expression,
increased or constitutive protein activity, and novel protein functions are
mechanisms which are all associated with gain of function mutations (Wilkie,
1994). It is possible that the Sd gene product assumes a novel function in
mutant mice which alters the transcriptional control or expression of other
genes. A secondary effect such as this may be responsible for a semi-
dominant phenotype, since in the presence of one unaffected allele, there
may be sufficient wild type activity to allow the partial functioning of genes
downstream of Sd. However, alterations in protein function are often
deleterious to survival.
A key objective in cloning the Sd gene is to investigate its involvement in
human neural tube and renal disorders. Towards this end, a collaboration
has been set up with Phillip Cox at the pathology department of the
Hammersmith Hospital, London. Dr. Cox has assembled a database of foetal
post mortems which have occurred over the past ten years. There are
numerous incidences of renal malformations occurring concurrently with
neural tube defects, and tissue samples would be available for each case in
the database. This offers a valuable opportunity for future work on the Sd
gene, to define a possible role in humans. Providing tissue samples which
are paraffin embedded have been carefully prepared, DNA could be
extracted from them to investigate whether Sd is altered in those cases with
neural tube and renal defects. Tissue samples which are fresh or which have
been stored in liquid nitrogen may also become available for analysis.
A more immediate plan for future work, in addition to the positional cloning
project, is to further investigate the in vitro development of Sd kidneys using
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the organ culture assay. It would be interesting to repeat the tissue
combination assays performed by Gluecksohn-Waelsch and Rota (1963)
(section 1.2), using defined media and laser scanning confocal microscopy.
By enzymatically separating mutant ureteric bud from its surrounding
metanephric mesenchyme, and culturing each tissue in combination with wild
type and mutant inducers, it may be possible to clarify which aspect of the
reciprocal induction process is affected by the mutation. An analysis of
ureteric markers in Sd kidneys, such as c-ret and c-ros, would also be of
interest, to investigate whether the mutation affects their expression. In
addition, a transgenic mouse has recently been generated at the Human
Genetics Unit which expresses the Lac-Z gene under the control of a WT1
promoter (A.Schedl, personal communication). By crossing Sd mice with the
WT1-LacZ mouse it would be possible to make a detailed analysis of any
alterations in WT1 exp/ession brought about by the mutation. Since WT1 is
known to be active in both kidney development and the development of the
myotome (Miyagawa et al., 1994), it is likely that its expression will be altered
in the Sd mouse. Such a study could provide valuable information
concerning the way in which the Sd and WT1 genes interact during
development, and ultimately it may be possible to extend this type of
analysis to identify other gene acting downstream of Sd.
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Data for maximum likelihood analysis of chromosome 10 mapping data from











-0.0815 0.3133 -0.178 0.286 96.97 108.7 7.53801
-0.0820 0.3193 -0.105 0.309 96.79 108.7 7.66066
-0.0825 0.3269 -0.008 0.335 96.49 108.7 7.86558
-0.0829 0.3365 0.119 0.363 96.04 108.7 8.17416
-0.0833 0.3482 0.280 0.393 95.37 108.7 8.6363
-0.0836 0.3620 0.474 0.421 0.421 108.7 9.27619
-0.0836 0.3767 0.689 0.444 93.28 108.7 10.099
-0.0833 0.3903 0.897 0.460 91.96 108.7 11.0398
-0.0827 0.4002 1.059 0.463 90.67 108.7 11.9724
-0.0818 0.4043 1.144 0.454 89.64 108.7 12.7266
-0.0808 0.4024 1.144 0.435 89.00 108.7 13.1996
-0.0799 0.3961 1.078 0.410 88.77 108.7 13.3704
-0.0791 0.3873 0.973 0.382 88.85 108.7 13.311
-0.0785 0.3778 0.854 0.353 89.12 108.7 13.1107
-0.0816 0.4158 0.229 0.325 89.73 108.7 12.6604
-0.0820 0.4208 0.339 0.368 89.53 108.7 12.8077
-0.0825 0.4261 0.465 0.418 89.37 108.7 12.9257
-0.0830 0.4303 0.587 0.472 89.31 108.7 12.9701
-0.0834 0.4309 0.654 0.520 89.50 108.7 12.8298
-0.0836 0.4252 0.601 0.546 90.02 108.7 12.4474
-0.0833 0.4139 0.416 0.539 90.77 108.7 11.8997
-0.0827 0.4011 0.176 0.501 91.47 108.7 11.3925
-0.0820 0.3908 0.036 0.451 91.95 108.7 11.047
-0.0828 0.3635 0.629 0.400 92.97 108.7 10.3188
-0.0834 0.3638 0.741 0.470 93.39 108.7 10.0212
-0.0840 0.3611 0.808 0.555 94.13 108.7 9.50023
-0.0846 0.3524 0.725 0.645 95.26 108.7 8.71248
-0.0847 0.3363 0.373 0.706 96.53 108.7 7.83822
-0.0841 0.3189 0.172 0.700 97.24 108.7 7.35446
Appendix B
Data for maximum likelihood analysis of chromosome 10 mapping data from











-0.0873 0.0458 -0.240 0.233 28.50 29.56 2.34722
-0.0864 0.0460 -0.269 0.269 28.49 29.56 2.36977
-0.0854 0.0463 -0.296 0.309 28.49 29.56 2.36977
-0.0850 0.0466 -0.307 0.342 28.50 29.56 2.34722
-0.0856 0.0468 -0.283 0.354 28.53 29.56 2.27959
-0.0873 0.0467 -0.228 0.336 28.56 29.56 2.21204
-0.0891 0.0465 -0.171 0.300 28.58 29.56 2.16705
-0.0905 0.0462 -0.130 0.260 28.59 29.56 2.14456
-0.0839 0.0467 0.094 0.237 28.76 29.56 1.7635
-0.0841 0.0468 0.110 0.271 28.78 29.56 1.71882
-0.0835 0.0470 0.0470 0.109 0.304 29.56 1.67417
-0.0820 0.0470 0.078 0.324 28.84 29.56 1.58496
-0.0797 0.0468 0.021 0.320 28.87 29.56 1.51813
-0.0778 0.0465 -0.040 0.296 28.89 29.56 1.47362
-0.0765 0.0462 -0.084 0.262 28.89 29.56 1.47362
-0.0572 0.0460 0.221 0.185 28.85 29.56 1.56267
-0.0590 0.0462 0.263 0.205 28.81 29.56 1.65185
-0.0609 0.0464 0.308 0.227 28.77 29.56 1.74116
-0.0625 0.0466 0.352 0.249 28.74 29.56 1.80821
-0.0632 0.0468 0.382 0.270 28.75 29.56 1.78585
-0.0624 0.0469 0.383 0.283 28.80 29.56 1.67417
-0.0598 0.0468 0.346 0.284 28.90 29.56 1.45137
-0.0561 0.0466 0.280 0.275 29.02 29.56 1.18504
-0.0522 0.0463 0.204 0.256 29.13 29.56 0.941864
-0.0489 0.0461 0.135 0.235 29.22 29.56 0.743584
-0.0464 0.0458 0.080 0.213 29.27 29.56 0.633693
Appendix C
Mann Whitney U Test (Mann and Whitney, 1947)
The following formulae were used:
U1 = n,n2 + [n, (n1 + 1) / 2] - R,
Where: n, = the number of cases in the smaller group
n2 = the number of cases in the larger group
R, = the sum of the ranks assigned to the group of size n,
U2 = n1n2- U,
The smallest of U, and U2 was denoted by U. The significance level associated
with U was looked up in the table appropriate for the values of n, and n2.
Appendix D
F Test Calculation
The F test used in chapter 5 was calculated by A. Carrothers at the MRC
Human Genetics Unit Edinburgh. The Minitab statistical program (Minitab Inc.)
was used to calculate standard deviations.
Values used in the calculation of the F test were as follows:
Mean tail Standard
Phenotype Number length (cm) deviation
Sd 147 1.881 0.9755
WT 144 6.975 0.6091
All 291 2.678 2.6779
The data is given in rows. Only 291 mice were used for this calculation as the
backcross was not complete when this analysis was performed.
The significance value was calculated by squaring the ratio of the standard
deviations for the WT and Sd+ mice. From this calculation the value of 2.56
was obtained. With 146 and 143 degrees of freedom this gave a probability
value of p < 0.001.
Appendix E
The percentage contribution which the chromosome 10 modifier loci has on overall
tail length variation was assessed by calculating the effect that the loci has on the
mean tail length.
% of the mean = additive effect at maximum point / mean for Sdtail lengths
= (0.3961 / 1.87) x 100 = 21.1%
% of the mean = 21.1%
[see appendix A for additive effect at maximum point]
